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Kupu whakataki | Foreword 
The Health Quality & Safety Commission (the Commission) welcomes the 13th report of the Perinatal and 
Maternal Mortality Review Committee (the PMMRC). This report focuses on the epidemiology of perinatal 
mortality from 2007 to 2017, maternal mortality from 2006 to 2016, babies with neonatal encephalopathy 
from 2010 to 2017, and perinatal and maternal mortality and morbidity for the 2017 calendar year. 
The PMMRC has again provided us with a rigorous and carefully considered report. I would like to 
acknowledge the substantial amount of work by the Chair, Mr John Tait, and the PMMRC, and their 
determination to improve the quality of maternal and perinatal care. 
I am pleased to learn that the rate of stillbirth has significantly decreased for the period 2007–2017 for 
babies of both New Zealand European and Māori mothers. Unfortunately, this decrease has not occurred in 
people of other ethnicities. Rates of perinatal mortality, perinatal related mortality and fetal death have 
reduced since 2007 for babies of New Zealand European mothers, but there has been no change in these 
measures for other ethnic groups. 
All of us who work in the health sector are responsible for addressing this gap in equity. We need first to 
understand the differences and the various reasons for these, and then work to redesign our systems to 
eliminate preventable harm in ways that prioritise the most vulnerable. The Commission’s priority is to shine 
a light on potential opportunities to advance Māori health outcomes in particular, and outcomes that are 
both excellent and equitable for everyone, more generally. 
I fully support the PMMRC’s vision to promote the recommendations of this report and to follow up and 
better understand the impact of its previous recommendations. We owe this to the women, babies and their 
whānau at the centre of this report. 
This report would not be possible with the substantial contribution of a dedicated team of people: the local 
coordinators across Aotearoa/New Zealand who provide the data; Mr John Tait and the PMMRC members; 
the National Coordination Service at Auckland UniServices; the New Zealand Mortality Review Data Group, 
the epidemiology team at Otago University; and the mortality review committees’ secretariat staff at the 
Health Quality & Safety Commission. My sincere thanks goes to you all as you influence system change 
and improvement across our perinatal and maternity services. 
Professor Alan Merry ONZM FRSNZ 
Chair, Health Quality & Safety Commission 
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Te kupu whakataki a te manukura | Chair’s introduction – Mr John Tait 
I am honoured to present the 13th Annual Report of the Perinatal and Maternal Mortality Review 
Committee (the PMMRC). 
I would firstly like to acknowledge the mothers and babies whose lives have been lost, and the families and 
whānau who bear the grief of losing their loved ones. It is their stories that allow us to strive for and 
promote system change to reduce preventable death and deliver greater equity in perinatal and maternal 
outcomes. Our data show that systems change for Māori mothers and babies and their whānau is urgent. 
Therefore, it is my privilege to be the new Chair of the PMMRC and lead this incredibly vital work. 
I would like to thank the members of the PMMRC for their ongoing valuable contribution and commitment to 
improving the outcomes of mothers and babies here in Aotearoa/New Zealand. With three new members, 
we have increased our expertise in maternity services, Māori health, racial inequality and racism in health, 
and the importance of data governance and sovereignty. Equally, I would like to acknowledge the 
monumental work of local coordinators who work with the families and whānau and bring together their 
experiences. Without your dedication, the work of the PMMRC would not be possible. 
With a new Chair and new members, the PMMRC has taken this opportunity to re-establish ourselves and 
further examine areas where change might be required. It is central to the approach of the PMMRC to 
highlight inequities evident in maternity services and provide recommendations that can be implemented by 
the people who are able to directly effect change. 
Our new vision and approach for working together across the system prioritises working with bereaved 
families and whānau, health professionals, policy makers and researchers, with the aim to have greater 
influence on policy decisions. 
Te mahi tahi puta noa i te pūnaha 
kia kore rawa ai e mate, e whara ngā māmā me ā rātau 
pēpi, whānau hoki mai i ngā mate, wharanga rānei ka taea te ārai. 
Working together across the system towards zero preventable deaths or harm for all mothers and 
babies, families and whānau. 
The 13th PMMRC report investigates the epidemiology of perinatal mortality, maternal mortality and 
neonatal encephalopathy. The rate of stillbirth in Aotearoa/New Zealand has reduced significantly since 
2007. There has been a reduction of stillborn babies of Māori and New Zealand European mothers; 
however, this is not the case for other ethnic groups, particularly for babies of Indian women. 
There was also some evidence of a decrease in the rate of perinatal mortality, yet this was driven by a 
decrease in deaths in babies of New Zealand European mothers, with no changes in any other ethnic 
groups. 
Disproportionately, babies of mothers under 20 years of age have higher mortality than most other age 
groups, as well as Māori women living in New Zealand Index of Deprivation 2013 (NZDep2013) decile 10 
areas (the most deprived tenth of the population) experiencing the greatest loss from perinatal related 
deaths. 
The leading cause of perinatal related death continues to be congenital abnormality, followed by 
spontaneous preterm delivery. It is also unacceptable that suicide is the leading cause of maternal death 
and is substantially higher than the United Kingdom rate. 
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We therefore believe the implementation of our recommendations, alongside the monitoring of previous 
report recommendations, warrant the system changes required to ensure high quality, appropriate and 
equitable care for all. 
This report clearly demonstrates the need to increase our understanding, and research, of the reasons for 
adverse outcomes in certain groups. The PMMRC recognises the need to co-develop and implement 
models of care that meet the needs of mothers, through information, support and care, that are acceptable 
to her. It is important that DHBs monitor key indicators by ethnicity to identify variations in outcome and 
develop national guidelines for the provision of care of mothers and infants. As a matter of urgency, 
improvement to the quality of ethnicity data in the National Maternity Collection is needed. 
The PMMRC is also delighted to now include the Maternal Morbidity Working Group as a new morbidity 
subcommittee under the PMMRC. In achieving our vision, it was important to the PMMRC to continue the 
work of the Maternal Morbidity Working Group following the end of its time-limited contract with the Ministry 
of Health. The new subcommittee will continue to address systemic factors that may contribute to the 
severity of the illness, and opportunities for improvement. 
It is a privilege to present this report to you. 
John Tait 
Chair, Perinatal and Maternal Mortality Review Committee 
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Ngā mātua, ngā whānau me ngā hapori | Parents, whānau, families, 
communities 
Tuia i runga, tuia i raro, tuia i roto, tuia i waho, tuia te here tāngata e pae nei, tēnā koutou, tēnā koutou, 
tēnā koutou katoa – I thread together the forces from above, from below, from within and from what 
surrounds us, to bind all of us together – I greet you all. 
Once again it is my honour to stand on behalf of bereaved parents, families and whānau as a member of 
the PMMRC. My name is Lisa Paraku, and I hail from the beautiful Coromandel. My daughter Jasmine Lee, 
born beautiful and still, her five siblings who died in early pregnancy and their two brothers who live bring 
me to the PMMRC so that together we can work towards our purpose, working together across the system 
towards zero preventable deaths or harm for all mothers and babies, families and whānau. Te mahi tahi 
puta noa i te pūnaha kia kore rawa ai e mate, e whara ngā māmā me ā rātau pēpi, whānau hoki mai i ngā 
mate, wharanga rānei ka taea te ārai. 
To my fellow bereaved parents and whānau, can I offer the following mihi (greeting) to you: 
Me mihi aroha nui ki a koe me to whānau whānui, my love to you and to your entire family. 
E ngā pēpē, moe mai rā. Ki ngā huia kaimanawa kua ngaro ki te pō, moe mai koutou. 
To our precious ones who have disappeared into the night, rest in peace. I acknowledge our precious 
babies, our grief and our journey. 
As a proud wāhine Māori māmā I stand strong in support of equitable outcomes for all, a key focus for us 
at the PMMRC and for our recommendations to our health system. It is time for all of us to be brave and 
create a system that can serve all peoples, where, when and how they need it. 
I am heartened by the mahi (work) being done, and there is more to be done. You will see in our 
recommendations a consistent message for equitable outcomes for all. It remains a priority that we 
continue to educate ourselves in the ways of our priority populations – Māori, Pacific, Indian peoples and 
our young mothers – so that where we sit is not what we see but in fact we can move seats and see and 
serve a different worldview. 
For our bereaved parents, families and whānau we are pleading for national perinatal bereavement 
pathways in the hope that our grief journey can be as gentle as it can be. Within our report you will see our 
challenge to provide the same level of care, anywhere, anytime, for anyone as the driver for a number of 
specific recommendations. 
I would also like to take this opportunity to acknowledge my Sands NZ and Baby Loss NZ rōpū (groups). 
These peer-to-peer support groups are often the only service available to parents and families in their 
communities when our babies have died. Health professionals regularly refer bereaved parents to Sands, a 
voluntary, non-funded group (as is Baby Loss NZ) who are doing their best to provide as much support to 
an under-supported section of our population. In a recent survey of Sands bereaved parents, it was noted 
that overall support from health professionals was good – however, it is important to note that midwives are 
often not trained nor funded to provide support following the death of a baby, and many provide care in 
their own time as an extra service to our bereaved parents, families and whānau. To all of those who serve 
us, I thank you and I extend the wero (challenge) to our health system to recognise and provide more 
support to these rōpū, which are so very needed. 
Mahi is being done between these groups and government at an inter-agency level to work towards better 
outcomes based upon a ‘whānau pani model’, placing parents at the centre and having levels of care 
emulating from there. In essence, focusing on a wrap-around of aroha (love) to our bereaved parents. For 
all those involved, I salute you. The PMMRC mahi has identified improvements needed, and these are 
some of the groups standing up to do the mahi. After all, ‘he waka eke noa’ – we are all in this together! 
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E hoa mā, he kaupapa nui tēnei. My friends, this is such an important kaupapa for us all. To my fellow 
PMMRC whānau, e mihi nunui ki a koutou, many thanks for what you do. This is heavy mahi and mahi that 
must be done to improve our system, prevent our babies and mothers dying where we can, and create a 
gentle path when we must walk the path that nobody ever wants to walk, when our loved ones do die. You 
do this mahi with grace – I acknowledge you and on behalf, I thank you. 
Let me share my wish to us all in a section of karakia from my people: 
E whakamoemiti ana mō tēnei rā 
Hei tiritiri mō tātou katoa, mō tātou wairua te hanga tangata kotahi, kia mahitahi ai mō te ao hou tino pai 
rawa. 
We give thanks for this day, we will share our views without anger, build our friendships and work 
together for a better world. 
Ahakoa he mihi poto tēnei, he mihi aroha. Nō reira, tēnā koutou, tēnā koutou, tēnā tātou katoa – Although 
this greeting is short, it is from the heart with love. Therefore, greetings to us all. 
Nāku iti noa, nā, 
Lisa Paraku 
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Ngā kitenga matua mai i te pūrongo ā-tau 13 o te PMMRC | Key findings 
from the PMMRC’s 13th annual report 
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Whakarāpopototanga matua | Executive summary 
This report outlines some of the trends in mortality in babies and mothers, and serious morbidity from 
neonatal encephalopathy. Deaths are usually multifactorial in nature – usually not just one thing causes a 
death. The aim of this work is to monitor trends and look at systems issues that could be modified to 
prevent future deaths. To do this, good information is vital. For this reason, the PMMRC is recommending 
that our routinely collected data systems are improved to better capture information on risk factors for all 
pregnant women and to ensure that our ethnicity data are accurate and complete. The PMMRC is also 
recommending some areas for further research, as there are still many unanswered questions about 
factors that might contribute to a death, particularly for some population groups. In addition, we need to 
develop models of care that better meet the needs of the mothers, babies, and whānau, families and 
communities that we serve. 
Definitions used by the PMMRC 
(Adapted from New Zealand Health Information Service 2007 and Ministry of Health 2010.) 
Perinatal mortality 
Since 2007, when the PMMRC began collecting data, there has not been a significant reduction in deaths 
overall. However, there was a decrease in the rate of stillbirths. This was largely driven by a reduction in 
stillbirths in babies of Māori and New Zealand European women; there was no significant change in any 
other ethnic group.  
There was a significant decrease in perinatal mortalities (fetal and early neonatal deaths) seen in babies of 
New Zealand European mothers, but not for any other ethnic group. 
There were no statistically significant changes in rates for neonatal mortality overall; however, there was a 
significant increase in deaths in babies of Pacific women.  
Deaths due to congenital abnormalities remain the leading cause of death overall. 
Our results show that there are groups at higher risk of serious adverse outcomes; these include babies of 
Māori, Pacific and Indian mothers, and babies of mothers aged less than 20 years, with some increase in 
mortality for those aged 40 years and over.  
Mortality rates varied significantly by area deprivation, as measured by the New Zealand Index of 
Deprivation 2013 (NZDep2013). Those mothers living in the most deprived areas (quintile 5) were 
statistically significantly more likely to lose a baby from stillbirth, neonatal death, and overall, compared with 
those living in any other quintile. This variation in mortality rates by deprivation was most marked for deaths 
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Our data suggest that the National Maternity Collection (MAT) data set2 provides an underestimate of 
maternal body mass index (BMI). However, regardless of whether MAT or PMMRC data are used, there is 
a clear increase in mortality from stillbirths, neonatal deaths and perinatal related deaths overall with 
increasing maternal BMI. 
Mortality from stillbirths, neonatal deaths and perinatal related deaths (total) were higher in women who 
were smoking at the time of registration with a lead maternity carer (LMC) compared with those who were 
not. Given the significance of smoking as a risk factor, the clear improvement in outcomes when women 
are able to quit, and that effective smoking cessation programmes do exist, resource should be invested in 
reducing this modifiable risk factor.   
Small for gestational age babies have higher mortality than those who are appropriate, or large for 
gestational age. In particular, babies with a birthweight in the 5th customised centile or below have 
substantially higher mortality rates than all other groups. 
Overall, approximately half of babies who died had optimal investigation into the cause(s) of their death, 
defined here as post-mortem or karyotype confirming chromosomal abnormality or clinical 
examination/investigation confirming the diagnosis. This was higher for terminations of pregnancy and 
stillbirths, and less for neonatal deaths. There were some variations in both the rate of offering of post-
mortem and the rate of uptake if offered, by prioritised ethnic group. 
Local review of cases showed there were a number of deaths that had potentially avoidable aspects. 
Contributory factors were thought to be present in just under one third of perinatal related deaths (excluding 
termination of pregnancy). Contributory factors were characterised by organisational and/or management 
factors, personnel factors, and barriers to access. Of these, barriers to access was the most common 
contributory factor cited. 
Neontal encephalopathy 
Neonatal encephalopathy (NE) is a clinically defined syndrome of disturbed neurological function within the 
first week after birth in an infant born from 35 weeks’ gestation, manifested by difficulty in initiating and 
maintaining respiration, depression of tone and reflexes, subnormal level of consciousness and often 
seizures. 
The rate of NE cases per 1,000 term births fluctuated from year to year, with a high of 1.38 per 1,000 live 
births in 2012 and a low of 1.00 in 2014. However, between the years 2010 and 2017, the rate has not 
shown a statistically significant trend up or down. 
Babies of primiparous women had the highest rates of NE, being statistically significantly higher than 
women with one, two, three or four or more babies. There was variation in the rates of NE by gestational 
age at birth, with those at the extreme ends of term pregnancies having higher rates.  
Overall, 77% of babies were cooled,3 with a slightly higher proportion of babies with moderate NE being 
cooled. The rates of cooling for babies of Māori mothers were the same as for babies of New Zealand 
European mothers. Mortality was much higher in babies with severe NE, with 61% of babies dying, 
compared with 2% of babies with moderate NE. Of those babies with NE who survived, nearly half of those 
with moderate NE had a normal physical examination on discharge or transfer, compared with 15% of 
those with severe NE.  
2 The MAT data set is the primary source of information for publicly funded maternity care in Aotearoa/New Zealand 
3 Cooling refers to therapeutic hypothermia (33.0–35.0oC) used for hypoxic ischaemic encephalopathy (HIE) of term or near-term 
newborns to reduce possible neurological handicap. (Definition taken from: Ergenekon E. 2016. Therapeutic hypothermia in 
neonatal intensive care unit: Challenges and practical points. Journal of Clinical Neurology 5(1): 8–17).  
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Maternal mortality 
Maternal death is the death of a woman while pregnant or within 42 days of termination of pregnancy 
(miscarriage, termination4 or birth), irrespective of the duration and site of the pregnancy, from any cause 
related to or aggravated by the pregnancy or its management, but not from accidental or incidental causes. 
The number of maternal deaths has fluctuated substantially over the time period 2006–2017, with a range 
from 3.3 deaths per 100,000 to 24.4 deaths per 100,000 maternities. There is some evidence of a reduction 
in the total number of maternal deaths over the time period.  
The incidence of maternal death increased with age, with those aged 40 years and over having the highest 
rate (42.2 per 100,000 maternities). Women residing in the most deprived areas (NZDep2013 quintile 5) 
had the highest rate of mortality; there was some evidence of a statistically significant association between 
risk of death and increasing deprivation (p=0.02). When examined by prioritised ethnicity, Māori women, 
until recently, had higher mortality rates than New Zealand European women. However, over the past four 
years their mortality rate has reduced and is currently similar to that for New Zealand European women. 
Over the time period 2006–2017 there is some evidence of a statistically significant reduction in deaths for 
wāhine Māori (p=0.04). 
There were 66 direct maternal and 44 indirect maternal deaths over the 12-year study period 2006–2017 
inclusive. The single largest cause of maternal death in Aotearoa/New Zealand is suicide, with 30 deaths 
during this time (45%). The next leading causes were amniotic fluid embolism and neurological conditions, 
which caused 13 deaths (11.2%) each. 
Given that suicide is the leading cause of maternal death, it is imperative that comprehensive action is 
taken. There are currently screening guidelines during the antenatal and post-natal period; however, their 
use is variable. Difficulties arise when mild to moderate illness is diagnosed, as maternal mental health 
service provision is variable within Aotearoa/New Zealand, with particularly limited resources for women 
with mild to moderate illness. A previous review of maternal suicide in wāhine Māori made a number of 
recommendations around early recognition of risk factors, comprehensive assessment and active  
follow-up.5 
While some gains have been made since 2007, further improvements must be made. PMMRC’s vision is to 
work together with mothers, families and whānau, health professionals, policymakers and researchers to 
ensure that all women have access to high quality care that meets their needs.  
4 Termination of pregnancy is the interruption of an ongoing pregnancy (whether the baby was stillborn or live born). This report 
only includes termination of pregnancy from 20 weeks’ gestation. 
5 PMMRC. 2017. Eleventh Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2015. 
URL: https://www.hqsc.govt.nz/assets/PMMRC/Publications/2017_PMMRC_Eleventh_Annual_Report.pdf (accessed 2 September 
2019). 
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1 Ngā tūtohinga | Recommendations 
Research recommendation 
1. Collectively, we need to increase our understanding of the reasons for adverse outcomes in certain
groups. For example, within Aotearoa/New Zealand and internationally, we have an incomplete
understanding of what puts women and babies of Indian ethnicity at increased risk.
Evidence
There is evidence that Indian women are at higher risk of gestational diabetes than women of other
ethnic groups. However, this does not explain all the variation in mortality for babies of Indian women.
Justification
In Aotearoa/New Zealand, babies of Indian women have the highest mortality rates for perinatal related
death and stillbirths.
Delivery of care recommendations 
2. District health boards (DHBs) should demonstrate that they have co-developed and implemented
models of care that meet the needs of mothers of Indian ethnicity.
Evidence
Babies of women of Indian ethnicity have increased mortality from stillbirth and perinatal related
mortality.
Justification
Models of care that increase acceptability of and access to services should be investigated to reduce
avoidable mortality.
3. DHBs should monitor key maternity indicators by ethnic group to identify variations in outcomes. They
should then improve areas where there are differences in outcome.
Justification
Subgroups, particularly minority groups, of the population are likely to experience worse outcomes than
others. If their outcomes are not specifically monitored, poor outcomes can go unnoticed.
Perinatal mortality and morbidity 
4. The Ministry of Health should resource, support and facilitate the development of a national guideline
for the provision of care of mothers and infants facing delivery at <25 weeks gestational age to ensure
high-quality, appropriate and equitable care for all.
Justification
Babies born at the cusp of human viability (<25 weeks gestational age) represent a unique and complex
patient group. The provision of high-quality care to mother and baby needs to be tailored to their
specific individual needs: best practice includes recognition of both palliative care and intensive care
support of the newborn.
5. The Ministry of Health should resource, support and facilitate the development of a national perinatal
bereavement pathway with key stakeholders, including governmental and non-governmental
organisations, to ensure high-quality, appropriate and equitable care for all.
Justification
Provision of bereavement care across DHBs is inconsistent for bereaved families and whānau.
Neonatal encephalopathy 
6. The PMMRC recommends that DHBs provide interdisciplinary fetal surveillance education for all
clinicians involved in intrapartum care on a triennial basis. This is to be provided free for staff and at no
cost to lead maternity carers (LMCs). The PMMRC encourages the Midwifery Council, the New Zealand
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College of Midwives (NZCOM) and Royal Australian and New Zealand College of Obstetricians and 
Gynaecologists (RANZCOG) to work with DHBs in the implementation of this recommendation. 
a. This education includes risk assessment for babies throughout pregnancy as well as intrapartum 
observations. 
b. The aims include strengthening of supervision and support to promote professional judgement, 
interdisciplinary conversations and reflective practice. 
7. All neonatal encephalopathy (NE) cases need to be considered for a Severity Assessment Code (SAC) 
rating. Neonatal hypoxic brain injury resulting in permanent brain damage (or permanent and severe 
loss of function) should be rated as SAC 1. Those who received cooling with as yet undetermined 
outcome should be rated as SAC 3.6 
Justification 
SAC reviews can be a useful tool for identifying systems issues that can be modified to reduce the 
chance of further harm. Having a third-party assessment of the quality of the review will help DHBs to 
fully utilise this opportunity for improvement. 
8. All babies with NE, regardless of severity, should have a multidisciplinary discussion about whether to 
refer to the Accident Compensation Corporation (ACC) for consideration for cover as a treatment injury, 
using ACC’s Treatment Injury Claim Lodgement Guide.7 Parents should be advised that not all 
treatment claims are accepted. 
Evidence 
Currently there is little consistency as to which babies with NE are notified to ACC for assessment of a 
treatment injury claim. 
Justification 
Quality of life for the baby and their family or whānau may differ considerably depending on whether 
their condition is covered by ACC. 
Maternal 
9. For the management of suspected ectopic pregnancies, the Perinatal and Maternal Mortality Review 
Committee (the PMMRC) recommends: 
a. DHB gynaecology services have: 
i. clear pathways/processes for primary care regarding early pregnancy management 
ii. clear hospital guidelines for assessment of the collapsed woman of reproductive age that 
include the differential diagnosis of ectopic pregnancy. Collapse due to ectopic pregnancy 
requires rapid assessment and surgical management. 
b. the Royal Australian and New Zealand College of Radiologists endorse and promote the New 
Zealand Obstetric Ultrasound Guidelines being published by the Ministry of Health that suggest 
reporting wording to include the following information: 
An ectopic pregnancy cannot be excluded on this ultrasound alone. Please interpret scan with 
βhCG [beta human chorionic gonadotropin] using advice from gynaecology service or based on 
gynaecological protocols for PUL [pregnancy of unknown location].8 
                                               
6 Health Quality & Safety Commission. 2019. Maternity Severity Assessment Code (SAC) examples 2018–19. URL: 
https://www.hqsc.govt.nz/our-programmes/adverse-events/publications-and-resources/publication/2938/ (accessed 6 August 2019). 
7 Accident Compensation Corporation. 2019. Treatment Injury Claim Lodgement Guide. URL: 
https://www.acc.co.nz/assets/provider/405074f420/treatment-injury-claim-lodgement-guide.pdf (accessed 12 August 2019). 
8 Ministry of Health. 2019. New Zealand Obstetric Ultrasound Guidelines: consultation document. URL: 
https://consult.health.govt.nz/nsu/obstetric-ultrasound-guidelines/ (accessed 14 August 2019). 
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c. primary care use gynaecology pathways and consult with gynaecology services when an ultrasound 
cannot confirm an intrauterine pregnancy to help interpret beta human chorionic gonadotropin 
(βhCG) results and scan findings and guide ongoing management. 
Justification 
Deaths due to ruptured ectopic pregnancy are highly preventable. Deaths have occurred in the 10-day 
interval between scans, and therefore current practice needs to be improved. 
Previous recommendations yet to be fully implemented 
1. As a matter of urgency, the Ministry of Health improves the completion and quality of the ethnicity data 
in the National Maternity Collection (MAT), through consistent transfer of baby ethnicity from the birth 
certificate, and the transfer of mother ethnicity from the baby’s birth certificate into MAT. 
Evidence 
During the years 2007–2017, 51% of babies in the MAT data set did not have an ethnic group recorded. 
In addition to the use of MAT for reports such as this, MAT is the primary data source used for the 
Ministry of Health’s Annual Report of Maternity.9 
Justification 
a. Ethnicity as recorded on the birth certificate is most likely to be accurate for both the baby and 
parents, as it is completed by parents. It is therefore more likely to reflect the parental self-identified 
ethnicity, and provide the best information about the baby’s ethnicity. 
b. This is consistent with the Ministry of Health’s Ethnicity Data Protocols,10 which outline the 
importance of collecting high-quality ethnicity data, the need to collect data regularly, and the 
requirement for ethnicity data to be collected directly from individuals. This is vital for the current 
government goals of reducing inequity and improving child wellbeing. 
2. As a matter of urgency, the Ministry of Health requires DHBs to provide data for women who receive 
DHB-led antenatal care, and for this to be uploaded into MAT in its entirety. 
Evidence 
Women who receive antenatal care from their DHB can differ considerably from those who receive non-
DHB LMC care. 
Justification 
In order to accurately calculate mortality rates for risk factors for different population groups, precise 
denominator data are required. 
3. Government should fund the provision of specific maternal mental health services in order to provide 
holistic screening for maternal mental illness, intimate partner violence and family violence, and provide 
appropriate services and support. 
a. For terminations of pregnancy, written discharge information should include contact information for 
support services and inform women that a follow-up visit is funded. 
Evidence 
Suicide is the leading cause of maternal death in Aotearoa/New Zealand. 
Justification 
Review of suicide deaths showed mental illness, intimate partner violence and family violence were 
frequent experiences in those women who died by suicide.11 
                                               
9 Ministry of Health. 2019. National Maternity Collection. URL: https://www.health.govt.nz/nz-health-statistics/national-collections-
and-surveys/collections/national-maternity-collection (accessed 2 September 2019). 
10 Ministry of Health. 2017. HISO 10001:2017 Ethnicity Data Protocols. URL: https://www.health.govt.nz/publication/hiso-
100012017-ethnicity-data-protocols (accessed 5 July 2019). 
11 PMMRC. 2017. Eleventh Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2015. 
URL: https://www.hqsc.govt.nz/assets/PMMRC/Publications/2017_PMMRC_Eleventh_Annual_Report.pdf (accessed 2 September 
2019). 
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4. We strongly recommend to the Government/Ministry for Primary Industries that folic acid fortification of 
bread be mandatory to reduce both mortality and serious morbidity from neural tube defects. 
Evidence 
There is strong and convincing evidence that mandatory fortification of food with folic acid unequivocally 
reduces the prevalence of neural tube defects, and the benefits of this outweigh any potential adverse 
effects.12 
Justification 
a. Congenital abnormalities, particularly neural tube defects, are a significant contributor to 
terminations of pregnancy. 
b. There is significant lifelong morbidity and mortality risk to babies from neural tube defects. 
5. Until bread and flour fortification is implemented, and as an interim measure, folic acid should be 
provided free. This is not a suitable long-term measure. Fifty percent of pregnancies are unplanned; 
therefore, this method is less effective than fortification of bread and flour. 
6. DHBs should demonstrate that they have co-developed and implemented models of care that meet the 
needs of mothers under 20 years of age. 
Evidence 
Babies of women under 20 years of age have increased mortality from stillbirth and neonatal mortality. 
Justification 




                                               
12 Office of the Prime Minister’s Chief Science Advisor and the Royal Society Te Apārangi. 2018. The health benefits and risks of 
folic acid fortification of food. URL: https://www.pmcsa.org.nz/wp-content/uploads/The-health-benefits-and-risks-of-folic-acid-
fortification-of-food.pdf (accessed 14 August 2018). 
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2 Te tikanga | Methods 
See Methods and definitions for Perinatal and Maternal Mortality Review Committee (PMMRC) reporting 
document, available at: www.hqsc.govt.nz/our-programmes/mrc/pmmrc/publications-and-
resources/publication/3823. 
Definitions used by the PMMRC 
Fetal death is the death of a fetus at 20 weeks’ gestation or beyond (≥20 weeks) or weighing at 
least 400g if gestation is unknown. Fetal death includes stillbirth and termination of pregnancy. 
Termination of pregnancy is the interruption of an ongoing pregnancy (whether the baby was 
stillborn or live born). This report only includes termination of pregnancy from 20 weeks’ 
gestation. 
Neonatal death is the death of any baby showing signs of life at 20 weeks’ gestation or beyond 
or weighing at least 400g if gestation is unknown that occurs up until midnight of the 27th day of 
life. Early neonatal death is a death that occurs up until midnight on the sixth day of life. Late 
neonatal death is a death that occurs between the seventh day and midnight of the 27th day of 
life. 
Perinatal mortality is fetal and early neonatal death from 20 weeks’ gestation (or weighing at 
least 400g if gestation is unknown) until midnight of the sixth day of life. 
Perinatal related mortality is fetal deaths (including terminations of pregnancy and stillbirths) 
and neonatal deaths (up to midnight of the 27th day of life) per 1,000 total babies born at 20 
weeks’ gestation or beyond, and weighing at least 400g if gestation was unknown. 
A maternal death is the death of a woman while pregnant or within 42 days of termination of 
pregnancy (miscarriage, termination or birth), irrespective of the duration and site of the 
pregnancy, from any cause related to or aggravated by the pregnancy or its management. It 
does not include accidental or incidental causes of death of a pregnant woman. 
Maternities are all live births and all fetal deaths at 20 weeks’ gestation or beyond or weighing 
at least 400g if gestation is unknown. The maternal mortality ratio is calculated per 100,000 
maternities. 
Neonatal encephalopathy (NE) is a clinically defined syndrome of disturbed neurological 
function within the first week of life, manifested by difficulty in initiating and maintaining 
respiration, depression of tone and reflexes, subnormal level of consciousness and often 
seizures. 
Equity analyses 
Throughout the report, comparisons are made between prioritised ethnic groups. At times, outcomes for 
babies of Māori women are compared with outcomes for babies of New Zealand European women. This is 
not to provide commentary on the deficits of a group, rather to highlight the deficits of a society that creates, 
maintains and tolerates these differences. 
Comparison between mother and baby ethnicity 
Both mother and baby ethnicity are important for reporting on mortality. As many of the determinants of 
health for a baby relate to their mother, in many instances it is appropriate to examine maternal ethnicity to 
explore areas for improvement and intervention. In addition, to examine the burden of mortality for different 
ethnic groups, it is necessary to also examine mortality by baby ethnicity, which may be different to 
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maternal ethnicity. Table 2.1 and Table 2.2 show the differences in ethnicity by different data sources. 
‘PMMRC’ data are those that are collected directly by PMMRC, through their Rapid Reporting Forms, 
following the death of a baby. Therefore, these data relate only to babies who have died (numerator). ‘MAT’ 
data are those data that are in the National Maternity Collection, which contain data on pregnancy, delivery 
and babies. This source includes data on most babies born in Aotearoa/New Zealand (denominator 
population). Table 2.1 shows that for maternal ethnicity, there are no substantial differences between the 
two data sources. However, Table 2.2 shows that for baby ethnicity, substantial amounts of data are 
missing from MAT, with the overall effect being there is a large proportion (51%) of missing cases. This 
unfortunately makes the baby ethnicity data in MAT too unreliable to use. 
Table 2.1: Prioritised maternal ethnic group by PMMRC and MAT data sources for perinatal related deaths, 
2007–2017 
2007–2017 PMMRC MAT Unmatched 
Prioritised maternal ethnic group  
Māori 1,888 1,889 191,408 
Pacific peoples 966 979 73,861 
Indian 430 378 29,506 
Other Asian 550 521 60,536 
MELAA 140 161 13,400 
NZ European 2,794 2,472 251,943 
Other European 423 543 55,626 
Other 1 - - 
Unknown 2 7 5,809 
Total 7,194 6,950 682,089 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract 2007–2017; Denominator: MAT data 2007–2017. 
Table 2.2: Prioritised baby ethnic group by PMMRC and MAT data sources for perinatal related deaths, 
2007–2017 
2007–2017 PMMRC MAT 
Prioritised baby ethnic group 
Māori 2,251 998 
Pacific peoples 978 496 
Indian 443 232 
Other Asian 544 260 
MELAA 144 72 
NZ European 2,599 1,195 
Other European 226 186 
Other - - 
Unknown 9 3,511 
Total 7,194 6,950 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract 2007–2017; Denominator: MAT data 2007–2017. 
The National Maternity Collection (MAT) 
MAT is based upon two sources:  
• primary maternity services provided under Section 88 of the New Zealand Public Health and Disability 
Act 2000, which is sourced from LMC claims for payment 
• the National Minimum Dataset (NMDS), which contains information on inpatient and day patient health 
event data during pregnancy, birth and the postnatal period for the mother and baby. 
 
While MAT should have a record of most births that occur in New Zealand, either through the NMDS for 
those who give birth in hospital, or through LMC claims, antenatal data are not routinely uploaded for 
women who are receiving care from providers other than LMC midwives, general practitioners (GPs), or 
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obstetricians. In particular, women whose antenatal care is provided through their DHB will not have their 
antenatal data entered into MAT. Some DHBs, such as Counties Manukau, routinely provide antenatal 
care. Due to a technical issue, data from DHBs cannot be uploaded into MAT, even when they are 
provided. 
 
To approximate the effect of this, we have compared the details of women receiving LMC care through 
Counties Manukau DHB, with women in MAT (Table 2.3). 
Table 2.3: Demographic characteristics of women in MAT compared with women from Counties Manukau 






n % n % 
Maternal BMI (kg/m2)     
<18.50 3,124 2.6 75 1.6 
18.50–24.99 53,419 44.2 1,192 25.0 
25.00–29.99 29,794 24.6 1,081 22.7 
30.00–34.99 15,930 13.2 939 19.7 
35.00–39.99 7,745 6.4 629 13.2 
≥40 4,616 3.8 635 13.3 
Unknown 6,287 5.2 210 4.4 
Total 120,915 100.0 4,761 100.0 
Maternal smoking at registration     
Yes 15,402 12.7 1,040 21.8 
No 99,392 82.2 3,438 72.2 
Unknown 6,121 5.1 283 5.9 
Total 120,915 100.0 4,761 100.0 
BMI = body mass index. 
Sources: MAT data 2016–2017; Counties Manukau data provided by Counties Manukau DHB 2016–2017. 
 
Table 2.3 shows there are substantial differences in those women whose antenatal records are in MAT 
compared with those whose records are not. Compared with women in MAT, women from Counties 
Manukau whose antenatal records were not in MAT had a higher proportion of women with a higher BMI, 
and had a higher proportion of women who are more likely to smoke. 
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3 Te mate pēpi | Perinatal mortality 
Aotearoa/New Zealand overview and key findings 
Since 2007, when the PMMRC started collecting data, there has been a statistically significant decrease in 
the rate of stillbirths (chi-squared test for trend p<0.001) but no reduction in neonatal mortality. Overall, 
there is some evidence of a statistically significant decrease in the rates of perinatal (fetal and early 
neonatal) mortalities, and in deaths overall (perinatal related mortality) (Figure 3.1 and Table 3.1). 
To examine the populations that benefitted, further analyses by prioritised ethnic group were undertaken 
(data not shown). Over the time period 2007–2017, for stillbirths, there was a statistically significant 
decrease in stillbirths in babies of both Māori and New Zealand European mothers, and no change in other 
groups. 
The reduction in perinatal mortalities was driven by a statistically significant reduction in babies of New 
Zealand European mothers, with no change in other ethnic groups. Similarly, there was a statistically 
significant decrease in fetal deaths and perinatal related mortalities for New Zealand European mothers, 
but not for any other ethnic groups. 
There was a statistically significant increase in terminations of pregnancy for Māori mothers, but no 
significant change for other ethnic groups. 
Between the years 2007 and 2017, there was a statistically significant increase in neonatal deaths for 
babies of Pacific women, but no significant change for other groups. 
There were no statistically significant changes in any of the above mortality rates for babies of women of 
Indian; Other Asian; Middle Eastern, Latin American, or African (MELAA); or Other European groups (data 
not shown). 
Figure 3.1: Perinatal related mortality rates (per 1,000 births) using New Zealand definitions 2007–2017 
* In this report, ‘Termination of pregnancy’ refers to the interruption of an ongoing pregnancy from 20 weeks’ gestation onwards.




























Perinatal related mortalities (total) Stillbirths Neonatal deaths Termination of pregnancy*
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2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 
Total births 65,200 65,623 65,202 65,449 63,242 63,280 60,133 60,079 59,777 60,600 60,454   
Fetal deaths (terminations of pregnancy and stillbirths)* 513 524 547 498 503 492 447 477 412 458 421§  
Terminations of pregnancy 144 145 138 151 171 172 141 150 107 148 133  
Stillbirths 369 379 409 347 332 320 306 327 305 310 288§  
Early neonatal deaths <7 days 133 134 137 165 139 142 122 150 131 123‡ 137§  
Late neonatal deaths 7–27 days 34 43 46 45 25 36 31 32 35 31 35  
Neonatal deaths <28 days# 167 177 183 210 164 178 153 182 166 154‡ 172§  
Perinatal mortalities+ 646 658 684 663 642 634 569 627 543 581‡ 558§  
Perinatal related mortalities^ 680 701 730 708 667 670 600 659 578 612‡ 593§  
Perinatal mortalities excluding lethal and terminated fetal 
abnormalities• 
462 488 515 466 446 445 417 449 402 416‡ 409  
Perinatal related mortalities excluding lethal and terminated fetal 
abnormalities• 
482 516 546 497 462 467 436 468 420 437‡ 434  
  
Rate  Chi-squared 
test for trend 
(p) 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 
Total births                         
Fetal deaths (terminations of pregnancy and stillbirths)* 7.9 8.0 8.4 7.6 8.0 7.8 7.4 7.9 6.9 7.6 7.0 0.004 
Terminations of pregnancy 2.2 2.2 2.1 2.3 2.7 2.7 2.3 2.5 1.8 2.4 2.2 0.98 
Stillbirths 5.7 5.8 6.3 5.3 5.2 5.1 5.1 5.4 5.1 5.1 4.8 <0.001 
Early neonatal deaths <7 days                        
Late neonatal deaths 7–27 days                        
Neonatal deaths <28 days# 2.6 2.7 2.8 3.2 2.6 2.8 2.6 3.1 2.8 2.6 2.9 0.90 
Perinatal mortalities+ 9.9 10.0 10.5 10.1 10.2 10.0 9.5 10.4 9.1 9.6 9.2 0.024 
Perinatal related mortalities^ 10.4 10.7 11.2 10.8 10.5 10.6 10.0 11.0 9.7 10.1 9.8 0.017 
Perinatal mortalities excluding lethal and terminated fetal 
abnormalities• 
7.1 7.4 7.9 7.1 7.1 7.0 6.9 7.5 6.7 6.9 6.8 0.053 
Perinatal related mortalities excluding lethal and terminated fetal 
abnormalities• 
7.4 7.9 8.4 7.6 7.3 7.4 7.3 7.8 7.0 7.2 7.2 0.041 
* Fetal death rate per 1,000 babies born (includes terminations and stillbirths). 
# Neonatal death rate per 1,000 live born babies. 
+ Fetal deaths and early neonatal deaths per 1,000 babies born. 
^ Fetal deaths and early and late neonatal deaths per 1,000 babies born. 
• Lethal and terminated fetal abnormalities are all perinatal related deaths with Perinatal Society of Australia and New Zealand Perinatal Death Classification (PSANZ-PDC) of congenital abnormality, and neonatal 
deaths with PSANZ Neonatal Death Classification (PSANZ-NDC) of congenital abnormality. 
‡ Included two late notifications. 
§ Included two late notifications. 
Sources: Numerator: PMMRC’s perinatal data extract 2007–2017; Denominator: MAT births 2007–2017. 
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Using international definitions, there is strong evidence of a statistically significant decrease in fetal deaths, stillbirths, perinatal mortalities and perinatal related 
mortalities since 2007 (Table 3.2 and Figure 3.2). 





2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 
Total births 64,650 65,076 64,629 64,885 62,694 62,717 59,600 59,513 59,316 60,090 59,928  
Fetal deaths (terminations of pregnancy and stillbirths)* 212 207 231 199 191 166 155 162 164 171 158  
Terminations of pregnancy 6 14 9 17 24 13 12 13 7 15 16  
Stillbirths 206 193 222 182 167 153 143 149 157 156 142  
Early neonatal deaths <7 days 57 67 59 68 65 54 45 59 57 53 46  
Late neonatal deaths 7–27 days 28 35 30 31 18 24 24 23 28 23 22  
Neonatal deaths <28 days# 85 102 89 99 83 78 69 82 85 76 68  
Perinatal mortalities+ 269 274 290 267 256 220 200 221 221 224 204  
Perinatal related mortalities^ 297 309 320 298 274 244 224 244 249 247 226  
Perinatal mortalities excluding lethal and terminated fetal 
abnormalities• 
224 220 238 204 180 169 158 168 177 170 159  
Perinatal related mortalities excluding lethal and terminated fetal 
abnormalities• 




test for trend 
(p) 
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017  
Total births                         
Fetal deaths (terminations of pregnancy and stillbirths)* 3.3 3.2 3.6 3.1 3.0 2.6 2.6 2.7 2.8 2.8 2.6 <0.001 
Terminations of pregnancy 0.1 0.2 0.1 0.3 0.4 0.2 0.2 0.2 0.1 0.2 0.3 0.25 
Stillbirths 3.2 3.0 3.4 2.8 2.7 2.4 2.4 2.5 2.6 2.6 2.4 <0.001 
Early neonatal deaths <7 days                        
Late neonatal deaths 7–27 days                        
Neonatal deaths <28 days# 1.3 1.6 1.4 1.5 1.3 1.2 1.2 1.4 1.4 1.3 1.1 0.11 
Perinatal mortalities+ 4.2 4.2 4.5 4.1 4.1 3.5 3.4 3.7 3.7 3.7 3.4 <0.001 
Perinatal related mortalities^ 4.6 4.7 5.0 4.6 4.4 3.9 3.8 4.1 4.2 4.1 3.8 <0.001 
Perinatal mortalities excluding lethal and terminated fetal 
abnormalities• 
3.5 3.4 3.7 3.1 2.9 2.7 2.7 2.8 3.0 2.8 2.7 <0.001 
Perinatal related mortalities excluding lethal and terminated fetal 
abnormalities• 
3.7 3.7 3.9 3.4 3.0 2.9 2.9 3.0 3.2 3.0 2.9 <0.001 
* Fetal death rate per 1,000 babies born (includes terminations and stillbirths). 
# Neonatal death rate per 1,000 live born babies. 
+ Fetal deaths and early neonatal deaths per 1,000 babies born. 
^ Fetal deaths and early and late neonatal deaths per 1,000 babies born. 
• Lethal and terminated fetal abnormalities are all perinatal related deaths with PSANZ-PDC of congenital abnormality, and neonatal deaths with PSANZ-NDC of congenital abnormality. 
Sources: Numerator: PMMRC’s perinatal data extract using the international definition (≥1,000g or ≥28 weeks if birthweight unknown) 2007–2017; Denominator: MAT births using the international definition (≥1,000g or 
≥28 weeks if birthweight unknown) 2007–2017. 
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Figure 3.2: Perinatal related mortality annual rates (per 1,000 births) using international definitions*  
2007–2017 
 
* Rates of fetal death, neonatal death, perinatal mortality and perinatal related mortality of babies weighing ≥1,000g, or ≥28 weeks if 
birthweight is unknown, per 1,000 total births of babies weighing ≥1,000g, or ≥28 weeks if birthweight is unknown. Babies without 
birthweight or gestation are included if they have been registered. 
Sources: Numerator: PMMRC’s perinatal data extract using the international definition (≥1,000g or ≥28 weeks if birthweight 
unknown) 2007–2017; Denominator: MAT births using the international definition (≥1,000g or ≥28 weeks if birthweight unknown) 
2007–2017. 
 
In 2017, from 20 weeks’ gestation onwards, 75% of terminations of pregnancy were classified as Perinatal 
Society of Australia and New Zealand (PSANZ) Perinatal Death Classification (PDC) congenital 
abnormality, with 8.3% classified as PSANZ-PDC for maternal conditions. Nearly 30% of stillbirths were 
classified as PSANZ-PDC unexplained antepartum death (for unknown reasons). There were no 
statistically significant differences between rates of unexplained stillbirth between Māori and New Zealand 
European women. Sixteen percent of stillbirths were due to specific perinatal conditions, and 13% due to 
antepartum haemorrhage. The leading PSANZ PDC category of neonatal death was spontaneous preterm 
birth (27.5%), followed by antepartum haemorrhage (22.8%) (Table 3.3). 
 
During the period 2007–2017, congenital abnormalities were the most frequent cause of death. Published 
research shows there is good evidence that folic acid supplementation prior to and in the first weeks of 
pregnancy prevents neural tube defects,13 and we should consider ways to increase folic acid consumption 
in the childbearing population. 
 
                                               
13 De-Regil LM, Peña-Rosas JP, Fernández-Gaxiola AC, et al. 2015. Effects and safety of periconceptional oral folate 
supplementation for preventing birth defects. Cochrane Database of Systematic Reviews 2015(12): CD007950. URL: 



























Perinatal related mortalities (total) Stillbirths
Neonatal deaths Termination of pregnancy
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Table 3.3: Perinatal related deaths by perinatal death classification (PSANZ-PDC) 2017 





deaths (total) Termination of 
pregnancy 
Stillbirths 
n=133 n=287 n=171 n=591 
n % n % n % n % 
Congenital abnormality 100 75.2 26 9.1 31 18.1 157 26.6 
Perinatal infection 4 3.0 17 5.9 7 4.1 28 4.7 
Hypertension <3 x 10 3.5 <3 x 13 2.2 
Antepartum haemorrhage <3 x 37 12.9 39 22.8 78 13.2 
Maternal conditions 11 8.3 11 3.8 6 3.5 28 4.7 
Specific perinatal conditions 3 2.3 45 15.7 16 9.4 64 10.8 
Hypoxic peripartum death - - 4 1.4 9 5.3 13 2.2 
Fetal growth restriction <3 x 33 11.5 6 3.5 41 6.9 
Spontaneous preterm 10 7.5 20 7.0 47 27.5 77 13.0 
Unexplained antepartum death - - 84 29.3 - - 84 14.2 
No obstetric antecedent - - - - 8 4.7 8 1.4 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s perinatal data extract 2017. 
 
Our data show there is strong evidence that perinatal deaths due to maternal hypertension have statistically 
significantly reduced over the time period (p<0.01). There is some evidence of a reduction in the rate of 
death from hypoxic peripartum death, fetal growth restriction, and spontaneous preterm births (Table 3.4). 
 
Using the international definition of birth weight greater than or equal to 1,000g, or gestational age 28 
weeks or greater, there was some evidence for a statistically significant reduction in deaths due to 
antepartum haemorrhage. There was strong evidence for a statistically significant decrease in the rate of 
deaths due to fetal growth restriction, and hypoxic peripartum deaths (Table 3.5). 
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Table 3.4: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 1,000 births) using New Zealand definition 2007–2017 
Perinatal death classification 
(PSANZ-PDC) 
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 
Chi-squared  
test for trend 
(p) 
N=65,200 N=65,623 N=65,202 N=65,449 N=63,242 N=63,280 N=60,133 N=60,079 N=59,777 N=60,600 N=60,454 
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Congenital abnormality 197 3.02 185 2.82 182 2.79 211 3.22 203 3.21 201 3.18 160 2.66 189 3.15 158 2.64 174 2.87 157 2.60 0.19 
Perinatal infection 29 0.44 28 0.43 25 0.38 28 0.43 21 0.33 19 0.30 20 0.33 24 0.40 22 0.37 26 0.43 28 0.46 0.97 
Hypertension 19 0.29 22 0.34 29 0.44 27 0.41 21 0.33 19 0.30 13 0.22 13 0.22 21 0.35 9 0.15 13 0.22 0.0083 
Antepartum haemorrhage 64 0.98 66 1.01 79 1.21 78 1.19 78 1.23 60 0.95 75 1.25 69 1.15 79 1.32 72 1.19 78 1.29 0.076 
Maternal conditions 27 0.41 23 0.35 38 0.58 32 0.49 26 0.41 36 0.57 34 0.57 39 0.65 29 0.49 37 0.61 28 0.46 0.11 
Specific perinatal conditions 57 0.87 71 1.08 76 1.17 69 1.05 73 1.15 70 1.11 63 1.05 70 1.17 60 1.00 69 1.14 64 1.06 0.56 
Hypoxic peripartum death 33 0.51 34 0.52 28 0.43 20 0.31 20 0.32 20 0.32 11 0.18 17 0.28 17 0.28 13 0.21 13 0.22 0.038 
Fetal growth restriction 48 0.74 62 0.94 53 0.81 48 0.73 44 0.70 49 0.77 48 0.80 35 0.58 33 0.55 41 0.68 41 0.68 0.041 
Spontaneous preterm  99 1.52 94 1.43 110 1.69 113 1.73 85 1.34 102 1.61 80 1.33 106 1.76 65 1.09 72 1.19 77 1.27 0.015 
Unexplained antepartum death 96 1.47 102 1.55 103 1.58 72 1.10 92 1.45 85 1.34 90 1.50 90 1.50 87 1.46 91 1.50 84 1.39 0.91 
No obstetric antecedent 11 0.17 14 0.21 7 0.11 10 0.15 4 0.06 9 0.14 6 0.10 7 0.12 7 0.12 6 0.10 8 0.13 0.17 
Sources: Numerator: PMMRC’s perinatal data extract 2007–2017; Denominator: MAT births 2007–2017. 
Table 3.5: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 1,000 births) using international definition (≥1,000g or  
≥28 weeks if birthweight unknown) 2007–2017 
Perinatal death classification 
(PSANZ-PDC) 
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 
Chi-squared  
test for trend 
(p) 
 N=64,650   N=65,076   N=64,629   N=64,885   N=62,694   N=62,717   N=59,600   N=59,513   N=59,316   N=60,090   N=59,928  
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Congenital abnormality 58 0.90 69 1.06 64 0.99 77 1.19 85 1.36 64 1.02 51 0.86 64 1.08 61 1.03 63 1.05 52 0.87 0.58 
Perinatal infection 16 0.25 16 0.25 15 0.23 13 0.20 12 0.19 9 0.14 9 0.15 12 0.20 12 0.20 17 0.28 16 0.27 0.88 
Hypertension 7 0.11 7 0.11 14 0.22 11 0.17 9 0.14 3 0.05 5 0.08 6 0.10 10 0.17 6 0.10 6 0.10 0.37 
Antepartum haemorrhage 23 0.36 25 0.38 24 0.37 23 0.35 17 0.27 13 0.21 18 0.30 11 0.18 17 0.29 12 0.20 19 0.32 0.036 
Maternal conditions 14 0.22 9 0.14 19 0.29 19 0.29 7 0.11 17 0.27 22 0.37 14 0.24 15 0.25 16 0.27 8 0.13 0.84 
Specific perinatal conditions 29 0.45 23 0.35 32 0.50 30 0.46 32 0.51 21 0.33 24 0.40 25 0.42 32 0.54 27 0.45 25 0.42 0.85 
Hypoxic peripartum death 33 0.51 34 0.52 28 0.43 20 0.31 20 0.32 20 0.32 11 0.18 17 0.29 17 0.29 13 0.22 13 0.22 <0.001 
Fetal growth restriction 31 0.48 32 0.49 31 0.48 31 0.48 18 0.29 32 0.51 21 0.35 20 0.34 14 0.24 15 0.25 13 0.22 <0.001 
Spontaneous preterm  9 0.14 7 0.11 10 0.15 19 0.29 9 0.14 10 0.16 5 0.08 9 0.15 14 0.24 8 0.13 9 0.15 0.91 
Unexplained antepartum death 66 1.02 73 1.12 75 1.16 45 0.69 61 0.97 46 0.73 52 0.87 59 0.99 50 0.84 64 1.07 57 0.95 0.40 
No obstetric antecedent 11 0.17 14 0.22 7 0.11 10 0.15 4 0.06 9 0.14 6 0.10 7 0.12 7 0.12 6 0.10 8 0.13 0.17 
Sources: Numerator: PMMRC’s perinatal data extract using the international definition (≥1,000g or ≥28 weeks if birthweight unknown) 2007–2017; Denominator: MAT births using the 
international definition (≥1,000g or ≥28 weeks if birthweight unknown) 2007–2017. 
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For stillbirths, there is strong evidence there was a statistically significant reduction in spontaneous preterm and hypoxic peripartum deaths between the years 
2007 and 2017. There was some evidence of a reduction in the rate of stillbirths due to fetal growth restriction. For this time period, the largest category of 
death for stillbirth was unexplained antepartum death (Table 3.6). 
Table 3.6: Perinatal death classification (PSANZ-PDC) specific stillbirth rates (per 1,000 births) 2007–2017 
Perinatal death classification 
(PSANZ-PDC) 




N=65,200 N=65,623 N=65,202 N=65,449 N=63,242 N=63,280 N=60,133 N=60,079 N=59,777 N=60,600 N=60,454 
n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Congenital abnormality 35 0.54 28 0.43 30 0.46 37 0.57 27 0.43 35 0.55 22 0.37 34 0.57 25 0.42 31 0.51 26 0.43 0.68 
Perinatal infection 21 0.32 15 0.23 16 0.25 17 0.26 10 0.16 9 0.14 10 0.17 12 0.20 12 0.20 10 0.17 17 0.28 0.23 
Hypertension 13 0.20 12 0.18 24 0.37 18 0.28 12 0.19 9 0.14 8 0.13 9 0.15 16 0.27 8 0.13 10 0.17 0.096 
Antepartum haemorrhage 46 0.71 49 0.75 53 0.81 46 0.70 48 0.76 31 0.49 44 0.73 33 0.55 46 0.77 38 0.63 37 0.61 0.19 
Maternal conditions 20 0.31 13 0.20 26 0.40 23 0.35 13 0.21 19 0.30 22 0.37 21 0.35 22 0.37 17 0.28 11 0.18 0.76 
Specific perinatal condition 38 0.58 53 0.81 60 0.92 45 0.69 51 0.81 42 0.66 39 0.65 43 0.72 42 0.70 53 0.87 45 0.74 0.78 
Hypoxic peripartum death 18 0.28 15 0.23 11 0.17 7 0.11 9 0.14 11 0.17 3 0.05 7 0.12 9 0.15 4 0.07 4 0.07 <0.001 
Fetal growth restriction 43 0.66 53 0.81 44 0.67 39 0.60 37 0.59 42 0.66 44 0.73 33 0.55 27 0.45 33 0.54 33 0.55 0.032 
Spontaneous preterm 39 0.60 39 0.59 42 0.64 43 0.66 33 0.52 37 0.58 24 0.40 45 0.75 19 0.32 25 0.41 20 0.33 0.002 
Unexplained antepartum death 96 1.47 102 1.55 103 1.58 72 1.10 92 1.45 85 1.34 90 1.50 90 1.50 87 1.46 91 1.50 84 1.39 0.91 
No obstetric antecedent - - - - - - - - - - - - - - - - - - - - - - - 
Sources: Numerator: PMMRC’s perinatal data extract, stillbirths only, 2007–2017; Denominator: MAT births 2007–2017. 
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Neonatal death 
For babies aged 20–28 weeks’ gestation, extreme prematurity was the leading cause of neonatal death. The mortality rate from extreme prematurity in babies 
under 28 weeks’ gestation was the same for Māori as for babies of New Zealand European mothers. There was some evidence of increase in deaths due to 
neurological conditions over the study period in these extremely preterm babies. 
 
For babies aged 28 weeks and over, congenital abnormalities were the leading cause of death, followed by neurological conditions. Unlike babies aged less 
than 28 weeks, for those aged 28 weeks and over there was strong evidence of a decrease in deaths over the study period. In this age group (28 weeks and 
over) there was a significant increase in the rate of death from cardio-respiratory disorders but a statistically significant decrease in deaths due to neurological 
conditions (Table 3.7). 









(p) n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate n Rate 
Gestation <28 weeks N=275 N=277 N=286 N=292 N=242 N=256 N=257 N=274 N=255 N=249 N=281   
Congenital abnormality <3 s - - <3 s - - <3 s <3 s <3 s <3 s 3 11.76 <3 s 4 14.23 0.093 
Extreme prematurity 57 207.27 52 187.73 57 199.30 84 287.67 54 223.14 67 261.72 63 245.14 69 251.82 51 200.00 53 212.85 69 245.55 0.34 
Cardio-respiratory disorders 9 32.73 9 32.49 11 38.46 16 54.79 7 28.93 10 39.06 5 19.46 12 43.80 10 39.22 6 24.10 9 32.03 0.57 
Infection 6 21.82 9 32.49 5 17.48 7 23.97 7 28.93 10 39.06 5 19.46 7 25.55 <3 s 4 16.06 8 28.47 0.54 
Neurological 6 21.82 3 10.83 10 34.97 <3 s 8 33.06 6 23.44 8 31.13 12 43.80 11 43.14 8 32.13 8 28.47 0.040 
Gastrointestinal <3 s - - 5 17.48 4 13.70 <3 s <3 s <3 s <3 s <3 s 3 12.05 4 14.23 0.68 
Other <3 s 3 10.83 3 10.49 - - - - <3 s <3 s <3 s 4 15.69 <3 s <3 s 0.98 
Gestation ≥28 weeks N=63,687 N=63,718 N=63,784 N=64,108 N=61,996 N=61,609 N=59,102 N=58,938 N=58,727 N=59,443 N=59,107  
Congenital abnormality 36 0.57 43 0.67 41 0.64 46 0.72 48 0.77 36 0.58 31 0.52 43 0.73 42 0.72 33 0.56 28 0.47 0.39 
Extreme prematurity - - - - <3 s - - - - - - - - - - - - - - - - 0.36 
Cardio-respiratory disorders <3 s <3 s - - <3 s 4 0.06 4 0.06 <3 s 4 0.07 6 0.10 5 0.08 7 0.12 0.0019 
Infection 8 0.13 12 0.19 7 0.11 12 0.19 8 0.13 7 0.11 7 0.12 8 0.14 5 0.09 10 0.17 7 0.12 0.53 
Neurological 25 0.39 30 0.47 30 0.47 26 0.41 15 0.24 19 0.31 17 0.29 12 0.20 20 0.34 16 0.27 14 0.24 0.0023 
Gastrointestinal - - - - 3 0.05 <3 s - - <3 s - - <3 s <3 s <3 s - - 0.76 
Other 12 0.19 14 0.22 8 0.13 10 0.16 9 0.15 13 0.21 13 0.22 9 0.15 10 0.17 8 0.13 12 0.20 0.91 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract, neonatal deaths only, 2007–2017; Denominator: MAT births excluding fetal deaths 2007–2017. 
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Figure 3.3 shows the neonatal mortality rate by prioritised ethnic group (congenital abnormalities excluded). 
This shows that the burden of mortality for all ethnic groups is in babies born at 20–24 weeks’ gestation. By 
prioritised ethnic group, neonatal mortality rates are statistically significantly higher in babies born to 
mothers of Indian, Pacific and Māori ethnicities, compared with mothers of New Zealand European 
ethnicity. Directing more resource into understanding and preventing preterm delivery is needed to reduce 
these high mortality rates. 
Figure 3.3: Neonatal death rates (per 1,000 ongoing pregnancies) by gestation at birth and maternal 
ethnicity excluding death with congenital abnormalities 2008–2017* 
 
* Unknown/Other ethnicity not represented. 
MELAA = Middle Eastern, Latin American, or African. 
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Maternal age 
Perinatal related mortality rates have a U-shaped trend by maternal age, with the highest rates at the 
extremes of childbearing age. This is particularly evident for stillbirths, with mothers aged under 20 years 
and 40 years and over having the highest rates of stillbirth. Neonatal deaths were highest in babies of 
mothers who were under 20 years of age (Figure 3.4 and Table 3.8). 
Figure 3.4: Perinatal related mortality rates (per 1,000 births) by maternal age (with 95% confidence 
intervals (CIs)) 2013–2017 
 
Sources: Numerator: PMMRC’s perinatal data extract 2013–2017; Denominator: MAT births 2013–2017. 








deaths (total) Termination of 
pregnancy 
Stillbirths 
N=301,043 n=679 n=1,535 n=824 n=3,038 
N % n % Rate n % Rate n % Rate n % Rate 
<20 14,077 4.7 39 5.7 2.77 116 7.6 8.24 92 11.2 6.61 247 8.1 17.55 
20–24 50,888 16.9 95 14.0 1.87 274 17.9 5.38 175 21.2 3.46 544 17.9 10.69 
25–29 81,438 27.1 168 24.7 2.06 383 25.0 4.70 199 24.2 2.46 750 24.7 9.21 
30–34 91,189 30.3 203 29.9 2.23 416 27.1 4.56 203 24.6 2.24 822 27.1 9.01 
35–39 50,530 16.8 130 19.1 2.57 252 16.4 4.99 114 13.8 2.27 496 16.3 9.82 
≥40 12,826 4.3 44 6.5 3.43 92 6.0 7.17 41 5.0 3.23 177 5.8 13.80 
Unknown 95 0.0 - - - <3 x - - - - <3 x - 
‘x’ indicates percentage suppressed due to small numbers. 
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Over the past 11 years there has been little change in perinatal related mortality rates by maternal age group. There is some evidence of an increase in 
deaths of babies born to mothers younger than 20 years, and no evidence of any substantial change in any other age group (Table 3.9). 




2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017  
n N n N n N n N n N n N n N n N n N n N n N  
<20 61 5,118 85 5,336 80 4,910 57 4,625 65 4,128 63 3,968 65 3,382 51 3,047 45 2,829 54 2,491 32 2,328  
20–24 140 11,371 133 11,868 142 12,086 164 12,258 116 11,939 126 11,697 115 11,007 116 10,477 86 10,137 124 9,776 103 9,491  
25–29 161 15,812 153 15,904 169 16,003 162 16,305 147 15,866 149 16,265 139 15,598 165 16,015 150 15,991 143 16,893 153 16,941  
30–34 163 18,630 169 18,012 169 17,841 149 18,105 160 17,608 163 17,854 147 17,130 175 17,983 158 18,296 169 18,745 173 19,035  
35–39 124 11,778 125 11,977 138 11,765 136 11,396 145 11,028 119 10,676 89 10,317 111 9,940 107 9,976 89 10,199 100 10,098  
≥40 31 2,463 35 2,503 32 2,568 40 2,732 34 2,648 50 2,801 45 2,678 40 2,596 32 2,528 30 2,482 30 2,542  









Rate Rate Rate Rate Rate Rate Rate Rate Rate Rate Rate 
<20  11.9  15.9  16.3  12.3  15.7  15.9  19.2  16.7  15.9  21.7  13.7 0.030 
20–24  12.3  11.2  11.7  13.4  9.7  10.8  10.4  11.1  8.5  12.7  10.9 0.13 
25–29  10.2  9.6  10.6  9.9  9.3  9.2  8.9  10.3  9.4  8.5  9.0 0.088 
30–34  8.7  9.4  9.5  8.2  9.1  9.1  8.6  9.7  8.6  9.0  9.1 0.97 
35–39  10.5  10.4  11.7  11.9  13.1  11.1  8.6  11.2  10.7  8.7  9.9 0.078 
≥40  12.6  14.0  12.5  14.6  12.8  17.9  16.8  15.4  12.7  12.1  11.8 0.83 
Unknown  -  -  -  -  -  -  -  -  -  -  - - 
Sources: Numerator: PMMRC’s perinatal data extract 2007–2017; Denominator: MAT births 2007–2017. 
 
Spontaneous preterm was the leading cause of perinatal related death in babies born to mothers under 24 years of age. In mothers aged 25–34 years, the 
leading category of perinatal related death was unexplained antepartum death. However, the rate of unexplained antepartum death was less than that seen in 
women aged 24 years and less, reflecting the overall lower perinatal related mortality rate in the 25–34-year age group. For mothers aged 35 years and over, 
the leading classification of death was specific perinatal conditions. Perinatal infection particularly affected mothers under 20 years of age, and hypertension 
was an uncommon cause of perinatal related death in this age group. 
 
The rate of antepartum haemorrhage was highest in mothers under 20 years of age, and reduced with age until 40 years and over. Deaths due to specific 
perinatal conditions tended to increase with age. The rates of deaths classified as due to spontaneous preterm and fetal growth restriction were higher in 
mothers under 20 years of age, compared with other age groups (Table 3.10 and Figure 3.5). See Table 3.11 for further information on women under 20 years 
of age who were pregnant, and Table 3.12 for information about perinatal related deaths in this age group. 
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Table 3.10: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (excluding congenital abnormalities) by maternal age  
2013–2017 
Perinatal death classification  
(PSANZ-PDC) 
Maternal age (years) 
<20 20–24 25–34 35–39 ≥40 
N=14,026 N=50,768 N=172,204 N=50,369 N=12,751 
n % Rate n % Rate n % Rate n % Rate n % Rate 
Perinatal infection 17 8.8 1.21 23 5.5 0.45 63 5.5 0.37 16 4.8 0.32 <3 x s 
Hypertension <3 x s 17 4.0 0.33 37 3.2 0.21 8 2.4 0.16 6 5.8 0.47 
Antepartum haemorrhage 31 16.0 2.21 70 16.6 1.38 205 18.0 1.19 49 14.8 0.97 18 17.5 1.41 
Maternal conditions 17 8.8 1.21 36 8.6 0.71 73 6.4 0.42 22 6.6 0.44 11 10.7 0.86 
Specific perinatal condition 10 5.2 0.71 50 11.9 0.98 168 14.7 0.98 74 22.4 1.47 23 22.3 1.80 
Hypoxic peripartum death 5 2.6 0.36 12 2.9 0.24 40 3.5 0.23 13 3.9 0.26 <3 x s 
Fetal growth restriction 21 10.8 1.50 30 7.1 0.59 107 9.4 0.62 32 9.7 0.64 8 7.8 0.63 
Spontaneous preterm* 58 29.9 4.14 89 21.1 1.75 188 16.5 1.09 50 15.1 0.99 14 13.6 1.10 
Unexplained antepartum death* 30 15.5 2.14 82 19.5 1.62 245 21.5 1.42 64 19.3 1.27 20 19.4 1.57 
No obstetric antecedent 4 2.1 0.29 12 2.9 0.24 14 1.2 0.08 3 0.9 0.06 <3 x s 
* Excludes two babies where maternal age was unknown. 
‘x’ indicates percentage not calculated due to small numbers. 
‘s’ indicates rate not calculated due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract (excluding congenital abnormalities) 2013–2017; Denominator: MAT births 2013–2017. 
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Figure 3.5: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (excluding 
congenital abnormalities) by maternal age (with 95% CIs) 2013–2017 
 
Sources: Numerator: PMMRC’s perinatal data extract (excluding congenital abnormalities) 2013–2017; Denominator: MAT births 
2013–2017. 
Mothers under 20 years of age 
Of mothers under 20 years of age, over 40% were 19 years of age. There were relatively few women living 
in the least deprived areas, with the highest proportion living in New Zealand Index of Deprivation 2013 
(NZDep2013) quintile 5 (Table 3.11). 
Table 3.11: Demographic and other characteristics of all births of mothers under 20 years of age by time 
period (2008–2012 and 2013–2017) 
  2008–2012 2013–2017  2008–2017 
  N=22,967 N=14,077  N=37,044 
  N % N %  N % 
Age (years)        
<16 764 3.3 471 3.3  1,235 3.3 
16 1,956 8.5 1,114 7.9  3,070 8.3 
17 4,188 18.2 2,308 16.4  6,496 17.5 
18 6,740 29.3 4,040 28.7  10,780 29.1 
19 9,319 40.6 6,144 43.6  15,463 41.7 
NZDep2013 quintile        
1 (least deprived) 1,181 5.1 644 4.6  1,825 4.9 
2 1,884 8.2 1,070 7.6  2,954 8.0 
3 3,222 14.0 1,729 12.3  4,951 13.4 
4 5,841 25.4 3,363 23.9  9,204 24.8 
5 (most deprived) 10,576 46.0 7,151 50.8  17,727 47.9 
Missing 263 1.1 120 0.9  383 1.0 
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Prioritised ethnic group (mother)        
Māori 13,167 57.3 8,483 60.3  21,650 58.4 
Pacific peoples 3,064 13.3 1,933 13.7  4,997 13.5 
Asian 353 1.5 218 1.5  571 1.5 
Indian 107 0.5 60 0.4  167 0.5 
Other Asian 246 1.1 158 1.1  404 1.1 
MELAA 168 0.7 121 0.9  289 0.8 
European 6,204 27.0 3,318 23.6  9,522 25.7 
NZ European 5,634 24.5 3,001 21.3  8,635 23.3 
Other European 570 2.5 317 2.3  887 2.4 
Unknown 11 0.0 4 0.0  15 0.0 
Limited to LMC* N=18,072 N=12,396  N=30,468 
Smoking at registration with LMC        
Yes 6,570 36.4 4,266 34.4  10,836 35.6 
No 11,497 63.6 8,130 65.6  19,627 64.4 
Missing 5 0.0 - -  5 0.0 
BMI at registration        
<18.50 746 4.1 463 3.7  1,209 4.0 
18.50–24.99 9,576 53.0 5,846 47.2  15,422 50.6 
25.00–29.99 4,863 26.9 3,497 28.2  8,360 27.4 
30.00–34.99 1,972 10.9 1,728 13.9  3,700 12.1 
35.00–39.99 630 3.5 601 4.8  1,231 4.0 
≥40.00 229 1.3 239 1.9  468 1.5 
Unknown 56 0.3 22 0.2  78 0.3 
First registration with LMC        
First  7,184 39.8 6,349 51.2  13,533 44.4 
Second 9,391 52.0 5,126 41.4  14,517 47.6 
Third 1,392 7.7 838 6.8  2,230 7.3 
Postpartum 104 0.6 83 0.7  187 0.6 
Missing <3 x - -  <3 x 
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
BMI = body mass index. 
MELAA = Middle Eastern, Latin American, or African. 
LMC = lead maternity carer. 
‘x’ indicates percentage not calculated due to small numbers. 
Source: MAT births of babies of mothers <20 years of age 2008–2017. 
 
Of mothers under 20 years of age, 58% were Māori, and overall 65% did not smoke. Half of the mothers 
had a BMI in the normal range. Ninety-nine percent of the mothers registered with an LMC during their 
pregnancy. Of the mothers under 20 years of age who were recorded as having registered with an LMC 
during their pregnancy (between 2008 and 2017), 44% did so in their first trimester. However, because 
these data are limited to mothers who registered with a midwife, obstetrician or GP LMC, the actual 
percentages may be lower than this (Table 3.11). 
 
For babies of mothers under 20 years of age, the stillbirth rate was 1.5 times higher than for mothers aged 
20 years and over (7.42 per 1,000 births compared with 4.95 per 1,000 births respectively), and the 
neonatal mortality rate was two times higher (rate 5.4 per 1,000 births compared with 2.58 per 1,000 
births). The rate for termination of pregnancy was similar between the two groups (Table 3.12). 
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Table 3.12: Perinatal death classification (PSANZ-PDC) among babies of mothers <20 years of age and 
those ≥20 years of age, 2008–2017 
Perinatal death classification 
(PSANZ-PDC) 
2008–2017 
Mothers <20 years old Mothers ≥20 years old 
N=37,044 N=586,576 
n Rate n Rate 
Termination of pregnancy (/1,000 births) 96 2.59 1,301 2.22 
Stillbirth (/1,000 births) 275 7.42 2,905 4.95 
Neonatal death (/1,000 live births) 198 5.34 1,514 2.58 
Perinatal death classification (PSANZ-PDC)    
Congenital abnormality 133 3.59 1,632 2.78 
Perinatal infection 32 0.86 202 0.34 
Hypertension <3 s 181 0.31 
Antepartum haemorrhage 68 1.84 647 1.10 
Maternal conditions 29 0.78 254 0.43 
Specific perinatal conditions 35 0.94 640 1.09 
Hypoxic peripartum death 17 0.46 172 0.29 
Fetal growth restriction 46 1.24 397 0.68 
Spontaneous preterm birth 126 3.40 743 1.27 
Unexplained antepartum death 69 1.86 790 1.35 
No obstetric antecedent 12 0.32 62 0.11 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC's perinatal data extract, where matched to MAT data 2008–2017; Denominator: MAT births 2008–
2017. 
 
The 12th report of the PMMRC showed that mothers under 20 years of age had higher risk of perinatal 
related death (excluding from congenital abnormalities) from spontaneous preterm birth, fetal growth 
restriction, antepartum haemorrhage, and perinatal infection than any other age group.14 World-wide, 
mothers who are pregnant under 20 years of age are viewed as a high-risk group.15,16 However, there is 
little strengths-based research involving this group to evaluate their perspectives and develop antenatal 
care pathways that meet their needs. In Aotearoa/New Zealand, a research study called E Hine was 
conducted to explore the lived realities of 44 Māori mothers under 20 years of age who were pregnant, and 
their babies. The study found that mothers in the study generally did not have a delay in diagnosing 
pregnancy, particularly those who were already engaged with a health service provider, such as a school-
based health clinic or youth health provider. However, the research demonstrated that fragmentation of 
service delivery and poor communication around finding a midwife made accessing antenatal care difficult. 
This was further complicated by a lack of available midwives in their area for some mothers. Participants 
were more likely to experience continuous care in their pregnancy when the first health professional they 
saw ensured that their ongoing needs, particularly in terms of finding an antenatal care provider, were met. 
This research highlighted the fragmentation between primary non-LMC services and LMC services, which 
is negatively impacting on women’s access to antenatal care.17 
  
                                               
14 PMMRC. 2018. Twelfth Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2016. 
URL: https://www.hqsc.govt.nz/assets/PMMRC/Publications/12th-PMMRC-report-final.pdf (accessed 14 August 2019), p 100. 
15 Solivan AE, Wallace ME, Kaplan KC, et al. 2015. Use of a resiliency framework to examine pregnancy and birth outcomes 
among adolescents: A qualitative study. Families, Systems and Health 33(4): 349–55. 
16 Chen XK, Wen SW, Fleming N, et al. 2007. Teenage pregnancy and adverse birth outcomes: A large population based 
retrospective cohort study. International Journal of Epidemiology 36: 368–73. 
17 Makowharemahihi C, Lawton B, Cram F et al. 2014. Initiation of maternity care for young Māori women under 20 years of age. 
New Zealand Medical Journal 127(1393): 52–61. 
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Perinatal related mortality by prioritised ethnic group 
There were significant differences in perinatal related mortality by both maternal (Figure 3.6 and  
Table 3.13) and baby (Figure 3.7 and Table 3.14) prioritised ethnic group. These patterns were the same, 
regardless of whether mother or baby prioritised ethnic group was used. 
Figure 3.6: Perinatal related mortality rates (per 1,000 births) by maternal prioritised ethnic group (with  
95% CIs) 2013–2017 
 
MELAA = Middle Eastern, Latin American, or African. 
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Figure 3.7: Perinatal related mortality rates (per 1,000 births) by baby prioritised ethnic group (with  
95% CIs) 2013–2017 
 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract 2013–2017; Denominator: MAT births 2013–2017. 









deaths (total) Termination of 
pregnancy 
Stillbirths 
N=301,043* n=679 n=1,535 n=824 n=3,038 
n % n % Rate n % Rate n % Rate n % Rate 
Māori 75,328 25.0 120 17.7 1.59 399 26.0 5.30 279 33.9 3.73 798 26.3 10.59 
Pacific peoples 31,055 10.3 43 6.3 1.38 208 13.6 6.70 142 17.2 4.61 393 12.9 12.65 
Asian 48,313 16.0 142 20.9 2.94 241 15.7 4.99 118 14.3 2.46 501 16.5 10.37 
Indian 15,738 5.2 47 6.9 2.99 129 8.4 8.20 59 7.2 3.79 235 7.7 14.93 
Other Asian 32,575 10.8 95 14.0 2.92 112 7.3 3.44 59 7.2 1.82 266 8.8 8.17 
MELAA 6,932 2.3 19 2.8 2.74 29 1.9 4.18 17 2.1 2.47 65 2.1 9.38 
European 139,281 46.3 355 52.3 2.55 656 42.7 4.71 268 32.5 1.94 1,279 42.1 9.18 
NZ European 109,887 36.5 294 43.3 2.68 567 36.9 5.16 245 29.7 2.25 1,106 36.4 10.06 
Other European 29,394 9.8 61 9.0 2.08 89 5.8 3.03 23 2.8 0.79 173 5.7 5.89 
* Includes 134 unknown maternal ethnicity among total births and 2 unknown maternal ethnicity perinatal related deaths (total). 
MELAA = Middle Eastern, Latin American, or African. 
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deaths (total) Termination of 
pregnancy 
Stillbirths 
N=301,043* n=679 n=1,535 n=824 n=3,038 
n % n % Rate n % Rate n % Rate n % Rate 
Māori 86,006 28.6 160 23.6 1.86 456 29.7 5.30 313 38.0 3.67 929 30.6 10.80 
Pacific peoples 30,732 10.2 40 5.9 1.30 213 13.9 6.93 148 18.0 4.86 401 13.2 13.05 
Asian 48,993 16.3 137 20.2 2.80 249 16.2 5.08 118 14.3 2.43 504 16.6 10.29 
Indian 16,716 5.6 51 7.5 3.05 134 8.7 8.02 58 7.0 3.51 243 8.0 14.54 
Other Asian 32,277 10.7 86 12.7 2.66 115 7.5 3.56 60 7.3 1.87 261 8.6 8.09 
MELAA 6,772 2.2 15 2.2 2.22 29 1.9 4.28 18 2.2 2.68 62 2.0 9.16 
European 125,362 41.6 325 47.9 2.59 586 38.2 4.67 226 27.4 1.82 1,137 37.4 9.07 
NZ European 99,406 33.0 302 44.5 3.04 524 34.1 5.27 213 25.8 2.16 1,039 34.2 10.45 
Other European 25,956 8.6 23 3.4 0.89 62 4.0 2.39 13 1.6 0.50 98 3.2 3.78 
* Includes 3,178 unknown baby’s ethnicity total births and 5 unknown baby’s ethnicity perinatal related deaths (total). 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract 2013–2017; Denominator: MAT births 2013–2017. 
 
There was significant variation in the classification of perinatal death by prioritised ethnic group. For deaths 
due to spontaneous preterm delivery, maternal conditions and antepartum haemorrhage, mortality rates 
were statistically significantly higher in Indian, Pacific and Māori women, compared with all others (‘Other 
Asian’, MELAA, and all European). For unexplained antepartum death, rates were statistically significantly 
higher in Indian and Pacific mothers than others. There was no significant difference in mortality rates by 
prioritised ethnic category for deaths due to fetal growth restriction, hypoxic peripartum death, 
hypertension, and deaths where no obstetric antecedent was identified. Deaths due to perinatal infection 
were statistically significantly higher in babies of Pacific and Māori mothers than babies of ‘Other’ mothers 
(Figure 3.8). 
 
While there is year-to-year variation in perinatal related mortality, there has been little change for most 
ethnic groups in the past 11 years. There was strong evidence that mortality rates have decreased in 
babies of New Zealand European mothers – however, there was no change for other ethnic groups. 
Mortality rates alone do not provide a complete picture of the burden of mortality in specific communities. 
For communities with high fertility rates, such as Pacific and Māori communities,18 the burden of perinatal 
deaths is greater than in communities with lower fertility rates. Therefore, these deaths have a greater 
impact in the community (Table 3.15). 
                                               
18 Statistics New Zealand. 2016. National ethnic population projections. URL: 
http://archive.stats.govt.nz/browse_for_stats/population/estimates_and_projections/projections-overview/nat-ethnic-pop-proj.aspx 
(accessed 8 August 2019).  
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Figure 3.8: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 1,000 
births) (excluding congenital abnormalities) by maternal prioritised ethnic category (with 95% CIs) 2013–
2017 
 
* ‘All other’ includes Other Asian, Middle Eastern, Latin American, or African (MELAA), Other European, New Zealand European, 
Unknown/Other. 
Sources: Numerator: PMMRC’s perinatal data extract (excluding congenital abnormalities) 2013–2017; Denominator: MAT births 
2013–2017. 
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Table 3.15: Perinatal related mortality rates (per 1,000 births) by maternal prioritised ethnic group* and year 2007–2017 
Maternal 
ethnic group 
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017  
n N n N n N n N n N n N n N n N n N n N n N  
Māori 179 17,053 170 17,254 209 17,096 193 16,973 176 16,414 163 16,273 156 15,141 166 14,791 143 15,016 181 15,252 152 15,128  
Pacific peoples 87 8,007 98 7,843 106 7,568 109 7,650 79 7,250 94 7,069 84 6,526 83 6,294 71 6,179 74 5,969 81 6,087  
Asian 61 5,953 69 6,116 75 6,414 88 7,035 86 7,250 100 8,596 83 8,247 95 9,359 96 9,332 106 10,669 121 10,706  
Indian 25 1,838 30 1,921 33 1,936 34 2,088 35 2,169 38 2,378 37 2,458 45 2,776 43 3,126 52 3,506 58 3,872  
Other Asian 36 4,115 39 4,195 42 4,478 54 4,947 51 5,081 62 6,218 46 5,789 50 6,583 53 6,206 54 7,163 63 6,834  
MELAA 17 1,032 12 1,133 12 1,211 5 1,325 13 1,316 16 1,268 10 1,312 15 1,303 15 1,358 8 1,392 17 1,567  
European 336 33,113 352 33,216 328 32,866 312 32,424 313 30,958 297 30,034 267 28,873 299 28,290 253 27,871 240 27,296 220 26,951  
NZ European 300 27,087 312 27,000 292 26,647 271 26,228 263 24,943 250 24,155 230 22,990 262 22,389 224 21,997 208 21,480 182 21,031  
Other 
European 
36 6,026 40 6,216 36 6,219 41 6,196 50 6,015 47 5,879 37 5,883 37 5,901 29 5,874 32 5,816 38 5,920  
Maternal 
ethnic group 




trend (p) Rate Rate Rate Rate Rate Rate Rate Rate Rate Rate Rate 
Māori   10.5  9.9  12.2  11.4  10.7  10.0  10.3  11.2  9.5  11.9  10.0 0.73 
Pacific peoples   10.9  12.5  14.0  14.2  10.9  13.3  12.9  13.2  11.5  12.4  13.3 0.73 
Asian   10.2  11.3  11.7  12.5  11.9  11.6  10.1  10.2  10.3  9.9  11.3 0.33 
Indian   13.6  15.6  17.0  16.3  16.1  16.0  15.1  16.2  13.8  14.8  15.0 0.69 
Other Asian   8.7  9.3  9.4  10.9  10.0  10.0  7.9  7.6  8.5  7.5  9.2 0.19 
MELAA   16.5  10.6  9.9  3.8  9.9  12.6  7.6  11.5  11.0  5.7  10.8 0.41 
European   10.1  10.6  10.0  9.6  10.1  9.9  9.2  10.6  9.1  8.8  8.2 0.002 
NZ European   11.1  11.6  11.0  10.3  10.5  10.3  10.0  11.7  10.2  9.7  8.7 0.005 
Other 
European 
  6.0  6.4  5.8  6.6  8.3  8.0  6.3  6.3  4.9  5.5  6.4 0.55 
* Excludes 420 unknown maternal ethnicity total births and 2 unknown maternal ethnicity perinatal related deaths (total). 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract 2007–2017; Denominator: MAT births 2007–2017. 
 
Unexplained antepartum death was a leading classification of cause of death regardless of maternal prioritised ethnic group. However, other leading causes 
varied by ethnic group. For babies of Māori and Pacific mothers, spontaneous preterm births were the leading cause. For babies of Indian mothers, 
antepartum haemorrhage was a frequent cause of death. For babies of mothers in the MELAA, New Zealand European and Other European prioritised ethnic 
groups, specific perinatal conditions were a leading cause of death (Table 3.16). 
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Table 3.16: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (excluding congenital abnormalities) by maternal prioritised 
ethnic group* 2013–2017 
Perinatal death classification 
(PSANZ-PDC)  
Māori Pacific peoples 
Asian 
Indian Other Asian Total Asian 
n=75,150 n=30,976 n=15,690 n=32,477 n=48,167 
n % Rate n % Rate n % Rate n % Rate n % Rate 
Perinatal infection 39 6.3 0.52 23 7.3 0.74 9 4.9 0.57 9 5.6 0.28 18 5.2 0.37 
Hypertension 26 4.2 0.35 13 4.1 0.42 <3 x s 4 2.5 0.12 6 1.7 0.12 
Antepartum haemorrhage 108 17.3 1.44 56 17.7 1.81 37 20.2 2.36 30 18.8 0.92 67 19.5 1.39 
Maternal conditions 50 8.0 0.67 34 10.7 1.10 13 7.1 0.83 8 5.0 0.25 21 6.1 0.44 
Specific perinatal conditions 62 10.0 0.83 39 12.3 1.26 32 17.5 2.04 21 13.1 0.65 53 15.5 1.10 
Hypoxic peripartum death 25 4.0 0.33 3 0.9 0.10 <3 x s <3 x s 4 1.2 0.08 
Fetal growth restriction 40 6.4 0.53 17 5.4 0.55 20 10.9 1.27 17 10.6 0.52 37 10.8 0.77 
Spontaneous preterm 146 23.4 1.94 65 20.5 2.10 29 15.8 1.85 23 14.4 0.71 52 15.2 1.08 
Unexplained antepartum death 112 18.0 1.49 62 19.6 2.00 38 20.8 2.42 44 27.5 1.35 82 23.9 1.70 
No obstetric antecedent 15 2.4 0.20 5 1.6 0.16 <3 x s <3 x s 3 0.9 0.06 
Perinatal death classification 
(PSANZ-PDC)  
MELAA 
European    
NZ European Other European Total European    
n=6,906 n=109,574 n=29,306 n=138,880    
n % Rate n % Rate n % Rate n % Rate    
Perinatal infection <3 x s 32 4.2 0.29 7 6.9 0.24 39 4.5 0.28    
Hypertension <3 x s 21 2.8 0.19 <3 x s 22 2.5 0.16    
Antepartum haemorrhage 7 16.7 1.01 120 15.7 1.10 15 14.7 0.51 135 15.6 0.97    
Maternal conditions 3 7.1 0.43 46 6.0 0.42 5 4.9 0.17 51 5.9 0.37    
Specific perinatal conditions 10 23.8 1.45 137 18.0 1.25 24 23.5 0.82 161 18.6 1.16    
Hypoxic peripartum death 3 7.1 0.43 34 4.5 0.31 <3 x s 36 4.2 0.26    
Fetal growth restriction - - - 93 12.2 0.85 11 10.8 0.38 104 12.0 0.75    
Spontaneous preterm 6 14.3 0.87 118 15.5 1.08 12 11.8 0.41 130 15.0 0.94    
Unexplained antepartum death 10 23.8 1.45 150 19.7 1.37 25 24.5 0.85 175 20.3 1.26    
No obstetric antecedent - - - 11 1.4 0.10 - - - 11 1.3 0.08    
* Excludes 134 unknown maternal ethnicity among total births (denominator) and 2 unknown maternal ethnicity perinatal related deaths (total) (numerator). 
‘x’ indicates percentage suppressed due to small numbers. 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract (excluding congenital abnormalities) 2013–2017; Denominator: MAT births 2013–2017.
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Socioeconomic deprivation 
Perinatal related mortality varied significantly by New Zealand Index of Deprivation 2013 (NZDep2013) 
quintile, with babies of mothers living in quintile 5 (most deprived areas) having statistically significantly 
higher mortality rates than all others, with the exception of termination of pregnancy (Figure 3.9 and Table 
3.17). There was a statistically significantly lower rate of termination of pregnancy in women residing in 
NZDep2013 quintiles 4 and 5, compared with quintile 1. However, the rate of stillbirth was significantly 
increased in women residing in NZDep2013 quintiles 4 and 5, compared with quintile 1. The rate of 
neonatal death was statistically significantly higher in babies of women living in quintiles 3, 4 and 5, 
compared with quintile 1. 
Figure 3.9: Perinatal related mortality rates (per 1,000 births) by NZDep2013 quintile (with 95% CIs)  
2013–2017 
 
Sources: Numerator: PMMRC’s perinatal data extract 2013–2017; Denominator: MAT births 2013–2017. 







deaths (total) Termination of 
pregnancy 
Stillbirths 
n=301,043 n=679 n=1,535 n=824 n=3,038 
N % n % Rate n % Rate n % Rate n % Rate 
1 (least deprived) 43,032 14.3 115 16.9 2.67 168 10.9 3.90 82 10.0 1.92 365 12.0 8.48 
2 47,755 15.9 116 17.1 2.43 218 14.2 4.56 88 10.7 1.86 422 13.9 8.84 
3 53,971 17.9 142 20.9 2.63 250 16.3 4.63 144 17.5 2.69 536 17.6 9.93 
4 67,300 22.4 133 19.6 1.98 332 21.6 4.93 169 20.5 2.53 634 20.9 9.42 
5 (most deprived) 86,565 28.8 171 25.2 1.98 560 36.5 6.47 335 40.7 3.90 1,066 35.1 12.31 
Unknown 2,420 0.8 <3 x - 7 0.5 - 6 0.7 - 15 0.5 - 
‘x’ indicates percentage not calculated due to small numbers. 
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This variation in mortality rates by deprivation was most marked for deaths due to spontaneous preterm 
delivery, with mortality rates increasing with increasing deprivation. There was little significant variation by 
deprivation for other causes of death (Figure 3.10 and Table 3.19). This pattern has been stable over time, 
with no significant changes in mortality rates by deprivation for the 11-year study period (Table 3.18). 
Figure 3.10: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per  
1,000 births) (excluding congenital abnormalities) by NZDep2013 quintile (with 95% CIs) 2013–2017 
 
Sources: Numerator: PMMRC’s perinatal data extract (excluding congenital abnormalities) 2013–2017; Denominator: MAT births 
2013–2017.











PSANZ-PDC specific perinatal related mortality rates/1,000 births
Quintile 1 (least deprived) Quintile 2 Quintile 3 Quintile 4 Quintile 5 (most deprived)
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Table 3.18: Perinatal related mortality rates (per 1,000 births) by NZDep2013 quintile and year 2007–2017 
NZDep2013 
quintile 
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017  
n N n N n N n N n N n N n N n N n N n N n N  
1 (least 
deprived) 
72 9,124 98 8,783 76 9,105 80 9,028 103 8,833 80 8,969 59 8,321 93 8,600 74 8,370 69 8,821 70 8,920  
2 94 9,571 88 9,553 106 9,540 104 9,773 99 9,549 89 9,540 78 9,384 77 9,331 83 9,479 91 9,800 93 9,761  
3 131 11,414 134 12,051 120 12,101 117 12,162 116 11,689 106 11,773 126 10,799 118 10,702 90 10,733 99 10,859 103 10,878  
4 171 15,619 142 15,395 178 15,168 155 15,200 152 14,794 141 14,717 114 13,575 138 13,464 138 13,437 126 13,460 118 13,364  
5 (most 
deprived) 
210 18,801 236 19,117 249 18,595 251 18,645 195 17,780 253 17,751 220 17,570 229 17,446 189 17,257 223 17,188 205 17,104  
Unknown <3 671 3 724 <3 693 <3 641 <3 597 <3 530 3 484 4 536 4 501 <3 472 <3 427  
NZDep2013 
quintile 






Rate Rate Rate Rate Rate Rate Rate Rate Rate Rate Rate 
1 (least 
deprived) 
 7.9  11.2  8.3  8.9  11.7  8.9  7.1  10.8  8.8  7.8  7.8 0.24 
2  9.8  9.2  11.1  10.6  10.4  9.3  8.3  8.3  8.8  9.3  9.5 0.15 
3  11.5  11.1  9.9  9.6  9.9  9.0  11.7  11.0  8.4  9.1  9.5 0.068 
4  10.9  9.2  11.7  10.2  10.3  9.6  8.4  10.2  10.3  9.4  8.8 0.061 
5 (most 
deprived) 
 11.2  12.3  13.4  13.5  11.0  14.3  12.5  13.1  11.0  13.0  12.0 0.96 
Unknown  -  -  -  -  -  -  -  -  -  -  - - 
Sources: Numerator: PMMRC’s perinatal data extract 2007–2017; Denominator: MAT births 2007–2017. 
 
With regard to specific conditions that show a consistent gradient by deprivation, only deaths due to spontaneous preterm delivery showed a clear increase 
with increasing deprivation. However, due to the smaller numbers of deaths due to other conditions, any potential gradients will require more years’ data to 
become apparent (Table 3.19). 
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Table 3.19: Perinatal death classification (PSANZ-PDC) specific perinatal related mortality rates (per 1,000 births) (excluding congenital abnormalities) by 
NZDep2013 quintile* 2013–2017 
Perinatal death 
classification (PSANZ-PDC) 
Quintile 1 (least 
deprived) 
Quintile 2 Quintile 3 Quintile 4 
Quintile 5 (most 
deprived) 
n=42,919 n=47,625 n=53,822 n=67,134 n=86,301 
n % Rate n % Rate n % Rate n % Rate n % Rate 
Perinatal infection 11 4.3 0.26 18 5.9 0.38 26 6.4 0.48 20 4.3 0.30 45 6.0 0.52 
Hypertension 6 2.4 0.14 8 2.6 0.17 9 2.2 0.17 22 4.8 0.33 24 3.2 0.28 
Antepartum haemorrhage 44 17.3 1.03 47 15.5 0.99 62 15.3 1.15 80 17.4 1.19 135 17.9 1.56 
Maternal conditions 18 7.1 0.42 16 5.3 0.34 26 6.4 0.48 27 5.9 0.40 72 9.5 0.83 
Specific perinatal condition 46 18.1 1.07 57 18.8 1.20 61 15.1 1.13 75 16.3 1.12 82 10.8 0.95 
Hypoxic peripartum death 5 2.0 0.12 10 3.3 0.21 12 3.0 0.22 22 4.8 0.33 22 2.9 0.25 
Fetal growth restriction 29 11.4 0.68 26 8.6 0.55 48 11.9 0.89 35 7.6 0.52 60 7.9 0.70 
Spontaneous preterm 30 11.8 0.70 55 18.2 1.15 61 15.1 1.13 88 19.1 1.31 164 21.7 1.90 
Unexplained antepartum death 59 23.2 1.37 64 21.1 1.34 91 22.5 1.69 86 18.7 1.28 140 18.5 1.62 
No obstetric antecedent 6 2.4 0.14 <3 x s 8 2.0 0.15 6 1.3 0.09 12 1.6 0.14 
* Excludes 11 babies with unknown NZDep2013 quintile. 
‘x’ indicates percentage suppressed due to small numbers. 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract (excluding congenital abnormalities) 2013–2017; Denominator: MAT births 2013–2017. 
 
When the effect of deprivation is examined for Māori and New Zealand Europeans, it is important to consider the distribution of deprivation in these two 
groups. Figure 3.11 shows the distribution of all infants under the age of 1 year in Aotearoa/New Zealand by NZDep2013 decile. Deprivation deciles, as the 
name implies, divide the population of Aotearoa/New Zealand into 10 deciles, with 10% of the population in each one. For babies of New Zealand European 
mothers, there is approximately 10% of the population in each decile, with the exception of decile 10, in which there is 5%. However, for Māori, there are very 
few babies born into NZDep2013 deciles 1 to 5, with over half of babies being born into deciles 8 to 10. This shows the unequal distribution of deprivation 
between babies of Māori and New Zealand European mothers. 
 
Figure 3.12 shows the perinatal related mortality rate by NZDep2013 decile. Overall, mortality rates increase with increasing deprivation for babies of both 
Māori and New Zealand European mothers, with those in decile 10 having the highest mortality rates. 
 
For Māori, because mortality rates are highest in those in decile 10 areas, and there are a larger number of Māori babies born into decile 10 areas, they are 
disproportionately affected by perinatal related mortality. Figure 3.13 presents the number of deaths by NZDep2013 decile, and shows that the burden of 
perinatal related mortality is experienced by Māori communities living in decile 10 areas, with nearly twice as many deaths in this group as in any other. 
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Figure 3.11: All births by NZDep2013 decile, Māori and New Zealand European, 2008–2017 
 
Source: MAT births 2008–2017. 
Figure 3.12: Perinatal related mortality rates (per 1,000 births) by NZDep2013 decile, Māori and  
New Zealand European, 2008–2017 
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Figure 3.13: Perinatal related mortality (number of deaths) by NZDep2013 decile, Māori and New Zealand 
European, 2008–2017 
 
Source: PMMRC’s perinatal data extract 2008–2017. 
Body mass index (BMI) 
BMI is used here as a proxy indicator of risk. Higher BMI has a number of implications for the health of the 
mother and the baby, as well as implications for care. While not a perfect measure of all these aspects, it is 
straightforward to calculate, and therefore forms the basis of most risk assessment in studies that help in 
our understanding of adverse weight-related outcomes. 
 
Women with a high BMI are more likely to have higher amounts of visceral fat, which is associated with a 
higher risk of gestational diabetes.19 However, as it is not currently feasible to determine visceral fat on all 
pregnant women, BMI is used as a proxy, albeit imperfect, indicator of risk. In general, women with a higher 
BMI have an increased amount of visceral fat.20 However, distribution of fat does vary by ethnic group. For 
example, women of Indian ethnicity tend to have higher amounts of total body fat with lower BMI.21 As well 
                                               
19 Bartha JL, Marín-Segura P, González-González NL, et al. 2007. Ultrasound evaluation of visceral fat and metabolic risk factors 
during early pregnancy. Obesity 15: 2233–9. 
20 Carrol JF, Chiapa AL, Rodriquez M, et al. 2008. Visceral fat, waist circumference and BMI: Impact of race/ethnicity. Obesity 16: 
600–7. 
21 Lear SA, Kohli S, Bondy GP, et al. 2009. Ethnic variation in fat and lean body mass and the association with insulin resistance. 
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as the risk from gestational diabetes,22 obesity as measured by BMI increases the risk of stillbirth,23, 24 
hypertension25 and pre-eclampsia.26 
 
In addition, it is important for providers to consider the care needs of women with higher weight. Increased 
access to ultrasound may be required, as abdominal palpation can be difficult. Furthermore, different 
equipment is often needed, such as appropriate-sized blood pressure cuffs, hoists, and suitably weight-
rated beds and operating tables. DHBs need to have appropriate equipment to meet the needs of women in 
their care, in order to provide care in a way that does not cause discomfort or distress to women. 
 
Our data show that regardless of whether data from MAT (Table 3.20 and Figure 3.14) or the PMMRC 
(Table 3.21) were used, mortality from stillbirths, neonatal deaths and perinatal related deaths overall 
increased with increasing maternal BMI. Due to incomplete matching between the two data sets, there 
were some individuals who were in the PMMRC data set but not in MAT, and other situations where 
individuals in MAT were not able to be matched to the PMMRC records. Using PMMRC data for maternal 
BMI (numerator) had the net effect of reducing the numbers of women in BMI categories 25.00–29.99 and 
30.00–34.99, and increasing the numbers of women in BMI categories 35.00–39.99 and ≥40. This suggests 
that MAT records provide an underestimate of true maternal BMI. 
Table 3.20: Perinatal related mortality rates (per 1,000 births) by maternal BMI at registration with maternity 








deaths (total) Termination of 
pregnancy 
Stillbirths 
N=274,506 n=551 n=1,261 n=655 n=2,467 
N % n % Rate n % Rate n % Rate n % Rate 
<18.50 7,648 2.8 16 2.9 2.09 21 1.7 2.75 14 2.1 1.84 51 2.1 6.67 
18.50–24.99 130,864 47.7 291 52.8 2.22 491 38.9 3.75 247 37.7 1.90 1,029 41.7 7.86 
25.00–29.99 71,278 26.0 139 25.2 1.95 371 29.4 5.20 173 26.4 2.44 683 27.7 9.58 
30.00–34.99 36,988 13.5 67 12.2 1.81 179 14.2 4.84 122 18.6 3.32 368 14.9 9.95 
35.00–39.99 17,290 6.3 24 4.4 1.39 119 9.4 6.88 60 9.2 3.50 203 8.2 11.74 
≥40 9,941 3.6 13 2.4 1.31 76 6.0 7.65 38 5.8 3.86 127 5.1 12.78 
Unknown 497 0.2 <3 x - 4 0.3 - <3 x - 6 0.2 - 
Data not supplied to MAT 18   -   −21   −3   
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice.  
‘x’ indicates percentage suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, 2013–2017; Denominator: MAT births 2013–
2017. 
 
                                               
22 Torloni MR, Betrán AP, Horta BL, et al. 2008. Prepregnancy BMI and the risk of gestational diabetes: A systematic review of the 
literature with meta-analysis. Obesity Reviews 10(2): 194–203. 
23 Yao R, Ananth CV, Park BY, et al. 2014. Obesity and the risk of stillbirth: A population-based cohort study. American Journal of 
Obstetrics and Gynaecology 210: 457.e1–9. 
24 Lindam A, Johansson S, Stephansson O, et al. 2016. High maternal body mass index in early pregnancy and risks of stillbirth 
and infant mortality – a population-based sibling study in Sweden. American Journal of Epidemiology 184(2): 98–105. 
25 Weiss JL, Malone FD, Emig D, et al. 2004. Obesity, obstetric complications and cesarean delivery rate – a population-based 
screening study. American Journal of Obstetrics & Gynecology 190: 1091–7. 
26 Anderson N, McCowan L, Fyfe E, et al, on behalf of the SCOPE Consortium. 2012. The impact of maternal body mass index on 
the phenotype of pre-eclampsia: A prospective cohort study. British Journal of Obstetrics and Gynaecology 119: 589–95.  
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Table 3.21: Perinatal related mortality rates (per 1,000 births) by maternal BMI at registration with maternity 








deaths Termination of 
pregnancy 
Stillbirths 
N=274,506 n=569 n=1,261 n=634 n=2,464 
N % n % Rate n % Rate n % Rate n % Rate 
<18.50 7,648 2.8 16 2.8 2.09 22 1.7 2.88 8 1.3 1.05 46 1.9 6.01 
18.50–24.99 130,864 47.7 295 51.8 2.25 497 39.4 3.80 240 37.9 1.83 1,032 41.9 7.89 
25.00–29.99 71,278 26.0 143 25.1 2.01 354 28.1 4.97 174 27.4 2.44 671 27.2 9.41 
30.00–34.99 36,988 13.5 66 11.6 1.78 183 14.5 4.95 106 16.7 2.87 355 14.4 9.60 
35.00–39.99 17,290 6.3 26 4.6 1.50 121 9.6 7.00 62 9.8 3.59 209 8.5 12.09 
≥40 9,941 3.6 17 3.0 1.71 78 6.2 7.85 40 6.3 4.02 135 5.5 13.58 
Unknown 497 0.2 6 1.1 - 6 0.5 - 4 0.6 - 16 0.6 - 
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
BMI = body mass index. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, 2013–2017; Denominator: MAT births 2013–
2017. 
Figure 3.14: Perinatal related death rates (per 1,000 births) by maternal BMI* (with 95% CIs) 2013–2017 
 
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
BMI = body mass index. 
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Parity 
Overall, mortality rates showed a U-shaped curve by parity, with primiparous and multiparous women with 
four or more previous babies having the highest mortality rate. This was largely driven by the high rate of 
stillbirths. There is no statistically significant variation in mortality by parity for neonatal deaths or 
terminations of pregnancy (Figure 3.15 and Table 3.22). 
Figure 3.15: Perinatal related mortality rates (per 1,000 births) by maternal parity* (with 95% CIs)  
2013–2017 
 
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, 2013–2017; Denominator: MAT births 2013–
2017. 





Perinatal related deaths 
(total) Termination of 
pregnancy 
Stillbirths 
N=274,506 n=551 n=1,261 n=655 n=2,467 
N % n % Rate n % Rate n % Rate n % Rate 
0 112,322 40.9 238 43.2 2.12 584 46.3 5.20 312 47.6 2.80 1,134 46.0 10.10 
1 92,610 33.7 191 34.7 2.06 325 25.8 3.51 174 26.6 1.89 690 28.0 7.45 
2 40,727 14.8 83 15.1 2.04 176 14.0 4.32 99 15.1 2.45 358 14.5 8.79 
3 15,937 5.8 25 4.5 1.57 81 6.4 5.08 41 6.3 2.59 147 6.0 9.22 
4 6,741 2.5 10 1.8 1.48 47 3.7 6.97 13 2.0 1.94 70 2.8 10.38 
≥5 6,067 2.2 4 0.7 0.66 48 3.8 7.91 16 2.4 2.66 68 2.8 11.21 
Unknown 102 0.0 - - - - - - - - - - - - 
Data not supplied to MAT  18   -   −21   −3   
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
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Maternal smoking 
Data on smoking in pregnancy come from MAT and are based on LMC registration data; specifically, the 
smoking status of the woman at first LMC registration.27 
 
Our data showed mortality rates were statistically significantly higher in babies of mothers who smoked, 
compared with those who did not smoke, for all types of death, excluding termination of pregnancy (Figure 
3.16 and Table 3.23). 
 
There is evidence from the literature that outcomes for babies can be improved where women are 
supported to stop smoking. In a multi-centre study of nulliparous women, rates of spontaneous preterm 
birth and small for gestational age babies in women who quit smoking before 15 weeks’ gestation were the 
same as for non-smokers.28 Furthermore, there is evidence that incentives are effective in reducing 
smoking rates in pregnancy.29 For example, Counties Manukau DHB has had the Smokefree Pregnancy 
Incentives Programme operating since 2013. This programme has a 70% 4-week quit rate, which is similar 
across all ethnicities.30 Given the significance of smoking as a risk factor, the clear improvement in 
outcomes when women are able to quit, and that effective smoking cessation programmes exist, resource 
should be invested in reducing this modifiable risk factor. 
                                               
27 National Health Board Business Unit. 2011. National Maternity Collection Data Mart Data Dictionary. URL: 
https://www.health.govt.nz/system/files/documents/publications/mat-dict-v1-0.pdf (accessed 15 August 2018), p 174. 
28 McCowan L, Dekker GA, Chan E, et al. 2009. Spontaneous preterm birth and small for gestational age infants in women who 
stop smoking early in pregnancy: prospective cohort study. BMJ 338: b1081. URL: https://doi.org/10.1136/bmj.b1081 (accessed 15 
August 2019). 
29 Tappin D, Bauld L, Purves D, et al. 2015. Financial incentives for smoking cessation in pregnancy: randomised controlled trial. 
BMJ 350: h134. URL: https://doi.org/10.1136/bmj.h134 (accessed 15 August 2019). 
30 Counties Manukau Health. 2018. Women’s Health and Newborn Annual Report 2017–2018. URL: 
https://countiesmanukau.health.nz/our-services/womens-health/maternity-services/womens-health-and-newborn-annual-report/ 
(accessed 30 August 2019). 
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Figure 3.16: Perinatal related mortality rates (per 1,000 births) by smoking at registration with maternity 
care* (with 95% CIs) 2013–2017 
 
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, 2013–2017; Denominator: MAT births 2013–
2017. 









deaths (total) Termination of 
pregnancy 
Stillbirths 
N=274,506 n=551 n=1,261 n=655 n=2,467 
N % n % Rate n % Rate n % Rate n % Rate 
Smoker 39,041 14.2 49 8.9 1.26 242 19.2 6.20 156 23.8 4.03 447 18.1 11.45 
Non-smoker 235,385 85.7 502 91.1 2.13 1,019 80.8 4.33 499 76.2 2.13 2,020 81.9 8.58 
Unknown 80 0.0 - - - - - - - - - - - - 
Data not supplied to MAT  18   -   −21   −3   
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, 2013–2017; Denominator: MAT births 2013–
2017. 
DHB of residence 
Variations in rates by DHB may exist for a number of reasons. Mortality rates can be influenced by 
underlying population characteristics, geographic isolation, resourcing, delivery of care and other factors. 
Despite this, DHBs are charged with meeting the needs of the population they serve. Furthermore, those 
DHBs with a rate similar to the national rate may still have groups within their DHBs who do not experience 
the same level of care and outcomes of others in the DHB region, and a within-DHB assessment of any 
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Perinatal related mortality rates varied by DHB of residence, with Waitematā and Capital & Coast DHBs 
having rates that were statistically significantly lower than the national rate of 10.09 per 1,000 births. 
Women living in Northland and Counties Manukau DHBs had perinatal related mortality rates that were 
statistically significantly higher than the national rate (Figure 3.17 and   
   50 
Table 3.24). 
Figure 3.17: Unadjusted perinatal related mortality rates (per 1,000 births) by DHB of residence (mother) 
compared with New Zealand perinatal related mortality (with 95% CIs) 2013–2017 
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Table 3.24: Perinatal related mortality rates (per 1,000 births) by DHB of maternal residence 2013–2017 






deaths (total) Termination of 
pregnancy 
Stillbirths 
N=301,043 n=679 n=1,535 n=824 n=3,038 
N % n % Rate n % Rate n % Rate n % Rate 
Northland 11,016 3.7 26 3.8 2.36 75 4.9 6.81 33 4.0 3.02 134 4.4 12.16 
Waitematā 39,286 13.0 113 16.6 2.88 160 10.4 4.07 81 9.8 2.08 354 11.7 9.01 
Auckland 30,399 10.1 93 13.7 3.06 135 8.8 4.44 75 9.1 2.49 303 10.0 9.97 
Counties Manukau 41,713 13.9 98 14.4 2.35 268 17.5 6.42 172 20.9 4.16 538 17.7 12.90 
Waikato 26,774 8.9 60 8.8 2.24 149 9.7 5.57 85 10.3 3.20 294 9.7 10.98 
Bay of Plenty 14,529 4.8 28 4.1 1.93 77 5.0 5.30 54 6.6 3.74 159 5.2 10.94 
Lakes 7,527 2.5 17 2.5 2.26 41 2.7 5.45 15 1.8 2.01 73 2.4 9.70 
Hauora Tairāwhiti 3,669 1.2 4 0.6 1.09 19 1.2 5.18 8 1.0 2.19 31 1.0 8.45 
Taranaki 7,502 2.5 13 1.9 1.73 39 2.5 5.20 22 2.7 2.95 74 2.4 9.86 
Hawke’s Bay 10,571 3.5 19 2.8 1.80 55 3.6 5.20 21 2.5 2.00 95 3.1 8.99 
Whanganui 4,151 1.4 6 0.9 1.45 20 1.3 4.82 14 1.7 3.39 40 1.3 9.64 
MidCentral 10,693 3.6 20 2.9 1.87 46 3.0 4.30 27 3.3 2.54 93 3.1 8.70 
Wairarapa 2,461 0.8 3 0.4 1.22 21 1.4 8.53 5 0.6 2.05 29 1.0 11.78 
Capital & Coast 17,901 5.9 24 3.5 1.34 74 4.8 4.13 40 4.9 2.25 138 4.5 7.71 
Hutt Valley 9,787 3.3 13 1.9 1.33 48 3.1 4.90 28 3.4 2.88 89 2.9 9.09 
Nelson Marlborough 7,465 2.5 14 2.1 1.88 30 2.0 4.02 18 2.2 2.43 62 2.0 8.31 
West Coast 1,787 0.6 7 1.0 3.92 12 0.8 6.72 5 0.6 2.83 24 0.8 13.43 
Canterbury 31,186 10.4 72 10.6 2.31 165 10.7 5.29 65 7.9 2.10 302 9.9 9.68 
South Canterbury 3,282 1.1 4 0.6 1.22 13 0.8 3.96 14 1.7 4.29 31 1.0 9.45 
Southern 17,140 5.7 43 6.3 2.51 83 5.4 4.84 36 4.4 2.12 162 5.3 9.45 
Other* 2,204 0.7 <3 x - 5 0.3 - 6 0.7 - 13 0.4 - 
Total 301,043 100.0 679 100.0 2.26 1,535 100.0 5.10 824 100.0 2.76 3,038 100.0 10.09 
* Other includes Overseas, Unknown and Other. 
‘x’ indicates percentage suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract 2013–2017; Denominator: MAT births 2013–2017. 
 
There was substantial variation in stillbirth rates by DHB of residence. Compared with the national rate, 
mothers in Waitematā DHB had a statistically significantly lower rate. Mothers residing in Northland, 
Counties Manukau and Wairarapa DHBs had a statistically significantly higher rate than the national rate 
(Figure 3.18). 
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Figure 3.18: Unadjusted stillbirth rates (per 1,000 births) by DHB of residence (mother) compared with 
average stillbirth rates (with 95% CIs) 2013–2017 
 
 
Sources: Numerator: PMMRC’s perinatal data extract stillbirths only, 2013–2017; Denominator: MAT births 2013–2017. 
 
Due to smaller numbers, the neonatal death rates by DHB of residence are more prone to variation and 
have wider confidence intervals. When compared with the national rate, Waitematā and Canterbury DHBs 
had statistically significantly lower rates, while Counties Manukau and Bay of Plenty had statistically 
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Figure 3.19: Unadjusted neonatal mortality rates (per 1,000 births) by DHB of residence (mother) compared 




Sources: Numerator: PMMRC’s perinatal data extract, neonatal deaths only, 2013–2017; Denominator: MAT births excluding fetal 
deaths 2013–2017. 
Gestational age and birthweight 
There has been little change in perinatal related mortality by gestational age over the time period 2009–
2017. While the risk of death appears highest from 41 weeks’ gestation onwards, this is influenced by the 
number of ongoing pregnancies (the denominator). As there are fewer ongoing pregnancies at this 
gestation compared with 23–24 weeks’ gestation, the mortality ratio (per 1,000 ongoing pregnancies) is 
higher from 41 weeks (Figure 3.20). While the rate of death at later gestations is lower (2.01 per 1,000 
births at ≥40 weeks’ gestation compared with 736.36 per 1,000 births at 23–24 weeks’ gestation) (Table 






































DHB of maternal residence
Unadjusted neonatal death rate NZ neonatal death rate 2013–2017
   54 
Figure 3.20: Perinatal related mortality risk (per 1,000 ongoing pregnancies) by gestational age at birth and 
year 2009–2017 
 

















































Gestation at birth (weeks)
2009–2011 2012–2014 2015–2017
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deaths (total) Termination of 
pregnancy 
Stillbirths 
N=60,454 n=133 n=287 n=171 n=591 
N % n % Rate n % Rate n % Rate n % Rate 
Gestation at birth (weeks) 
20–22 210 0.3 81 60.9 * 72 25.1 * 56 32.7 * 209 35.4 * 
23–24 110 0.2 25 18.8 227.27 27 9.4 245.45 29 17.0 500.00 81 13.7 736.36 
25–27 212 0.4 16 12.0 75.47 30 10.5 141.51 18 10.5 108.43 64 10.8 301.89 
28–31 474 0.8 5 3.8 10.55 30 10.5 63.29 13 7.6 29.61 48 8.1 101.27 
32–36 3,730 6.2 5 3.8 1.34 48 16.7 12.87 23 13.5 6.26 76 12.9 20.38 
37–40 46,621 77.1 <3 x s 68 23.7 1.46 27 15.8 0.58 96 16.2 2.06 
≥41 8,451 14.0 - - - 12 4.2 1.42 5 2.9 0.59 17 2.9 2.01 
Unknown 646 1.1 - - - - - - - - - - - - 
Birthweight (g) 
<500  206 0.3 69 51.9 * 96 33.4 * 45 26.3 * 210 35.5 * 
500–999 314 0.5 47 35.3 149.68 49 17.1 156.05 58 33.9 266.06 154 26.1 490.45 
1,000–1,499 364 0.6 13 9.8 35.71 16 5.6 43.96 13 7.6 38.81 42 7.1 115.38 
1,500–1,999 659 1.1 <3 x s 25 8.7 37.94 7 4.1 11.06 33 5.6 50.08 
2,000–2,499 2,227 3.7 <3 x s 18 6.3 8.08 8 4.7 3.62 28 4.7 12.57 
2,500–2,999 8,055 13.3 - - - 20 7.0 2.48 16 9.4 1.99 36 6.1 4.47 
3,000–3,499 19,517 32.3 - - - 43 15.0 2.20 12 7.0 0.62 55 9.3 2.82 
3,500–3,999 18,037 29.8 - - - 14 4.9 0.78 9 5.3 0.50 23 3.9 1.28 
4,000–4,499 6,593 10.9 - - - 4 1.4 0.61 <3 x s 6 1.0 0.91 
≥4,500 1,359 2.2 - - - <3 x s - - - <3 x s 
Unknown 3,123 5.2 <3 x s <3 x s <3 x s 3 0.5 - 
* Denominator data unreliable where asterisk is present, and therefore rates have not been calculated. 
‘x’ indicates percentage suppressed due to small numbers. 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract 2017; Denominator: MAT births 2017. 
 
Over the time period 2007–2017, there is some evidence of a statistically significant decrease in the risk of 
death for babies born at 28–31 and 37–38 weeks’ gestation (Table 3.26). 
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Table 3.26: Perinatal related mortality risk (per 1,000 ongoing pregnancies) 2007–2017 



































Gestation at birth (weeks)  
20–22 204 217 207 218 210 216 231 248 230 235 231 247 215 217 245 253 169 175 206 214 210 209  
23–24 117 81 131 98 137 105 122 81 129 95 119 94 123 85 137 98 117 92 126 84 110 81  
25–27 232 64 241 62 237 70 228 73 185 52 219 70 192 55 187 49 206 52 187 50 212 64  
28–31 530 57 559 65 539 66 560 52 511 58 503 50 471 49 462 46 458 41 482 48 474 48  
32–36 3,842 88 3,959 80 3,978 90 4,004 101 3,909 87 3,931 73 3,723 91 3,727 85 3,648 78 3,817 79 3,730 76  
37–38 12,852 65 13,019 59 13,145 78 13,610 62 13,171 64 13,440 65 13,399 38 13,678 56 13,600 42 14,484 59 14,658 45  
39–40 34,367 73 34,736 82 34,630 72 34,593 65 33,877 59 33,589 51 32,205 51 32,161 60 32,125 69 32,067 56 31,963 51  
≥41  12,330 34 11,667 37 11,740 32 11,550 26 10,729 17 10,325 20 9,478 14 9,092 12 9,071 29 8,781 20 8,451 17  
Unknown 726 <3 1,104 - 586 <3 551 - 501 - 923 - 327 - 390 - 383 - 450 - 646 -  






  Risk Risk Risk Risk Risk Risk Risk Risk Risk Risk Risk 
Gestation at birth (weeks) 
20–22 3.37 3.38 3.34 3.82 3.75 3.96 3.63 4.24 2.95 3.56 3.49 0.68 
23–24 1.26 1.52 1.63 1.25 1.52 1.51 1.43 1.65 1.55 1.40 1.36 0.76 
25–27 1.00 0.97 1.09 1.13 0.83 1.13 0.92 0.83 0.88 0.84 1.08 0.33 
28–31 0.89 1.02 1.03 0.81 0.93 0.81 0.83 0.78 0.70 0.80 0.81 0.049 
32–36 1.39 1.26 1.42 1.58 1.41 1.19 1.55 1.45 1.33 1.34 1.29 0.73 
37–38 1.09 0.99 1.31 1.04 1.11 1.13 0.69 1.02 0.77 1.07 0.82 0.023 
39–40 1.56 1.77 1.55 1.41 1.32 1.16 1.22 1.45 1.67 1.37 1.26 0.14 
≥41  2.76 3.17 2.73 2.25 1.58 1.94 1.48 1.32 3.20 2.28 2.01 0.074 
Unknown - - - - - - - - - - - - 
Sources: Numerator: PMMRC’s perinatal data extract 2007–2017; Denominator: MAT births 2007–2017. 
 
There has been no significant increase in termination of pregnancy rates by gestation (from 20 weeks’ gestation onwards) over the study period 2007–2017 
(Table 3.27). 
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Termination of pregnancy  
                     
20–22 204 103 207 94 210 88 231 92 230 107 231 118 215 83 245 91 169 66 206 87 210 81  
23–24 117 22 131 25 137 31 122 20 129 29 119 32 123 32 137 31 117 27 126 32 110 25  
25–27 232 10 241 14 237 9 228 20 185 15 219 14 192 16 187 10 206 8 187 13 212 16  
28–31 530 6 559 7 539 4 560 6 511 11 503 5 471 5 462 7 458 3 482 14 474 5  
≥32 63,391 3 63,381 5 63,493 6 63,757 13 61,686 9 61,285 3 58,805 5 58,658 11 58,444 3 59,149 2 58,802 6  
Unknown 726 - 1,104 - 586 - 551 - 501 - 923 - 327 - 390 - 383 - 450 - 646 -  








Risk Risk Risk Risk Risk Risk Risk Risk Risk Risk Risk 
Termination of pregnancy            
20–22 1.60 1.46 1.36 1.42 1.71 1.89 1.39 1.52 1.11 1.45 1.35 0.21 
23–24 0.34 0.39 0.48 0.31 0.46 0.52 0.54 0.52 0.46 0.53 0.42 0.11 
25–27 0.16 0.22 0.14 0.31 0.24 0.23 0.27 0.17 0.14 0.22 0.27 0.62 
28–31 0.09 0.11 0.06 0.09 0.18 0.08 0.08 0.12 0.05 0.23 0.08 0.39 
≥32 0.05 0.08 0.09 0.20 0.15 0.05 0.09 0.19 0.05 0.03 0.10 0.78 
Unknown - - - - - - - - - - - - 
Sources: Numerator: PMMRC’s perinatal data extract, terminations of pregnancy only, 2007–2017; Denominator: MAT births 2007–2017. 
 
There is some evidence of a statistically significant decrease in stillbirths at 28–31 weeks’ gestation, and at term (37–40 weeks) (Table 3.28). There is also 
some evidence of a statistically significant reduction in neonatal death in those born at ≥41 weeks’ gestation, but a statistically significant increase in deaths at 
20–22 weeks’ gestation (Table 3.29). 
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Table 3.28: Stillbirth risk (per 1,000 ongoing pregnancies) 2007–2017 
Gestation at 
birth (weeks) 


































Stillbirths                        
20–22 204 79 207 95 210 88 231 94 230 90 231 85 215 88 245 110 169 73 206 83 210 72  
23–24 117 25 131 40 137 43 122 31 129 37 119 28 123 29 137 28 117 32 126 29 110 27  
25–27 232 39 241 34 237 39 228 32 185 24 219 36 192 25 187 25 206 31 187 26 212 30  
28–31 530 43 559 38 539 48 560 32 511 34 503 30 471 32 462 31 458 29 482 22 474 30  
32–36 3,842 64 3,959 54 3,978 60 4,004 66 3,909 55 3,931 54 3,723 63 3,727 58 3,648 48 3,817 60 3,730 48  
37–40 47,219 98 47,755 99 47,775 111 48,203 78 47,048 83 47,029 78 45,604 60 45,839 72 45,725 72 46,551 76 46,621 68  
≥41 12,330 20 11,667 19 11,740 19 11,550 14 10,729 9 10,325 9 9,478 9 9,092 3 9,071 20 8,781 14 8,451 12  
Unknown 726 <3 1,104 - 586 <3 551 - 501 - 923 - 327 - 390 - 383 - 450 - 646 -  
Gestation at 
birth (weeks) 
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Chi-squared 
test for trend 
(p) Risk Risk Risk Risk Risk Risk Risk Risk Risk Risk Risk 
Stillbirths             
20–22 1.23 1.47 1.36 1.45 1.43 1.36 1.47 1.84 1.23 1.38 1.20 0.9993 
23–24 0.39 0.62 0.67 0.48 0.59 0.45 0.49 0.47 0.54 0.48 0.45 0.44 
25–27 0.61 0.53 0.61 0.50 0.38 0.58 0.42 0.42 0.52 0.43 0.50 0.18 
28–31 0.67 0.59 0.75 0.50 0.55 0.49 0.54 0.52 0.49 0.37 0.51 0.012 
32–36 1.01 0.85 0.94 1.04 0.89 0.88 1.07 0.99 0.82 1.01 0.82 0.65 
37–40 1.65 1.67 1.87 1.31 1.44 1.36 1.09 1.31 1.31 1.37 1.23 0.0015 
≥41 1.62 1.63 1.62 1.21 0.84 0.87 0.95 0.33 2.20 1.59 1.42 0.60 
Unknown - - - - - - - - - - - - 
Sources: Numerator: PMMRC’s perinatal data extract, stillbirths only, 2007–2017; Denominator: MAT births 2007–2017. 
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Table 3.29: Neonatal death risk (per 1,000 ongoing pregnancies) 2007–2017 
Gestation at 
birth (weeks) 


































Neonatal deaths  
20–22 22 35 18 29 34 40 45 62 33 38 28 44 44 46 44 52 30 36 36 44 57 56  
23–24 70 34 66 33 63 31 71 30 63 29 59 34 62 24 78 39 58 33 65 23 58 29  
25–27 183 15 193 14 189 22 176 21 146 13 169 20 151 14 152 14 167 13 148 11 166 18  
28–31 481 8 514 20 487 14 522 14 466 13 468 15 434 12 424 8 426 9 446 12 439 13  
32–36 3,775 21 3,900 21 3,913 25 3,929 26 3,846 24 3,874 16 3,656 24 3,664 22 3,597 27 3,755 17 3,677 23  
37–40 47,121 40 47,656 42 47,663 38 48,121 45 46,964 39 46,951 38 45,543 28 45,761 38 45,653 39 46,475 39 46,552 27  
≥41 12,310 14 11,648 18 11,721 13 11,536 12 10,720 8 10,316 11 9,469 5 9,089 9 9,051 9 8,767 6 8,439 5  
Unknown 725 - 1,104 - 585 - 551 - 501 - 923 - 327 - 390 - 383 - 450 - 646 -  
Gestation at 
birth (weeks) 
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 Chi-squared 
test for 
trend (p) Risk Risk Risk Risk Risk Risk Risk Risk Risk Risk Risk 
Neonatal deaths 
20–22 0.55 0.45 
0.52 
0.62 0.96 0.61 0.71 0.77 0.88 0.61 0.74 0.94 0.006 
23–24 0.53 0.48 0.47 0.47 0.55 0.40 0.66 0.56 0.39 0.49 0.84 
25–27 0.23 0.22 0.34 0.33 0.21 0.32 0.24 0.24 0.22 0.18 0.30 0.65 
28–31 0.13 0.31 0.22 0.22 0.21 0.24 0.20 0.14 0.15 0.20 0.22 0.57 
32–36 0.33 0.33 0.39 0.41 0.39 0.26 0.41 0.38 0.46 0.29 0.39 0.73 
37–40 0.67 0.71 0.64 0.75 0.68 0.66 0.51 0.69 0.71 0.71 0.49 0.38 
≥41 1.14 1.55 1.11 1.04 0.75 1.07 0.53 0.99 0.99 0.68 0.59 0.033 
Unknown - - - - - - - - - - - - 
Sources: Numerator: PMMRC’s perinatal data extract specific neonatal deaths 2007–2017; Denominator: MAT births excluding fetal deaths 2007–2017. 
 
Over the time period 2007–2017, there was some evidence of a decrease in the mortality rate from intrapartum stillbirth in babies aged 23–27 weeks. There 
was strong evidence for a reduction in intrapartum stillbirth in babies born at term (37 weeks onwards) (Table 3.30 and Figure 3.21). The reduction in deaths 
of babies was similar in Māori mothers as in New Zealand European mothers (data not shown). 
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Table 3.30: Intrapartum stillbirth rates (per 1,000 ongoing pregnancies) by gestation excluding congenital abnormalities 2007–2017 
Gestation at 
birth (weeks) 
2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017  
n N n N n N n N n N n N n N n N n N n N n N  
23–27 8 64,173 13 64,218 18 64,303 13 64,550 16 62,394 10 62,021 10 59,497 8 59,335 8 59,131 6 59,835 4 59,509  
28–36 6 63,856 5 63,876 5 63,962 <3 64,243 4 62,115 3 61,725 <3 59,220 3 59,049 <3 58,841 <3 59,565 3 59,228  
≥37 25 59,518 21 59,394 22 59,486 16 59,722 9 57,743 12 57,327 3 55,061 10 54,897 17 54,764 12 55,307 10 55,060  
Gestation at 
birth (weeks) 





Rate Rate Rate Rate Rate Rate Rate Rate Rate Rate Rate 
23–27 0.12 0.20 0.28 0.20 0.26 0.16 0.17 0.13 0.14 0.10 0.07 0.015 
28–36 0.09 0.08 0.08 0.03 0.06 0.05 0.03 0.05 0.03 0.03 0.05 0.094 
≥37 0.42 0.35 0.37 0.27 0.16 0.21 0.05 0.18 0.31 0.22 0.18 0.001 
Sources: Numerator: PMMRC’s perinatal data extract, stillbirths only (excluding congenital abnormalities) 2007–2017; Denominator: MAT births 2007–2017. 
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Figure 3.21: Intrapartum stillbirth risks (per 1,000 ongoing pregnancies) by gestation at birth (weeks) 
excluding congenital abnormalities 2007–2017 
 
Sources: Numerator: PMMRC’s perinatal data extract, stillbirths only (excluding congenital abnormalities), 2007–2017; 
Denominator: MAT births 2007–2017. 
Mortality by customised birthweight centile 
There has been very little change in the perinatal related mortality rate in singleton non-anomalous 
appropriate and large for gestational age babies over the last 10 years. However, deaths in small for 
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Figure 3.22: Perinatal related mortality rates by customised centile group among singleton births* from 26 
weeks’ gestation without congenital abnormalities 2008–2017 
 
 
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, from 26 weeks’ gestation without congenital 
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Small for gestational age Appropriate for gestational age Large for gestational age Unknown/missing data Total 
N=49,441 n=451   N=384,014 n=952   N=63,563 n=188   N=24,740 n=107   N=521,758 n=1,698   
N n Rate N n Rate N n Rate N n Rate N n Rate 
2008 4,805 50 10.41 36,473 99 2.71 6,160 21 3.41 2,700 17 6.30 50,138 187 3.73 
2009 5,016 53 10.57 37,093 110 2.97 6,149 21 3.42 2,567 19 7.40 50,825 203 3.99 
2010 5,074 52 10.25 38,148 96 2.52 6,288 22 3.50 2,678 7 2.61 52,188 177 3.39 
2011 5,089 44 8.65 37,956 80 2.11 6,127 22 3.59 2,746 13 4.73 51,918 159 3.06 
2012 5,032 44 8.74 39,194 96 2.45 6,533 12 1.84 2,234 6 2.69 52,993 158 2.98 
2013 4,885 42 8.60 37,972 87 2.29 6,199 23 3.71 2,367 7 2.96 51,423 159 3.09 
2014 4,955 44 8.88 38,655 93 2.41 6,377 15 2.35 2,273 5 2.20 52,260 157 3.00 
2015 4,864 43 8.84 39,180 102 2.60 6,381 19 2.98 2,477 7 2.83 52,902 171 3.23 
2016 4,952 36 7.27 39,579 97 2.45 6,660 19 2.85 2,407 16 6.65 53,598 168 3.13 
2017 4,769 43 9.02 39,764 92 2.31 6,689 14 2.09 2,291 10 4.36 53,513 159 2.97 
Data not supplied to MAT 86   −38   −59   5   −6  
* MAT data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the Section 88 Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, among singleton births from 26 weeks’ gestation without congenital abnormalities 2008–2017; Denominator: 
MAT births among singleton births from 26 weeks’ gestation 2008–2017. 
 
From 26 weeks’ gestation onwards, there was a significant reduction in mortality as baby birthweight approached the 50th–74th customised centile group. 
Those babies with a customised birthweight under the 5th centile had a substantially higher mortality rate, even compared with those in the 5th–9th centile. 
Mortality was lowest in those with a birthweight in the 50th–74th centile group. Babies with a birthweight in the customised centile group 90th or above had a 
statistically significantly higher mortality rate than those in the 50th–74th and 75th–90th centiles (Figure 3.23). 
 
 
   64 
Figure 3.23: Perinatal related mortality rates (with 95% CIs) by customised birthweight centile group among 
singleton births from 26 weeks’ gestation without congenital abnormalities 2008–2017* 
 
* All data limited to mothers who were registered for care with an LMC (either a midwife, Obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, among singleton births from 26 weeks’ 
gestation without congenital abnormalities 2008–2017; Denominator: MAT births among singleton births from 26 weeks’ gestation 
2008–2017. 
Multiple pregnancies 
Mortality rates in multiple pregnancies were substantially higher than for singletons, for all types of deaths 
except terminations of pregnancy. There have not been any significant changes in the mortality rates in 
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Figure 3.24: Perinatal related mortality rates (per 1,000 births) among babies born in multiple pregnancies 
2007–2017 
 
Sources: Numerator: PMMRC’s perinatal data extract among babies born in multiple pregnancies 2007–2017; Denominator: MAT 
births among babies born in multiple pregnancies 2007–2017. 
Table 3.32: Perinatal related mortality rates among babies born in multiple pregnancies 2007–2017 







deaths (total) Termination of 
pregnancy 
Stillbirths 
n=79 n=381 n=277 n=737 
n Rate n Rate n Rate n Rate 
2007 2,011 3 1.49 34 16.91 25 12.66 62 30.83 
2008 1,924 3 1.56 33 17.15 18 9.53 54 28.07 
2009 1,849 5 2.70 32 17.31 31 17.11 68 36.78 
2010 1,906 9 4.72 35 18.36 35 18.80 79 41.45 
2011 1,827 18 9.85 48 26.27 27 15.33 93 50.90 
2012 1,806 14 7.75 34 18.83 32 18.20 80 44.30 
2013 1,743 8 4.59 40 22.95 16 9.44 64 36.72 
2014 1,727 10 5.79 34 19.69 40 23.77 84 48.64 
2015 1,667 2 1.20 29 17.40 20 12.22 51 30.59 
2016 1,631 3 1.84 33 20.23 11 6.90 47 28.82 
2017 1,553 4 2.58 29 18.67 22 14.47 55 35.42 
Chi-squared test 
for trend (p) 
0.83 0.49 0.79 0.69 
‘s’ indicates rate suppressed due to small numbers. 
Sources: Numerator: PMMRC’s perinatal data extract among babies born in multiple pregnancies 2007–2017; Denominator: MAT 
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Death investigation 
Overall, approximately half of babies had optimal investigation into the cause(s) of their death. This is 
defined here as post-mortem or karyotype confirming chromosomal abnormality or clinical 
examination/investigation confirming the diagnosis. This was higher for terminations of pregnancy and 
stillbirths, and less for neonatal deaths (Table 3.33). 
Table 3.33: Perinatal related deaths and completeness of perinatal death investigations 2017 











n=133 n=287 n=171 n=591 
n % n % n % n % 
Optimal investigation* 75 56.39 146 50.87 61 35.67 282 47.72 
Post-mortem 43 32.33 131 45.64 46 26.90 220 37.23 
Karyotype 31 23.31 12 4.18 8 4.68 51 8.63 
Clinical examination/investigations confirm diagnosis 4 3.01 11 3.83 9 5.26 24 4.06 
Partial investigations only# 49 36.84 104 36.24 97 56.73 250 42.30 
Placental pathology performed+ 74 55.64 231 80.49 126 73.68 431 72.93 
No investigation^ 9 6.77 37 12.89 13 7.60 59 9.98 
Unknown - - - - - - - - 
* Optimal investigation is defined as post-mortem or karyotype confirming congenital abnormality or clinical 
examination/investigation confirming diagnosis. Note: more than 1 option can be selected. 
# No post-mortem; investigations may have included placental pathology, magnetic resonance imaging (MRI), ultrasound scan or x-
ray. 
+ Includes both placental histology with post-mortem and as part of partial investigation. 
^ No post-mortem, placental pathology, MRI, ultrasound scan or x-ray. 
Source: PMMRC’s perinatal data extract 2017. 
 
Table 3.34 shows the degree to which perinatal deaths were investigated. There were higher proportions of 
Māori mothers who were offered post-mortem but declined, and consequently a larger number of Māori 
babies who did not have any investigation. The proportion of women who were not offered a post-mortem 
for their babies was reasonably consistent by prioritised ethnic group, with the exception of MELAA, who 
were not offered a post-mortem more frequently than other groups (Table 3.34). 
 
   67 
























n=798 n=393 n=235 n=266 n=501 n=65 n=1,106 n=173 n=1,279 n=2 n=3,038 
n % n % n % n % n % n % n % n % n % n % n % 
Post-mortem offered and parental 
consent given 
183 22.9 123 31.3 98 41.7 117 44.0 215 42.9 29 44.6 540 48.8 91 52.6 631 49.3 2.0 100.0 1,183 38.9 
Post-mortem offered and parents 
declined 
558 69.9 241 61.3 130 55.3 134 50.4 264 52.7 28 43.1 492 44.5 68 39.3 560 43.8 - - 1,651 54.3 
Post-mortem not offered 47 5.9 24 6.1 3 1.3 14 5.3 17 3.4 8 12.3 64 5.8 11 6.4 75 5.9 - - 171 5.6 
Unknown 10 1.3 5 1.3 4 1.7 <3 x 5 1.0 - - 10 0.9 3 1.7 13 1.0 - - 33 1.1 
Optimal investigation* 252 31.6 156 39.7 113 48.1 162 60.9 275 54.9 38 58.5 655 59.2 112 64.7 767 60.0 2.0 100.0 1,490 49.0 
Post-mortem 183 22.9 123 31.3 98 41.7 117 44.0 215 42.9 29 44.6 540 48.8 91 52.6 631 49.3 2.0 100.0 1,183 38.9 
Karyotype 46 5.8 24 6.1 15 6.4 45 16.9 60 12.0 9 13.8 110 9.9 20 11.6 130 10.2 - - 269 8.9 
Clinical examination/ 
investigations confirm diagnosis 
38 4.8 15 3.8 5 2.1 11 4.1 16 3.2 <3 x 56 5.1 6 3.5 62 4.8 - - 133 4.4 
Partial investigations only# 362 45.4 194 49.4 111 47.2 90 33.8 201 40.1 23 35.4 397 35.9 51 29.5 448 35.0 - - 1,228 40.4 
No investigation+ 182 22.8 42 10.7 10 4.3 13 4.9 23 4.6 4 6.2 49 4.4 10 5.8 59 4.6 - - 310 10.2 
Unknown <3 x <3 x <3 x <3 x <3 x - - 5 0.5 - - 5 0.4 - - 10 0.3 
* Optimal investigation is defined as post-mortem or karyotype confirming congenital abnormality or clinical examination/investigation confirming diagnosis. Note: more than 1 option can be 
selected. 
# No post-mortem; investigations may have included placental pathology, magnetic resonance imaging (MRI), ultrasound scan or x-ray. 
+ No post-mortem, placental pathology, MRI, ultrasound scan or x-ray. 
‘x’ indicates percentage suppressed due to small numbers. 




Local review of cases showed there were a number of deaths that had potentially avoidable aspects. 
Contributory factors were thought to be present in just under one third of perinatal related deaths (excluding 
termination of pregnancy) (Table 3.35). 











n=133 n=287 n=171 n=591 
n % n % n % n % 
Contributory factors         
Present 8 6.0 90 31.4 51 29.8 149 25.2 
Absent 124 93.2 194 67.6 114 66.7 432 73.1 
Missing data <3 x 3 1.0 6 3.5 10 1.7 
Potentially avoidable         
Yes <3 x 52 18.1 25 14.6 78 13.2 
Contributory factors present but not potentially 
avoidable 
7 5.3 36 12.5 26 15.2 69 11.7 
Contributory factors present but avoidability 
unknown 
- - <3 x - - <3 x 
 ‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s perinatal data extract 2017, local review data. 
 
 
Contributory factors were characterised by organisational and/or management factors, personnel factors, 
and barriers to access. Of these, ‘barriers to access and/or engagement with care’ was the most common 
contributory factor cited (Table 3.36). 




Any contributory factor  1,539   26.5  
Organisational and/or management factors  296   5.1  
Personnel factors  472   8.1  
Barriers to access and/or engagement with care  1,105   19.0  
Source: PMMRC’s perinatal data extract 2009–2017, local review data. 
 
 
Barriers to care was most notable for perinatal infection, maternal conditions and situations where there 
was no obstetric antecedent. Personnel factors were more common in hypertension, hypoxic peripartum 
death and fetal growth restriction (Figure 3.25 and Table 3.37). 
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Figure 3.25: Main contributory factor(s) in potentially avoidable perinatal related deaths (as a percentage of 
all deaths in each PSANZ-PDC category) by perinatal death classification (PSANZ-PDC) 2013–2017* 
 
* Excludes two deaths where specific contributory factors were not identified. 
Source: PMMRC’s perinatal data extract 2013–2017, local review data. 
Table 3.37: Main contributory factor(s) in potentially avoidable perinatal related death by perinatal death 
classification (PSANZ-PDC) 2013–2017 





Potentially avoidable  
Organisation/management Personnel Barriers 
n n % n % n % 
Congenital abnormality 838 3 0.4 4 0.5 9 1.1 
Perinatal infection 120 <3 x 15 12.5 20 16.7 
Hypertension 69 5 7.2 12 17.4 7 10.1 
Antepartum haemorrhage 373 7 1.9 15 4.0 26 7.0 
Maternal conditions* 167 10 6.0 21 12.6 55 32.9 
Specific perinatal conditions 326 9 2.8 15 4.6 12 3.7 
Hypoxic peripartum death 71 15 21.1 23 32.4 14 19.7 
Fetal growth restriction 198 12 6.1 31 15.7 24 12.1 
Spontaneous preterm  400 13 3.3 16 4.0 32 8.0 
Unexplained antepartum death 442 7 1.6 24 5.4 40 9.0 
No obstetric antecedent 34 3 8.8 <3 x 21 61.8 
* Excludes two deaths where specific contributory factors were not identified. 
‘x’ indicates percentage suppressed due to small numbers. 





























Perinatal death classification (PSANZ-PDC)
Organisation/management Personnel Barriers
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Organisational or management barriers were frequent amongst Māori and Pacific mothers, with personnel 
being a significant factor for those in Asian and MELAA ethnic groups (Figure 3.26 and Table 3.38). 
Figure 3.26: Main contributory factor(s) in potentially avoidable perinatal related deaths (as a percentage of 
all deaths) by maternal prioritised ethnic group 2013–2017 
 
* Excludes one death where specific contributory factors were not identified. 
MELAA = Middle Eastern, Latin American, or African. 
Source: PMMRC’s perinatal data extract 2013–2017, local review data. 
Table 3.38: Main contributory factor(s) in potentially avoidable perinatal related deaths by maternal 






Potentially avoidable  
Organisation/management Personnel Barriers 
n n % n % n % 
Māori# 798 22 2.8 47 5.9 124 15.5 
Pacific peoples 393 13 3.3 28 7.1 57 14.5 
Asian 501 8 1.6 27 5.4 11 2.2 
Indian 235 5 2.1 18 7.7 8 3.4 
Other Asian 266 3 1.1 9 3.4 3 1.1 
MELAA 65 3 4.6 8 12.3 <3 x 
European 1,279 40 3.1 68 5.3 66 5.2 
NZ European 1,106 38 3.4 65 5.9 62 5.6 
Other European 173 <3 x 3 1.7 4 2.3 
* Excludes two unknown maternal ethnicity perinatal related deaths (total). 
# Excludes one death where specific contributory factors were not identified. 
‘x’ indicates percentage suppressed due to small numbers. 







































Maternal prioritised ethnic group
Organisation/management Personnel Barriers
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As the level of deprivation increased, barriers to accessing care became more significant, particularly in 
NZDep2013 quintile 5 (Figure 3.27 and Table 3.39). 
Figure 3.27: Main contributory factor(s) in potentially avoidable perinatal related deaths (as a percentage of 
all deaths) by NZDep2013 quintile 2013–2017 
 
* Excludes two deaths where specific contributory factors were not identified. 
Source: PMMRC’s perinatal data extract 2013–2017, local review data. 
Table 3.39: Main contributory factor(s) in potentially avoidable perinatal related deaths by NZDep2013 





Potentially avoidable  
Organisation/management Personnel Barriers 
n n % n % n % 
1 (least deprived) 365 6 1.6 14 3.8 18 4.9 
2 422 14 3.3 18 4.3 16 3.8 
3 536 23 4.3 29 5.4 32 6.0 
4* 634 12 1.9 36 5.7 43 6.8 
5 (most deprived)  1,066 29 2.7 81 7.6 146 13.7 
Unknown 15 <3 x - - 5 33.3 
* Excludes one death where specific contributory factors were not identified. 
‘x’ indicates percentage suppressed due to small numbers. 



































Resuscitation of babies born at 23–26 weeks’ gestation requires careful discussion with parents about the 
implications of resuscitating, or not. We are unable to determine for which babies resuscitation was 
discussed, offered and declined, and for which babies resuscitation was not discussed or offered. Table 
3.40 shows the number of babies for which resuscitation was attempted, by maternal prioritised ethnic 
group. 
Table 3.40: Resuscitation and survival (to 28 days) by maternal prioritised ethnic group for live born babies 
at 23–26 weeks’ gestation without congenital abnormalities 2008–2017 










Māori 573 115 43 158 
Pacific peoples 239 44 25 69 
Asian 201 36 16 52 
Indian 87 14 12 26 
Other Asian 114 22 4 26 
MELAA 33 6 4 10 
European 616 103 28 131 
NZ European 501 87 24 111 
Other European 115 16 4 20 
Unknown/Other 1 1 - 1 
Total 1,663 305 116 421 
* Includes congenital abnormalities 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s perinatal data extract where matched to MAT data, 23–26 weeks’ gestation, 2008–2017; Live 




Perinatal mortality appended tables 
Table 3.41: Perinatal related death and perinatal death classification (PSANZ-PDC) 2008–2017 
Perinatal death classification (PSANZ-PDC) 
2008–2012 2013–2017 
n=3,476 n=3,038 
n Rate n Rate 
  Congenital abnormality     
1.1 Central nervous system 189 0.59 159 0.53 
1.2 Cardiovascular system 133 0.41 126 0.42 
1.3 Urinary system 70 0.22 59 0.20 
1.4 Gastrointestinal system 18 0.06 17 0.06 
1.5 Chromosomal 301 0.93 266 0.88 
1.6 Metabolic 14 0.04 11 0.04 
1.7 Multiple/Non-chromosomal syndromes 124 0.38 100 0.33 
1.8 Other congenital abnormality     
1.81 Musculoskeletal 45 0.14 50 0.17 
1.82 Respiratory 5 0.02 4 0.01 
1.83 Diaphragmatic hernia 30 0.09 14 0.05 
1.84 Haematological 6 0.02 3 0.01 
1.85 Tumours 11 0.03 7 0.02 
1.88 Other specified congenital abnormality 16 0.05 10 0.03 
1.9 Unspecified congenital abnormality 20 0.06 12 0.04 
  Perinatal infection     
2.1 Bacterial     
2.11 Group B Streptococcus 23 0.07 26 0.09 
2.12 E. coli 12 0.04 10 0.03 
2.13 Listeria monocytogenes 7 0.02 10 0.03 
2.14 Spirochaetal (eg, syphilis) <3 s 3 0.01 
2.18 Other bacterial 13 0.04 22 0.07 
2.19 Unspecified bacterial 11 0.03 16 0.05 
2.2 Viral     
2.21 Cytomegalovirus 23 0.07 12 0.04 
2.22 Parvovirus 9 0.03 3 0.01 
2.23 Herpes simplex virus 3 0.01 3 0.01 
2.28 Other viral <3 s - - 
2.29 Unspecified viral <3 s - - 
2.3 Protozoal (eg, Toxoplasma) 7 0.02 5 0.02 
2.5 Fungal - - <3 s 
2.8 Other specified organism <3 s - - 
2.9 Other unspecified organism 9 0.03 9 0.03 
  Hypertension     
3.1 Chronic hypertension: essential 9 0.03 10 0.03 
3.2 Chronic hypertension: secondary (eg, renal disease) 5 0.02 <3 s 
3.3 Chronic hypertension: unspecified 4 0.01 <3 s 
3.4 Gestational hypertension 10 0.03 4 0.01 
3.5 Pre-eclampsia 63 0.20 37 0.12 
3.51 Pre-eclampsia: With laboratory evidence of thrombophilia 4 0.01 4 0.01 
3.6 Pre-eclampsia superimposed on chronic hypertension 16 0.05 7 0.02 
3.61 
Pre-eclampsia superimposed on chronic hypertension: With laboratory 
evidence of thrombophilia 
3 0.01 - - 
3.9 Unspecified hypertension 4 0.01 3 0.01 
  Antepartum haemorrhage (APH)     
4.1 Placental abruption 188 0.58 129 0.43 
4.11 Placental abruption: With laboratory evidence of thrombophilia 16 0.05 4 0.01 
4.2 Placenta praevia 10 0.03 9 0.03 
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4.3 Vasa praevia 3 0.01 <3 s 
4.8 Other APH 40 0.12 115 0.38 
4.9 APH of undetermined origin 104 0.32 114 0.38 
  Maternal conditions     
5.1 Termination of pregnancy for maternal psychosocial indications 19 0.06 23 0.08 
5.2 Diabetes/Gestational diabetes 62 0.19 58 0.19 
5.3 Maternal injury - - <3 s 
5.31 Maternal injury: Accidental 6 0.02 17 0.06 
5.32 Maternal injury: Non-accidental 5 0.02 5 0.02 
5.4 Maternal sepsis 8 0.02 14 0.05 
5.5 Antiphospholipid syndrome 15 0.05 11 0.04 
5.51 Other maternal thrombophilia (if considered cause of death) 3 0.01 <3 s 
5.6 Obstetric cholestasis - - 3 0.01 
5.8 Other specified maternal conditions 37 0.11 34 0.11 
  Specific perinatal conditions     
6.1 Twin–twin transfusion 110 0.34 73 0.24 
6.2 Fetomaternal haemorrhage 45 0.14 34 0.11 
6.3 
Antepartum cord complications (eg, cord haemorrhage; true knot with 
evidence of occlusion) 
12 0.04 - - 
6.31 Cord haemorrhage 6 0.02 7 0.02 
6.32 True knot with evidence of occlusion 13 0.04 13 0.04 
6.38 Other 42 0.13 36 0.12 
6.4 Uterine abnormalities (eg, bicornuate uterus, cervical incompetence) 61 0.19 65 0.22 
6.5 Birth trauma (typically infants of >24 weeks’ gestation or >600g birthweight) <3 s - - 
6.6 Alloimmune disease     
6.61 Alloimmune disease: Rhesus <3 s <3 s 
6.64 Alloimmune disease: Alloimmune thrombocytopenia 3 0.01 3 0.01 
6.63 Alloimmune disease: Kell - - <3 s 
6.68 Alloimmune disease: Other - - <3 s 
6.7 Idiopathic hydrops 20 0.06 20 0.07 
6.8 
Other specific perinatal conditions (includes iatrogenic conditions such as 
rupture of membranes after amniocentesis, termination of pregnancy for 
suspected but unconfirmed congenital abnormality) 
    
6.81 Rupture of membranes after amniocentesis 8 0.02 4 0.01 
6.82 
Termination of pregnancy for suspected but unconfirmed congenital 
abnormality 
- - 4 0.01 
6.83 Fetal subdural haematoma 4 0.01 4 0.01 
6.88 Other 33 0.10 57 0.19 
6.89 Unspecified - - <3 s 
  Hypoxic peripartum death     
7.1 With intrapartum complications     
7.11 With intrapartum complications: Uterine rupture 6 0.02 5 0.02 
7.12 With intrapartum complications: Cord prolapse 13 0.04 6 0.02 
7.13 With intrapartum complications: Shoulder dystocia 3 0.01 - - 
7.18 With intrapartum complications: Other 14 0.04 6 0.02 
7.2 
Evidence of non-reassuring fetal status in a normally grown infant (eg, 
abnormal fetal heart rate, fetal scalp pH/lactate, fetal pulse oximetry without 
intrapartum complications) 
51 0.16 39 0.13 
7.3 No intrapartum complications and no evidence of non-reassuring fetal status 7 0.02 10 0.03 
7.9 Unspecified hypoxic peripartum death 28 0.09 5 0.02 
  Fetal growth restriction (FGR)     
8.1 
With evidence of reduced vascular perfusion on Doppler studies and/or 
placental histopathology (eg, significant infarction, acute atherosis, maternal 
and/or fetal vascular thrombosis or maternal floor infarction) 
161 0.50 129 0.43 
8.2 With chronic villitis <3 s 10 0.03 
8.3 No placental pathology 25 0.08 7 0.02 
8.4 No examination of placenta 15 0.05 12 0.04 
8.8 Other specified placental pathology 51 0.16 38 0.13 
8.9 Unspecified or not known whether placenta examined <3 s <3 s 
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  Spontaneous preterm     
9.1 
Spontaneous preterm with intact membranes, or membrane rupture <24 
hours before delivery 
- - <3 s 
9.11 
Spontaneous preterm with intact membranes, or membrane rupture <24 
hours before delivery: With chorioamnionitis 
112 0.35 113 0.38 
9.12 
Spontaneous preterm with intact membranes, or membrane rupture <24 
hours before delivery: Without chorioamnionitis 
61 0.19 36 0.12 
9.13 
Spontaneous preterm with intact membranes, or membrane rupture <24 
hours before delivery: No examination of placenta 
7 0.02 11 0.04 
9.17 No clinical signs of chorioamnionitis, no examination of placenta 59 0.18 44 0.15 
9.19 
Spontaneous preterm with intact membranes, or membrane rupture <24 
hours before delivery: Unspecified or not known whether placenta examined 
33 0.10 5 0.02 
9.2 Spontaneous preterm with membrane rupture ≥24 hours before delivery     
9.21 
Spontaneous preterm with membrane rupture ≥24 hours before delivery: 
With chorioamnionitis 
130 0.40 121 0.40 
9.22 
Spontaneous preterm with membrane rupture ≥24 hours before delivery: 
Without chorioamnionitis 
19 0.06 10 0.03 
9.23 
Spontaneous preterm with membrane rupture ≥24 hours before delivery: 
With clinical evidence of chorioamnionitis, no examination of placenta 
21 0.07 12 0.04 
9.27 No clinical signs of chorioamnionitis, no examination of placenta 20 0.06 25 0.08 
9.29 
Spontaneous preterm with membrane rupture ≥24 hours before delivery: 
Unspecified or not known whether placenta examined 
11 0.03 3 0.01 
9.3 
Spontaneous preterm with membrane rupture of unknown duration before 
delivery 
    
9.31 
Spontaneous preterm with membrane rupture of unknown duration before 
delivery: With chorioamnionitis 
8 0.02 11 0.04 
9.32 
Spontaneous preterm with membrane rupture of unknown duration before 
delivery: Without chorioamnionitis 
3 0.01 4 0.01 
9.33 
Spontaneous preterm with membrane rupture of unknown duration before 
delivery: With clinical evidence of chorioamnionitis, no examination of 
placenta 
4 0.01 - - 
9.37 No clinical signs of chorioamnionitis, no examination of placenta 5 0.02 <3 s 
9.39 
Spontaneous preterm with membrane rupture of unknown duration before 
delivery: Unspecified or not known whether placenta examined 
11 0.03 <3 s 
  Unexplained antepartum death     
10.1 
With evidence of reduced vascular perfusion on Doppler studies and/or 
placental histopathology (eg, significant infarction, acute atherosis, maternal 
and/or fetal vascular thrombosis or maternal floor infarction) 
65 0.20 34 0.11 
10.2 With chronic villitis 6 0.02 10 0.03 
10.3 No placental pathology 114 0.35 110 0.37 
10.4 No examination of placenta 92 0.29 75 0.25 
10.8 Other specified placental pathology 161 0.50 211 0.70 
10.9 Unspecified or not known whether placenta examined 16 0.05 <3 s 
  No obstetric antecedent     
11.1 Sudden infant death syndrome (SIDS)     
11.11 
SIDS Category IA: Classic features of SIDS present, completely 
documented 
- - <3 s 
11.13 
SIDS Category II: Infant deaths that meet Category I except for one or more 
features 
<3 s - - 
11.2 Postnatally acquired infection 10 0.03 5 0.02 
11.3 Accidental asphyxiation - - <3 s 
11.4 Other accident, poisoning or violence (postnatal) 3 0.01 - - 
11.8 Other specified 3 0.01 4 0.01 
11.9 Unknown/Undetermined 3 0.01 <3 s 
11.91 Unclassified sudden infant death 22 0.07 21 0.07 
11.92 Other Unknown/Undetermined <3 s <3 s 
Sources: Numerator: PMMRC’s perinatal data extract 2008–2017; Denominator: MAT births 2008–2017. 
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Table 3.42: Neonatal death and primary neonatal death classification (PSANZ-NDC) 2008–2017 
  Neonatal death classification (PSANZ-NDC) 
2008–2012 2013–2017 
n=912 n=824 
n Rate n Rate 
  Congenital abnormality         
1.1 Central nervous system 23 0.07 18 0.06 
1.2 Cardiovascular system 34 0.11 30 0.10 
1.3 Urinary system 26 0.08 15 0.05 
1.4 Gastrointestinal system 4 0.01 6 0.02 
1.5 Chromosomal 52 0.16 45 0.15 
1.6 Metabolic 13 0.04 12 0.04 
1.7 Multiple/Non-chromosomal syndromes 30 0.09 32 0.11 
1.8 Other congenital abnormality     
1.81 Musculoskeletal 6 0.02 10 0.03 
1.82 Respiratory 4 0.01 <3 s 
1.83 Diaphragmatic hernia 21 0.07 8 0.03 
1.84 Haematological <3 s <3 s 
1.85 Tumours <3 s 4 0.01 
1.88 Other specified congenital abnormality 4 0.01 5 0.02 
1.9 Unspecified congenital abnormality - - <3 s 
  Extreme prematurity     
2.1 Not resuscitated 261 0.81 281 0.94 
2.2 Unsuccessful resuscitation 54 0.17 24 0.08 
2.9 Unspecified or not known whether resuscitation attempted - - - - 
  Cardio-respiratory disorders     
3.1 Hyaline membrane disease/Respiratory distress syndrome (RDS) 28 0.09 24 0.08 
3.2 Meconium aspiration syndrome - - 2 0.01 
3.3 Primary persistent pulmonary hypertension 3 0.01 4 0.01 
3.4 Pulmonary hypoplasia 15 0.05 19 0.06 
3.5 
Chronic neonatal lung disease (typically, bronchopulmonary 
dysplasia) 
5 0.02 - - 
3.6 Pulmonary haemorrhage 9 0.03 5 0.02 
3.7 Pneumothorax - - <3 s 
3.8 Other 5 0.02 10 0.03 
  Infection     
4.1 Bacterial     
4.11 Congenital bacterial     
4.111 Congenital bacterial: Group B Streptococcus 14 0.04 10 0.03 
4.112 Congenital bacterial: E. coli 9 0.03 8 0.03 
4.113 Congenital bacterial: Listeria monocytogenes <3 s 3 0.01 
4.114 Congenital bacterial: Spirochaetal (eg, syphilis) - - <3 s 
4.118 Congenital bacterial: Other bacterial 9 0.03 6 0.02 
4.119 Congenital bacterial: Unspecified bacterial 6 0.02 8 0.03 
4.12 Acquired bacterial     
4.121 Acquired bacterial: Group B Streptococcus 4 0.01 <3 s 
4.122 Acquired bacterial: E. coli 4 0.01 - - 
4.125 Acquired bacterial: Other Gram negative bacilli (other than E. coli) 3 0.01 <3 s 
4.126 Acquired bacterial: Staphylococcus aureus 4 0.01 6 0.02 
4.127 Acquired bacterial: Coagulase negative Staphylococcus 3 0.01 <3 s 
4.128 Acquired bacterial: Other specified bacterial 7 0.02 3 0.01 
4.129 Acquired bacterial: Unspecified bacterial <3 s <3 s 
4.2 Viral     
4.21 Congenital viral     
4.211 Congenital viral: Cytomegalovirus 3 0.01 <3 s 
4.213 Congenital viral: Herpes simplex virus <3 s 3 0.01 
4.218 Congenital viral: Other specified viral <3 s - - 
4.22 Acquired viral     
4.223 Acquired viral: Herpes simplex virus <3 s <3 s 
4.228 Acquired viral: Other specified viral 3 0.01 <3 s 
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4.229 Acquired viral: Unspecified viral <3 s - - 
4.5 Fungal - - 3 0.01 
4.9 Unspecified organism 7 0.02 <3 s 
  Neurological     
5.1 
Hypoxic ischaemic encephalopathy/Perinatal asphyxia (typically 
infants of >24 weeks’ gestation or >600g birthweight) 
117 0.37 77 0.26 
5.2 Intracranial haemorrhage     
5.21 Intraventrical haemorrhage 24 0.07 43 0.14 
5.22 Subgaleal haemorrhage <3 s - - 
5.23 Subarachnoid haemorrhage <3 s - - 
5.24 Subdural haemorrhage <3 s <3 s 
5.28 Other intracranial haemorrhage <3 s 4 0.01 
5.8 Other 3 0.01 - - 
  Gastrointestinal     
6.1 Necrotising enterocolitis 15 0.05 14 0.05 
6.8 Other 3 0.01 <3 s 
  Other     
7.1 Sudden infant death syndrome (SIDS)     
7.11 
SIDS Category IA: Classic features of SIDS present and completely 
documented 
- - <3 s 
7.13 
SIDS Category II: Infant deaths that meet category I except for one 
or more features 
<3 s - - 
7.2 Multisystem failure     
7.21 Multisystem failure: Secondary to intrauterine growth restriction 3 0.01 4 0.01 
7.28 Multisystem failure: Other specified 4 0.01 9 0.03 
7.29 
Multisystem failure: Unspecified/undetermined primary cause or 
trigger event 
<3 s - - 
7.3 Trauma - - <3 s 
7.31 Trauma: Accidental 3 0.01 4 0.01 
7.32 Trauma: Non-accidental <3 s - - 
7.4 Treatment complications     
7.41 Treatment complications: Surgical - - <3 s 
7.42 Treatment complications: Medical <3 s <3 s 
7.8 Other specified 8 0.02 9 0.03 
7.9 Unknown/Undetermined     
7.91 Unclassified sudden infant death <3 s 3 0.01 
7.911 Unclassified sudden infant death: Bed sharing 29 0.09 24 0.08 
7.912 Unclassified sudden infant death: Not bed sharing 4 0.01 3 0.01 
Sources: Numerator: PMMRC's perinatal data extract, neonatal deaths only, 2008–2017; Denominator: MAT births excluding fetal 
deaths 2008–2017.  
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Table 3.43: Perinatal death classification (PSANZ-PDC) of fetal death by gestational age 2013–2017 
Perinatal death 
classification (PSANZ-PDC) 
Gestation age (weeks) 
Total 
20–22 23–24 25–27 28–31 32–36 37–40 ≥41 weeks 
n % n % n % n % n % n % n % 
Congenital abnormality 656 342 52.1 129 19.7 59 9.0 42 6.4 55 8.4 24 3.7 5 0.8 
Perinatal infection 72 16 22.2 12 16.7 7 9.7 11 15.3 7 9.7 14 19.4 5 6.9 
Hypertension 56 6 10.7 6 10.7 13 23.2 8 14.3 14 25.0 8 14.3 <3 x 
Antepartum haemorrhage 226 128 56.6 25 11.1 8 3.5 10 4.4 32 14.2 21 9.3 <3 x 
Maternal conditions 134 48 35.8 16 11.9 11 8.2 14 10.4 21 15.7 20 14.9 4 3.0 
Specific perinatal conditions 249 63 25.3 34 13.7 25 10.0 27 10.8 45 18.1 49 19.7 6 2.4 
Hypoxic peripartum death 27 - - - - - - - - <3 x 20 74.1 6 22.2 
Fetal growth restriction 184 17 9.2 19 10.3 39 21.2 32 17.4 37 20.1 33 17.9 7 3.8 
Spontaneous preterm  168 129 76.8 26 15.5 3 1.8 5 3.0 5 3.0 - - - - 
Unexplained antepartum 
death 
442 85 19.2 25 5.7 35 7.9 29 6.6 79 17.9 167 37.8 22 5.0 
No obstetric antecedent - - - - - - - - - - - - - - - 
Total 2,214 834 37.7 292 13.2 200 9.0 178 8.0 296 13.4 356 16.1 58 2.6 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s perinatal data extract, fetal deaths only, 2013–2017. 
Table 3.44: Perinatal death classification (PSANZ-PDC) and neonatal death classification (PSANZ-NDC) of 
neonatal deaths by gestational age 2013–2017 
Death classification 
(PSANZ) 
Gestation age (weeks) 
Total 
20–22 23–24 25–27 28–31 32–36 37–40 ≥41 
n % n % n % n % n % n % n % 
Perinatal death classification (PSANZ-PDC) 
Congenital abnormality 182 7 3.8 1 0.5 5 2.7 16 8.8 61 33.5 79 43.4 13 7.1 
Perinatal infection 48 12 25.0 4 8.3 5 10.4 3 6.3 4 8.3 15 31.3 5 10.4 
Hypertension 13 - - 5 38.5 5 38.5 <3 x <3 x - - - - 
Antepartum haemorrhage 147 79 53.7 39 26.5 17 11.6 4 2.7 7 4.8 <3 x - - 
Maternal conditions 33 9 27.3 4 12.1 3 9.1 3 9.1 9 27.3 5 15.2 - - 
Specific perinatal conditions 77 30 39.0 14 18.2 7 9.1 11 14.3 9 11.7 5 6.5 <3 x 
Hypoxic peripartum death 44 - - - - - - <3 x <3 x 34 77.3 8 18.2 
Fetal growth restriction 14 - - - - <3 x 3 21.4 <3 x 6 42.9 <3 x 
Spontaneous preterm 232 97 41.8 81 34.9 26 11.2 12 5.2 16 6.9 - - - - 
Unexplained antepartum death - - - - - - - - - - - - - - - 
No obstetric antecedent 34 - - - - - - - - <3 x 26 76.5 6 17.6 
Neonatal death classification (PSANZ-NDC) 
Congenital abnormality 188 7 3.7 <3 x 3 1.6 16 8.5 66 35.1 82 43.6 13 6.9 
Extreme prematurity 305 226 74.1 75 24.6 4 1.3 - - - - - - - - 
Cardio-respiratory disorders 65 - - 26 40.0 16 24.6 12 18.5 6 9.2 4 6.2 <3 x 
Infection 63 - - 8 12.7 18 28.6 4 6.3 9 14.3 19 30.2 5 7.9 
Neurological 126 - - 27 21.4 20 15.9 10 7.9 23 18.3 37 29.4 9 7.1 
Gastrointestinal 15 <3 x 3 20.0 7 46.7 4 26.7 - - - - - - 
Other 62 - - 8 12.9 <3 x 8 12.9 9 14.5 29 46.8 6 9.7 
Total 824 234 28.4 148 18.0 70 8.5 54 6.6 113 13.7 171 20.8 34 4.1 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s perinatal data extract, neonatal deaths only, 2013–2017. 
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Perinatal mortality appendix: Update on previous neonatal mortality recommendations 
 
1. The PMMRC recommends the Ministry of 
Health establish a multidisciplinary working 
group to review current evidence for 
implementation of a preterm birth prevention 
programme such as that implemented in 
Western Australia, taking care to: 
a. identify and adequately resource evidence-
based solutions 
b. ensure equitable access to screening 
and/or treatment for priority populations 
c. ensure that priority populations have a 
voice in the development of health policy, 
process and practice in order to achieve 
equitable health outcomes 
d. ensure that the outcomes of any 
implemented programme, including equity 
of access, are evaluated. 
The Ministry of Health shares the PMMRC’s 
desire to see progress in reducing preterm birth 
and reducing inequalities in the maternity system. 
Over the past 10 months, the Ministry of Health 
has been working on planning and developing a 
whole of maternity system action plan that will be 
considered by Cabinet in the middle of the year. 
This action plan will direct the transformation of 
maternity services from 2019–2023 to ensure the 
maternity system is effective, sustainable and 
remains a world-class service. 
While this work is in a planning phase, through the 
Maternity Quality and Safety Programme (MQSP) 
every DHB has been asked to undertake and 
report on the following projects in the 2018/19 work 
programme: 
• reducing preterm birth and neonatal mortality 
• improving care for mothers under 20 years of 
age 
• accessing primary mental health services 
• promoting primary birthing where appropriate. 
2. Women with a previous preterm birth at less 
than 34 weeks are at increased risk of neonatal 
death. The PMMRC recommends that LMCs 
and DHBs employ strategies to reduce preterm 
birth by targeting this high-risk group, including: 
a. counselling at the time of a preterm birth to 
outline the strategies likely to be 
recommended for their next pregnancy, and 
advice to present for antenatal care as soon 
as they know they are pregnant 
b. ensuring that antenatal care is available to 
allow women to register as early as 
possible, and ensuring that early antenatal 
care includes attention to modifiable risk 
factors such as smoking, sexually 
transmitted infections, and urinary tract 
infections 
c. ensuring referral for specialist consultation 
in the first trimester to facilitate discussion 
of treatment options, which might include 
cervical cerclage or vaginal progesterone 
treatment and monitoring of cervical length 
using transvaginal ultrasound 
The Royal Australian and New Zealand College 
of Obstetricians and Gynaecologists 
(RANZCOG) plans to highlight and discuss this 
recommendation at the Clinical Directors and 
Midwifery Leaders meeting in August 2019. 
RANZCOG will also recommend that counselling at 
the time of preterm birth and strategies for possible 
future pregnancies be prominent in both DHB and 
RANZCOG guidelines as a best practice 
recommendation. 
The New Zealand College of Midwives (NZCOM) 
notes the expanding evidence base that describes 
the protective effect of midwifery continuity of care 
on preterm birth rates with a particularly strong 
protective effect for women of low socioeconomic 
position. The New Zealand model of maternity care 
is premised on continuity from a known midwife, 
and NZCOM consistently promotes and supports 
midwives to provide continuity of care as well as 
advocating for this model to be sustained as part of 
the New Zealand health system. 
NZCOM has developed and manages the Find 
Your Midwife website, which enables women to 
access up-to-date information on midwives 
availability and contact details. 
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d. counselling around signs and symptoms of 
preterm birth and how to respond to these 
to optimise outcome. 
 
It is standard midwifery practice as expressed in 
the competencies for entry to the register of 
midwives and the standards for practice that all 
women’s antenatal midwifery care includes a 
comprehensive booking visit, which includes 
assessment for modifiable risk factors. NZCOM is 
currently undertaking a review on the consensus 
statement Assessment and Promotion of Baby 
Wellbeing During Pregnancy, which includes a 
statement about booking assessment and referral. 
NZCOM’s consensus statement Sexually 
Transmitted Infections Screening has just been 
updated. 
NZCOM notes that DHBs are addressing the issue 
of first trimester registration and inequities in 
access to first trimester care through the MQSP, on 
which local midwives are contributing members. 
DHBs – The majority of DHBs note the importance 
of early registration with an LMC, early mid-stream 
urine screening, sexually transmitted infection 
screening and referral to specialist care, including 
counselling at the time of a preterm birth. This 
counselling should outline strategies likely to be 
recommended for any future pregnancy. Capital & 
Coast DHB has systems in place around triaging of 
appointments and ensuring women come to clinic 
for appropriate investigations. 
Through MQSP, the four Northern Region DHBs 
(Auckland, Counties Manukau, Northland and 
Waitematā) are working in collaboration to develop 
written information that can be used to support 
education of women and their families about the 
risks, prevention, and management of preterm 
birth. They are investigating the possibility of a 
video to support this work. Other DHBs have noted 
interest in utilising these resources once available. 
Early registration with an LMC was an area 
highlighted by multiple DHBs. Canterbury and 
West Coast DHBs note their early registration rates 
to be over 78.1% – however, there is an ethnic 
disparity in early registration. This is noted as a key 
feature in the formation of their draft strategy. 
Nelson Marlborough DHB notes their early 
registration rate to be 89% of women booked in 
first trimester. Northland DHB reports success of 
their work on early engagement in pregnancy. 
Rates of first trimester registration in Northland 
DHB have increased from 47% to 66% in the last 
financial year – however, more work needs to be 
done in the Far North, which has not reflected this 
increase. Engagement barriers were highlighted in 
Tairāwhiti and Whanganui DHBs. Whanganui DHB 
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has a severe shortage of community-based LMCs. 
In response, they have started a primary maternity 
care clinic run by a core midwife. 
A number of audits relating to preterm birth are 
underway in Hawke’s Bay, Northland, Waitematā, 
Auckland and Counties Manukau DHBs. 
Hawke’s Bay DHB has highlighted a need for a 
national approach to preterm birth. 
3. Birth in a tertiary centre is associated with 
improved outcomes for preterm babies at the 
lower limits of viability (prior to 25 weeks’ 
gestation). The PMMRC recommends the 
Ministry of Health leads the development of a 
national consensus pathway for the care of 
women in preterm labour or requiring delivery 
prior to 25 weeks’ gestation. The PMMRC 
recommends this pathway includes: 
a. ensuring that all groups of women 
(irrespective of ethnicity, age, 
socioeconomic status or place of residence) 
are offered and provided the same level of 
care 
b. strategies for secondary units for 
management of women in threatened or 
early preterm labour, or who require 
delivery, prior to 25 weeks’ gestation, 
including: 
i. administration of corticosteroids and 
magnesium sulphate 
ii. timely transfer from primary and 
secondary units to tertiary units 
iii. management of babies inadvertently 
born in their units at the lower limits of 
viability 
c. ensuring that priority populations have a 
voice in the development of health policy, 
process and practice in order to achieve 
equitable health outcomes 
d. guidance on monitoring that care provision 
is equitable by ethnicity, age, 
socioeconomic status and place of 
residence. 
As mentioned above, the Ministry of Health 
shares the PMMRC’s desire to see progress in 
reducing preterm birth and reducing inequalities in 
the maternity system. One of the themes 
mentioned in the whole of maternity system action 
plan is ‘strengthening commissioning and 
accountability; supporting quality and safety’, with 
the MQSP being central to this theme alongside 
the PMMRC, the National Maternity Monitoring 
Group, the Health Quality & Safety Commission 
and the Health Research Council. Part of this work 
is the development of a quality assurance 
framework that includes the above and will oversee 
the planning and development of: 
• maternity related reports 
• clinical indicators 
• national consensus pathways and 
guidance/guidelines 
• the MQSP. 
4. The PMMRC recommends DHBs make 
available appropriate information, including 
appropriate counselling, for parents, families 
and whānau about birth outcomes prior to 25 
weeks’ gestation to enable shared decision-
The New Zealand Newborn Clinical Network has 
produced a New Zealand Consensus Statement on 
the Care of Mother and Baby(ies) at Periviable 
Gestations, which is about to be released. The 
following bodies have endorsed this consensus 
statement: 
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making and planning of active care or palliative 
care options. 
• New Zealand Royal Australian College of 
Physicians 
• NZCOM 
• RANZCOG (formal letter is awaited) 
• Paediatric Society of New Zealand. 
This guideline standardises the care provided to 
mothers and babies. It includes parent information 
and decision aid for parents and families of babies 
likely to be born at 23–24 weeks’ gestation. 
DHBs – Some DHBs report already using this draft 
consensus statement, while others have said they 
will adopt it once finalised. 
Capital & Coast DHB collaborates with different 
areas within the hospital to provide women with 
appropriate information, including Maternal Fetal 
Medicine Services, Neonatal Intensive Care Unit, 
the DHB Palliative Care Service (when required) 
and Te Māhoe Pregnancy Counselling Service 
inpatient staff and Sands (a support network for 
bereaved parents if required). 
5. The PMMRC recommends that DHB maternity 
services audit the rates of antenatal 
corticosteroid administration, including repeat 
doses when indicated, to mothers of neonates 
live born at less than 34 weeks’ gestation, 
including auditing whether administration is 
equitable by ethnicity, DHB of residence, and 
maternal age. 
DHBs – Tairāwhiti, Hawke’s Bay, Auckland and 
Waikato DHBs have undertaken an audit of the 
rates of antenatal corticosteroid administration. 
Waikato plans to do a further audit in 2019/20 to 
look at ethnicity, DHB of residence and maternal 
age. Hawke’s Bay DHB reports that 48% of women 
completed steroids and another 30% started but 
did not complete. This was mainly due to the short 
timeframe from presentation of the labouring 
woman to the birth. Capital & Coast DHB has an 
audit in progress and Canterbury, West Coast, 
MidCentral and Hutt Valley DHBs all plan to audit 
in the 2019/20 financial year. Wairarapa DHB plans 
to be involved in a project auditing the use of 
corticosteroid administration and repeat doses 
through the MQSP. Taranaki DHB notes that they 
last audited antenatal corticosteroid administration 
in 2017. 
Northland, Hawke’s Bay and Tairāwhiti DHBs have 
also recently updated their preterm birth guidelines.  
6. The PMMRC recommends that tertiary 
obstetric and neonatal intensive care units 
investigate and address the difference between 
units in survival rates amongst infants born at 
23–26 weeks’ gestation as part of their 
benchmarking and quality and safety initiatives. 
The Newborn Clinical Network is reviewing data on 
survival over three years (numbers are small, so 
annual rates fluctuate widely). This is based on 
feedback from the Australia and New Zealand 
Neonatal Network. This review includes survival of 
all babies born after 22 weeks’ gestation but less 
than 32 weeks’ gestation. The review involves 
multidisciplinary team discussions to assess risk 
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factors and makes recommendations for future 
pregnanc(ies). 
7. The PMMRC recommends that regulatory 
bodies require cultural competency training of 
all individuals working across all areas of the 
maternity and neonatal workforce. Training 
should address awareness of, and strategies to 
reduce and minimise the impact of, implicit bias 
and racism. 
RANZCOG has introduced a mandatory 
component into the Fellowship of the Royal 
Australian and New Zealand College of 
Obstetricians and Gynaecologists training 
programme. This is an online and kanohi ki te 
kanohi (face to face) course called ‘Application of 
the Hui Process/Meihana Model to Clinical 
Practice’, which is facilitated by the Māori 
Indigenous Health Institute (MIHI), Otago 
University, Christchurch. Standards for doctors as 
part of the Medical Council of New Zealand 
statement on cultural competence will place a 
greater onus on all fellows to complete cultural 
competence and safety training like the MIHI 
course mentioned above. 
NZCOM – Although not a regulatory body, NZCOM 
has put significant focus on developing and 
providing continuing education in this area. Prior to 
the release of the PMMRC 12th annual report, 
NZCOM had initiated strategies to strengthen 
cultural consciousness within midwifery through the 
development and provision of the two new 
workshops for midwives nationally. The 
overarching aim of both workshops is to support an 
increased understanding and awareness of cultural 
consciousness within midwifery to benefit Māori 
and Pacifica women and whānau. The profession 
has welcomed the concept of raising cultural 
consciousness, which supports the development of 
cultural competency. The two workshops 
developed are: 
• Grounding Practice within Te Tiriti/the Treaty 
relationship (8-hour workshop unpacking the 
history of Aotearoa/New Zealand in order to 
understand how to be honourable partners in 
the Tiriti/Treaty relationship) 
• Birthing Across Cultures in Aotearoa/New 
Zealand (8-hour workshop for midwives to 
consider the inequities in health care outcomes 
and overall impact on health from a broader 
perspective). 
8. The PMMRC recommends that the Ministry of 
Health and DHBs have a responsibility to 
ensure that midwifery staffing ratios and 
staffing acuity tools: 
DHBs – All DHBs have the Care Capacity Demand 
Management programme, which is a set of tools 
and processes that help DHBs better match the 
capacity to care with patient demand. Many DHBs 
also have Trendcare, a planning and workload 
management system. DHBs that use these include 
Hawke’s Bay, Hutt Valley, Northland, Taranaki, 
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a. enable active observation of mothers and 
babies who are undertaking skin-to-skin 
contact in the postnatal inpatient period 
b. allow for the identification of, and additional 
needs of, mothers who have increased risk 
factors for sudden unexpected death in 
infancy (SUDI). 
Tairāwhiti, Lakes, Nelson Marlborough, Capital & 
Coast, Waikato and Canterbury. Capital & Coast 
DHB has recently participated in TrendC (acuity 
tool) timing studies to better reflect the maternity-
specific environment. 
Wairarapa DHB uses LMC advanced booking to 
allow for opportunities to plan for periods of 
increased activity and have the flexibility to 
increase the staffing on a shift-by-shift basis. 
While some DHBs do not have a problem with 
staffing, many do. Hawke’s Bay DHB notes that as 
per the national context the midwifery workforce is 
experiencing significant shortfalls, and this is a 
challenge for their DHB. Auckland and Lakes 
DHBs both also noted this challenge. 
Many DHBs have prioritised education for 
midwives, the mother and her family around safe 
sleeping and SUDI risk factors. This is due partly to 
the fact that while most often skin-to-skin time is 
supervised, there are times it is not and so 
education around safety is key. Hawke’s Bay DHB 
noted that 90–100% of women have been 
screening for SUDI risk factors, and all women who 
smoke have been referred to a smoke-free 
incentive-based programme. 
Taranaki DHB has appointed a safe sleep, SUDI, 
smoking cessation coordinator in their DHB. 
9. The PMMRC recommends that LMCs and 
DHBs ensure that every baby will have access 
to a safe sleep place on discharge from the 
hospital or birthing unit, or at home, that is their 
own place of sleep, on their back and with no 
pillow. If they do not have access to a safe 
sleep place, then a wahakura or Pēpi-Pod® 
must be made available for the baby’s use prior 
to discharge from hospital. 
RANZCOG plans to discuss this at the upcoming 
Clinical Directors and Midwifery Leaders meeting. 
NZCOM has promoted the National SUDI 
Prevention Online Training to its members, which 
includes the mnemonic PEPE, which stands for: 
• Place to put the baby in their own bed: includes 
wahakura and Pēpi-Pods 
• Eliminate smoking during pregnancy: midwives 
routinely refer for smoking cessation support 
• Position baby on their back to sleep 
• Encourage and support mum to breastfeed. 
DHBs are contracted by the Ministry of Health to 
distribute about 8,500 safe sleeping devices each 
year, including wahakura and Pēpi-Pods, with 
individual DHBs deciding which are most suitable 
for its population. In the 2018/19 period, Auckland 
DHB distributed 304 Pēpi-Pods. Many DHBs, 
including Canterbury, West Coast, Capital & Coast, 
Tairāwhiti and Hutt Valley, have wahakura for 
distribution. Canterbury, West Coast, MidCentral, 
Northland and Wairarapa DHBs also have 
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wahakura weaving wānanga (educational 
seminars) available in their DHB region. 
Auckland, Taranaki, Nelson Marlborough, 
Canterbury, West Coast and Tairāwhiti DHBs have 
appointed a safe sleep coordinator. All DHBs 
mention education as an important factor in SUDI 
prevention. This includes education of health 
professionals and education of mothers. A number 
of DHBs have mentioned the SUDI online training 
that they have encouraged staff to complete. 
Educating the mother and her family on safe sleep 
is also noted as an important part of SUDI 
prevention. Northland DHB extends education to a 
number of people and organisations, including 
midwives, childbirth educators, iwi health providers, 
Family Start, and maternal and infant health and 
pregnancy and parenting services.  
 
Perinatal mortality appendix: Update on perinatal mortality recommendations 
11. Maternity and primary care providers need to 
be aware of the increasing risk of perinatal 
mortality for mothers under 20 years of age in 
New Zealand. Inequity in perinatal mortality for 
babies born to mothers under 20 years of age 
needs to be actively addressed. The PMMRC 
recommends the Ministry of Health and DHBs: 
a. develop, in consultation with young 
mothers, acceptable and safe methods for 
mothers under 20 years of age to access 
and engage with care in order to achieve 
equitable health outcomes 
b. identify and adequately resource evidence-
based solutions to address risks for 
mothers under 20 years of age, paying 
attention to smoking cessation, screening 
and treatment for infections, screening for 
fetal growth restriction, and providing 
adequate information about the causes and 
symptoms of preterm labour 
c. consider how they can support LMCs caring 
for mothers aged under 20 years. 
DHBs – Through the MQSP, every DHB has been 
asked to undertake and report on improving care 
for mothers under 20 years of age in the 2018/19 
work programme. 
The majority of DHBs have noted antenatal (and 
postnatal) education for youth, tailored to youth, as 
well as wrap-around services for the young 
woman. These services are often provided at a 
place that is familiar to them. For example, in Hutt 
Valley DHB, antenatal education is provided at 
Vibe, a health and support youth service. In Lakes 
DHB, LMCs work in partnership with Rotovegas 
Youth Health and Anamata Cafe to provide 
integrated support for the woman. The incidence of 
unbooked or late-booking young women has 
decreased since these strategies have been 
implemented. Nelson Marlborough DHB has 
provided additional support to LMCs caring for 
pregnant women under 20 and wrap-around 
services to support these women. Services include 
mental health support care, alcohol and other drug 
addiction services, Māori health services, Well 
Child Tamariki Ora service providers, Family Start 
and Oranga Tamariki. 
GAP (Growth Assessment Protocol) is a tool often 
used to screen for fetal growth restriction. 
In Auckland DHB, the number of young mothers 
under 20 years old continues to slowly decrease 
(from 431 in 2000 to 137 in 2018, which is the 
lowest it has been). 
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12. The PMMRC recommends that DHBs with 
rates of perinatal related mortality significantly 
higher than the national rate review, or continue 
to review, the higher rate of mortality in their 
area and identify areas for improvement. 
Wairarapa DHB continues to hold PMMRC 
meetings annually or biannually depending on how 
many deaths there have been. The pathologist 
attends to present the findings of post-mortems 
that are undertaken. Stillbirths and neonatal deaths 
that occur in the DHB follow the process of 




4 Te māuiui roro i ngā pēpi whānau hou | Neonatal encephalopathy 
Introduction 
Neonatal encephalopathy (NE) is a clinically defined syndrome of disturbed neurological function within the 
first week after birth in an infant born from 35 weeks’ gestation, manifested by difficulty in initiating and 
maintaining respiration, depression of tone and reflexes, subnormal level of consciousness and often 
seizures. The severity of the encephalopathy is measured by the Sarnat stages 1, 2, or 3 or as mild, 
moderate or severe.31 
The PMMRC collects data on babies who present with moderate or severe NE in the first seven days after 
birth. Data have been collected on NE babies from 37 weeks onwards since 2010. In 2016, the PMMRC 
started collecting data on babies from 35 weeks’ gestation. Due to the small number of cases in 35–36 
weeks’ gestation babies collected to date, only data relating to babies born at 37 weeks or later are 
presented in this chapter. There are about 65 babies each year with moderate to severe NE in 
Aotearoa/New Zealand who are reported to the PMMRC. 
There are a number of risk factors for NE as identified in the peer reviewed literature. These include 
antenatal risk factors, such as maternal diabetes, obesity, thyroid dysfunction, pre-eclampsia and previous 
caesarean section, evidence of fetal growth restriction, abnormal amniotic fluid volume and abnormal fetal 
heart tracing before labour. Intrapartum risk factors include clinical chorioamnionitis and ominous fetal heart 
tracing,32 cord prolapse, placental abruption and uterine rupture.33 
Figure 4.1: NE annual and three-year rolling rates (per 1,000 term births) 2010–2017 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2017; Denominator: MAT births ≥37 weeks 2010–2017. 
31 Nelson KB, Leviton A. 1991. How much of neonatal encephalopathy is due to birth asphyxia? American Journal of Diseases of 
Children 145(11): 1325–31. 
32 Locatelli A, Incerti M, Paterlini G, et al. 2010. Antepartum and intrapartum risk factors for neonatal encephalopathy at term. 
American Journal of Perinatology 27(8): 649–54.
33 Martinez-Biarge M, Madero R, González A, et al. 2012. Perinatal morbidity and risk of hypoxic-ischemic encephalopathy 
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International comparisons 
It is frequently difficult to compare NE rates with other countries, due to differences in definitions of terms, 
inclusion and exclusion criteria, and data quality issues. A previous meta-analysis estimated the NE 
incidence in high-income regions to be 1.6 per 1,000 live births.34 The New Zealand rate of 1.2 per 1,000 
live births over the period 2010–2017 is therefore similar to other comparable countries. 
The rate of NE cases per 1,000 term births fluctuated from year to year, with a high of 1.38 per 1,000 live 
births in 2012 and a low of 1.00 in 2014. However, between the years 2010 and 2017, the rate has not 
shown a statistically significant trend up or down (chi-squared test for trend=2.41, p=0.12) (Figure 4.1). 
Over the past eight years there has been an average of 65–70 cases per year (Table 4.1). 
There was some variation in rates of NE by maternal prioritised ethnic group, with ‘Other European’ and 
‘Other Asian’ mothers having the lowest rates (Figure 4.2 and Table 4.11). 
Findings 
NE rates varied substantially by NZDep2013 quintile. Babies whose mothers lived in quintiles 2 to 5 were 
statistically significantly more likely to develop NE than those living in quintile 1 (Figure 4.3 and Table 
4.11).35
Figure 4.2: NE rates (per 1,000 term births) by maternal prioritised ethnic group (with 95% CIs) 2010–2017 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2017; Denominator: MAT births ≥37 weeks 2010–2017. 
34 Lee ACC, Kozuki N, Blencowe H, et al, 2013. Intrapartum-related neonatal encephalopathy incidence and impairment at regional 
and global levels for 2010 with trends from 1990. Pediatric Research 74(a1): 50–72. 
35 The rate ratio comparing quintile 2 with quintile 1 was 1.47, 95% CI 1.03–2.10. For quintile 3 compared with quintile 1 the rate 
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Figure 4.3: NE rates (per 1,000 term births) by NZDep2013 quintile (with 95% CIs) 2010–2017 
 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2017; Denominator: MAT births ≥37 weeks 2010–2017. 
 
There was also considerable variation in NE rates by DHB of residence. The rates in most DHBs were not 
statistically significantly different to the national rate of 1.20 per 1,000 term births. However, over the eight-
year reporting period 2010–2017, Waitematā DHB had a rate lower than the national average. Capital & 
Coast, Waikato and Taranaki DHBs all had rates that were higher than the national average (Figure 4.4 
and Table 4.12). Due to the statistically low frequency of cases, it was not possible to determine if there are 































Figure 4.4: NE rates (per 1,000 term births) by DHB of maternal residence* (compared with New Zealand 
NE rate) (with 95% CIs) 2010–2017 
 
* Excludes Wairarapa DHB, which had fewer than three cases. 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2017; Denominator: MAT births ≥37 weeks 2010–2017. 
 
Rates of NE varied by gestational age, with higher rates in those at 37 weeks’ gestation, and at ≥41 weeks. 
This is probably due to a number of different factors, and further case review will be required to analyse this 
in detail. There were no statistically significant differences by infant sex. Babies with lower birthweight had 
higher rates of NE, with those under 2,500g having the highest rate. While small in number, babies who 
were multiples were at higher risk than singletons (Table 4.1). Most of the twins who developed NE born 
from 37 weeks onwards were dichorionic diamniotic, with 75% being delivered by caesarean section. About 
half of the babies were the second twin to be delivered. Of the second twins who developed NE, most were 
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(/1,000 term births) 
N=450,097 n=542   
n % n % /1,000 95% CI 
Gestation at birth (weeks)       
37 31,286 7.0 61 11.3 1.95 1.49–2.50 
38 78,754 17.5 83 15.3 1.05 0.84–1.31 
39 129,059 28.7 123 22.7 0.95 0.78–1.12 
40 133,521 29.7 138 25.5 1.03 0.86–1.21 
41 67,704 15.0 122 22.5 1.80 1.48–2.12 
≥42 9,773 2.2 15 2.8 1.53 0.86–2.53 
Sex       
Male 230,113 51.1 292 53.9 1.27 1.12–1.41 
Female 219,964 48.9 250 46.1 1.14 1.00–1.28 
Undetermined/unknown 20 0.0 - - - - 
Birthweight (g)       
<2,500 8,267 1.8 23 4.2 2.78 1.76–4.17 
2,500–3,999 354,814 78.8 451 83.2 1.27 1.15–1.39 
4,000–4,499 55,660 12.4 50 9.2 0.90 0.67–1.18 
≥4,500 11,272 2.5 18 3.3 1.60 0.95–2.52 
Unknown 20,084 4.5 - - - - 
Plurality       
Singleton 442,890 98.4 530 97.8 1.20 1.09–1.30 
Multiple 5,411 1.2 12 2.2 2.22 1.15–3.87 
Unknown 1,796 0.4 - - - - 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2017; Denominator: MAT births ≥37 weeks 2010–2017. 
 
Babies of primiparous women had the highest rates of NE, being statistically significantly higher than 
women with one, two, three or four or more babies (Figure 4.5). The rate ratio for NE in babies of 
primiparous compared with multiparous women was 2.21, 95% CI 1.84–2.66. 
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Figure 4.5: NE rates (per 1,000 term births) by parity prior to index birth* 2010–2017 
 
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s NE data extract where matched to MAT data, ≥37 weeks 2010–2017; Denominator: MAT births 
≥37 weeks 2010–2017. 
 
There was variation in the rates of NE by gestational age at birth, with those at the extreme ends of term 




























Figure 4.6: NE rates (per 1,000 term births) by gestation at birth (≥37 weeks) 2010–2017 
 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2017; Denominator: MAT births ≥37 weeks 2010–2017. 
 
When examined by both parity and gestational age, the same patterns remained. Rates of NE were higher 
in babies born at 37 and 41 weeks’ gestation. Rates were elevated in primiparous women, regardless of 
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Figure 4.7: NE rates (per 1,000 term births) by parity and gestation* 2010–2017 
 
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. Excludes gestation at birth greater than 41 weeks with fewer than three cases 
among parity ≥1. Excludes 16 unknown parity among MAT births. 
Sources: Numerator: PMMRC’s NE data extract where matched to MAT data, ≥37 weeks 2010–2017; Denominator: MAT births 
≥37 weeks 2010–2017. 
 
During the study period, there were no differences in NE rates amongst babies of smoking mothers 
compared with non-smoking mothers. However, smoking is a risk factor for late stillbirth36 and small for 
gestational age37. NE rates were statistically significantly higher in babies of women who had a BMI of 35 or 
greater, compared with women with a BMI less than 25. This supports the Ministry of Health’s Guidelines 
for Consultation with Obstetric and Related Medical Services (Referral Guidelines), which state all women 
with a BMI of 35 or greater should be recommended by their LMC to have an obstetric consultation.38  
 
There was no significant variation in NE rates by baby gestation at first antenatal visit. However, it should 
be noted that 37% of mothers whose babies developed NE did not have antenatal care in the first trimester. 
This was similar to the percentage of all mothers who did not book in the first trimester (33%). The PMMRC 
has previously recommended that the Ministry of Health, DHBs and professional colleges explore barriers 
to early booking with a view to increasing the number of women who book with an LMC before 10 weeks’ 
gestation. This requires ongoing consideration and action. Consistent with the international literature, 
babies who were small for gestational age were twice as likely to have moderate to severe NE compared 
                                               
36 Cronin RS, Li M, Thompson JMD, et al. 2019. An individual participant data meta-analysis of maternal going-to-sleep position, 
interactions with fetal vulnerability, and the risk of late stillbirth. The Lancet 10: 49–57. URL: 
https://doi.org/10.1016/j.eclinm.2019.03.014 (accessed 15 August 2019).  
37 McCowan L, Horgan RP. 2009. Risk factors for small for gestational age infants. Best Practice & Research: Clinical Obstetrics & 
Gynaecology 23(6): 779–93. 
38 Ministry of Health. 2012. Guidelines for Consultation with Obstetric and Related Medical Services (Referral Guidelines). 
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with babies who were appropriate size for gestational age.39 As part of its NE prevention programme, ACC 
has funded the implementation of the Growth Assessment Protocol (GAP) in DHBs, which has occurred in 
some, but not all DHBs presently. We commend ACC on its action on this important issue, and anticipate 
the evaluation of this programme and its effectiveness once it has been established throughout 
Aotearoa/New Zealand. 
 
Babies of primiparous women make up 61% of babies with NE, and have an NE rate that is significantly 
higher than babies of multiparous women, regardless of whether they were para one, two, three, four, or 
more. While primiparous women make up 41% of the birthing population, 60% of babies with NE are born 
to primips (Table 4.2 and Figure 4.5). 
Table 4.2: Maternal smoking, BMI, gestation at first antenatal visit, customised birthweight centiles, and 






(/1,000 term births) 
N=403,616 n=469   
n % n % /1,000 95% CI 
Currently smoking       
Yes 57,615 14.3 69 14.7 1.20 0.93–1.52 
No 345,988 85.7 400 85.3 1.16 1.04–1.27 
Unknown 13 0.0 - - - - 
Maternal BMI (kg/m2)        
<18.50 11,347 2.8 6 1.3 0.53 0.19–1.15 
18.50–24.99 197,351 48.9 189 40.3 0.96 0.82–1.09 
25.00–29.99 104,354 25.9 141 30.1 1.35 1.13–1.57 
30.00–34.99 52,781 13.1 65 13.9 1.23 0.95–1.57 
35.00–39.99 23,742 5.9 43 9.2 1.81 1.31–2.44 
≥40 13,430 3.3 25 5.3 1.86 1.20–2.75 
Missing data for height and or weight 611 0.2 - - - - 
Gestation first antenatal visit (weeks)       
≤14 270,094 66.9 297 63.3 1.10 0.97–1.22 
15–27 114,963 28.5 148 31.6 1.29 1.08–1.49 
≥28 16,895 4.2 22 4.7 1.30 0.82–1.97 
Postnatal registration 1,655 0.4 <3 x s s 
Unknown 9 0.0 - - - - 
Customised birthweight centiles       
Small for gestational age 36,970 9.2 86 18.3 2.33 1.86–2.87 
Appropriate for gestational age 298,967 74.1 343 73.1 1.15 1.03–1.27 
Large for gestational age 47,571 11.8 40 8.5 0.84 0.60–1.14 
Unknown 20,108 5.0 - - - - 
Parity       
0 164,466 40.7 283 60.3 1.72 1.52–1.92 
1 137,219 34.0 104 22.2 0.76 0.61–0.90 
2 60,437 15.0 45 9.6 0.74 0.54–1.00 
3 23,086 5.7 23 4.9 1.00 0.63–1.49 
≥4 18,392 4.6 14 3.0 0.76 0.42–1.28 
Unknown 16 0.0 - - - - 
 
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
‘x’ indicates percentage suppressed due to small numbers. 
‘s’ indicates rate suppressed due to small numbers. 
BMI = body mass index. 
Sources: Numerator: PMMRC’s NE data extract where matched to MAT data, ≥37 weeks 2010–2017; Denominator: MAT births 
≥37 weeks 2010–2017. 
                                               
39 The rate ratio for small for gestational age infants compared with appropriate for gestational age infants was 2.03, 95% CI  
1.60–2.57. 
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There were a range of antenatal complications recorded for women whose babies developed NE, including 
antepartum haemorrhage and hypertension, including gestational hypertension and pre-eclampsia. Both 
primiparous and multiparous mothers of babies with NE experienced antenatal complications. The 
percentages of those affected generally followed patterns that would be expected from the birthing 
population – that is, there were lower numbers of multiparous women with pre-eclampsia compared with 
primiparous women. There were a number of women who were induced through a variety of means and 
who had epidural anaesthesia. Without denominator data – that is, without knowing the rates and use of 
these procedures during delivery of babies that did not have NE – we cannot comment on whether these 
factors indicated increased risk to babies. While most women whose babies developed NE had a good 
outcome, there were a number with an adverse outcome. Of those with an adverse outcome, 4 women died 
and 15 survived but with serious morbidity (Table 4.3). 
Table 4.3: Antenatal complications, obstetric interventions, and maternal outcome among NE cases by 
parity and Sarnat stage 2010–2017 
 
NE cases Primiparous# Multiparous+ 
Sarnat stage 
Moderate Severe 
n=542 n=318 n=224 n=375 n=167 
n % n % n % n % n % 
Antenatal complications           
Antepartum haemorrhage 
 (≥20 weeks vaginal bleeding) 
56 10.3 29 9.1 27 12.1 37 9.9 19 11.4 
Hypertension 68 12.5 48 15.1 20 8.9 52 13.9 16 9.6 
Maternal trauma (antenatal)* 12 2.2 5 1.6 7 3.1 6 1.6 6 3.6 
Induction/augmentation of labour           
Induction of labour 132 24.4 85 26.7 47 21.0 101 26.9 31 18.6 
Induced or augmented labour (any method) 254 46.9 173 54.4 81 36.2 194 51.7 60 35.9 
Oxytocin for induction or augmentation 125 23.1 91 28.6 34 15.2 99 26.4 26 15.6 
Epidural anaesthesia 142 26.2 104 32.7 38 17.0 113 30.1 29 17.4 
Maternal outcome           
Deceased or alive with serious morbidity 19 3.5 6 1.1 13 2.4 11 2.0 8 1.5 
Alive and well 523 96.5 312 57.6 211 38.9 364 67.2 159 29.3 
* Vehicular, violent personal injury, other. 
# Primiparous: parity = 0 defined prior to current birth. 
+ Multiparous: parity ≥1 defined prior to current birth. 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2017. 
 
Nearly one-quarter of babies with NE had an acute peripartum event, including abruption (7.6%) and 
shoulder dystocia (6.6%). Table 4.4 points to many antenatal and intrapartum factors that may indicate risk 
for NE for the babies. This table is not definitive in itself but provides an indication of possible areas to 
focus on in the future. 
  
 97 
Table 4.4: Peripartum complications and mode of birth among NE cases 2010–2017 
  
Total NE cases 
n=542 
n % 
Acute peripartum events 131 24.2 
Cord prolapse 18 3.3 
Abruption 41 7.6 
Uterine rupture 12 2.2 
Shoulder dystocia 36 6.6 
Breech complication 12 2.2 
Other complication 18 3.3 
Liquor   
Blood stained 46 8.5 
Thick meconium 120 22.1 
Thin meconium 71 13.1 
Mode of birth   
Normal vaginal birth 216 39.9 
Operative vaginal birth  80 14.8 
Forceps 32 5.9 
Ventouse 46 8.5 
Unknown 2 0.4 
Vaginal breech birth  10 1.8 
Caesarean section birth 236 43.5 
Elective 11 2.0 
Prelabour emergency 57 10.5 
Antepartum haemorrhage/Abruption 8 1.5 
Suspected fetal distress 41 7.6 
Other 8 1.5 
Unknown - - 
In labour emergency 168 31.0 
Antepartum haemorrhage/Abruption 14 2.6 
Suspected fetal distress 117 21.6 
Failure to progress/Cephalopelvic disproportion 17 3.1 
Other 20 3.7 
Attempt at operative vaginal birth before caesarean 16 3.0 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2017. 
 
There was some variation in rates of NE by the facility of birth (Figure 4.8 and Table 4.5). When examining 
rates of NE by the facility of birth, it is important to consider other information also. This includes where the 
intended place of birth was and, if transferred, when in the pregnancy or birthing process this occurred. 
Also important is whether the chosen facility of birth would be recommended for each particular woman and 
baby. This is the subject of a proposed research project by the Neonatal Encephalopathy Working Group. 
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Figure 4.8: NE rates (per 1,000 term births) by place of birth* (with 95% CIs) 2010–2017 
 
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s NE data extract where matched to MAT data, ≥37 weeks 2010–2017; Denominator: MAT births 
≥37 weeks 2010–2017. 
Table 4.5: NE rates (per 1,000 term births) by place of birth* 2010–2017 
Facility of 
birth 
MAT births ≥37 weeks NE cases Rate 
(/1,000 term births) N=403,616 n=469 
n % n % /1,000 95% CI 
Home 15,221 3.8 14 3.0 0.92 0.50–1.54 
Primary 43,288 10.7 38 8.1 0.88 0.62–1.20 
Secondary 173,696 43.0 213 45.4 1.23 1.06–1.39 
Tertiary 167,776 41.6 200 42.6 1.19 1.03–1.36 
Unknown 3,635 0.9 4 0.9 - - 
* All data limited to mothers who were registered for care with an LMC (either a midwife, obstetrician or GP) claiming from the 
Section 88 Primary Maternity Services Notice. 
Sources: Numerator: PMMRC’s NE data extract where matched to MAT data, ≥37 weeks 2010–2017; Denominator: MAT births 
≥37 weeks 2010–2017. 
 
Neonatal wellbeing just after birth, measured by Apgar scores, was consistently poor at 1 minute. In those 
babies with moderate to severe NE, 76.6% had an Apgar score less than 7 at five minutes. The percentage 
of babies who had cord blood gases recorded has fluctuated over the years. However, of note in 2017, 
22% of babies who went on to develop NE did not have cord blood gases recorded. Of all babies who 































Table 4.6: Immediate newborn wellbeing among NE babies 2010–2017 
  
2010 2011 2012 2013 2014 2015 2016 2017 Total 
n=82 n=67 n=79 n=70 n=55 n=70 n=56 n=63 n=542 
n % n % n % n % n % n % n % n % n % 
Apgar scores                   
Apgar score <3 at 1 minute 48 58.5 41 61.2 47 59.5 40 57.1 37 67.3 39 55.7 37 66.1 36 57.1 325 60.0 
Apgar score <5 at 1 minute 65 79.3 54 80.6 62 78.5 58 82.9 49 89.1 51 72.9 48 85.7 50 79.4 437 80.6 
Apgar score <7 at 1 minute 73 89.0 61 91.0 70 88.6 65 92.9 53 96.4 59 84.3 51 91.1 56 88.9 488 90.0 
Apgar score <7 at 5 minutes 61 74.4 54 80.6 62 78.5 57 81.4 43 78.2 50 71.4 46 82.1 42 66.7 415 76.6 
Apgar score <7 at 10 minutes 39 47.6 38 56.7 49 62.0 32 45.7 29 52.7 35 50.0 33 58.9 29 46.0 284 52.4 
Apgar score <9 at 10 minutes 52 63.4 52 77.6 62 78.5 52 74.3 45 81.8 48 68.6 44 78.6 41 65.1 396 73.1 
Cord blood gases: summary data                   
Normal (none of pH ≤7, BE ≤−12, lactate ≥6) 12 14.6 14 20.9 11 13.9 13 18.6 7 12.7 8 11.4 6 10.7 10 15.9 81 14.9 
Abnormal (any of pH ≤7, BE ≤−12, lactate ≥6) 47 57.3 41 61.2 55 69.6 48 68.6 40 72.7 47 67.1 42 75.0 39 61.9 359 66.2 
No gases reported 23 28.0 12 17.9 13 16.5 9 12.9 8 14.5 15 21.4 8 14.3 14 22.2 102 18.8 
No gases and Apgar <7 at 1 minute 14 17.1 8 11.9 8 10.1 6 8.6 8 14.5 6 8.6 6 10.7 10 15.9 66 12.2 
No gases and Apgar ≥7 at 1 minute 8 9.8 4 6.0 5 6.3 3 4.3 - - 9 12.9 <3 x 3 4.8 34 6.3 
No gases and unknown Apgar <3 x - - - - - - - - - - - - <3 x <3 x 
BE = base excess. 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2017. 
Table 4.7: Induced cooling therapy among NE babies 2010–2017 
Cooling 
2010 2011 2012 2013 2014 2015 2016 2017 Total 
n=82 n=67 n=79 n=70 n=55 n=70 n=56 n=63 n=542 
n % n % n % n % n % n % n % n % n % 
Yes 56 68.3 51 76.1 62 78.5 58 82.9 45 81.8 56 80.0 44 78.6 43 68.3 415 76.6 
No 26 31.7 16 23.9 17 21.5 12 17.1 10 18.2 14 20.0 12 21.4 20 31.7 127 23.4 
Age at cooling n=56 n=51 n=62 n=58 n=45 n=56 n=44 n=43 n=415 
≤6 hours 46 82.1 39 76.5 53 85.5 47 81.0 39 86.7 44 78.6 34 77.3 36 83.7 338 81.4 
>6 hours 10 17.9 8 15.7 9 14.5 11 19.0 6 13.3 11 19.6 10 22.7 7 16.3 72 17.3 
Unknown time - - 4 7.8 - - - - - - <3 x - - - - 5 1.2 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2017. 
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Table 4.7 reports on cooling therapy in babies with NE by year of birth. There was a slight reduction in the 
number and percentage of babies who were cooled in 2017 compared with previous years, with 20 babies 
who were not cooled. Of these, 8 had severe and 12 had moderate NE. Of those with severe NE, most 
babies died on the day of birth. The babies who had moderate NE who were not cooled usually either 
presented late or were not recognised within the 6-hour period. Of the seven babies in 2017 who were 
cooled starting at more than 6 hours after birth, all were born in a secondary unit and transferred to a 
tertiary unit. Some were cooled passively before this time (data not shown). 
 
The majority of babies with NE were resuscitated at birth (92%). Resuscitation ranged from giving oxygen 
only, through to cardiac massage, and adrenaline. A small percentage of babies had a positive blood 
culture. Over 70% of babies were given anticonvulsants (Table 4.8). 






n=542 n=375 n=167 
n  % n % n % 
Resuscitation at birth             
Yes 498 91.9 343 91.5 155 92.8 
No 44 8.1 32 8.5 12 7.2 
Type of resuscitation at birth*       
Oxygen only 8 1.5 7 1.9 <3 x 
IPPV with mask 357 65.9 256 68.3 101 60.5 
IPPV with ETT 285 52.6 166 44.3 119 71.3 
Cardiac massage 215 39.7 110 29.3 105 62.9 
Adrenaline 87 16.1 28 7.5 59 35.3 
Respiratory and ventilation management      
Mechanical ventilation 422 77.9 274 73.1 148 88.6 
Nitric oxide 125 23.1 77 20.5 48 28.7 
Infection       
Positive blood culture 21 3.9 16 4.3 5 3.0 
Antibiotics 488 90.0 349 93.1 139 83.2 
Anticonvulsant therapy 384 70.8 261 69.6 123 73.7 
Phenobarbitone 342 63.1 225 60.0 117 70.1 
Phenytoin 114 21.0 59 15.7 55 32.9 
Benzodiazepines 136 25.1 85 22.7 51 30.5 
Other 71 13.1 52 13.9 19 11.4 
* Categories not mutually exclusive. 
IPPV = intermittent positive pressure ventilation. 
ETT = endotracheal tube. 
‘x’ indicates percentage supressed due to small numbers. 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2017. 
 
 
Overall, 77% of babies were cooled, with a slightly higher proportion of babies with moderate NE being 
cooled. The rates of cooling were the same for babies of Māori mothers as for New Zealand European 
mothers. Mortality was much higher in babies with severe NE, with 61% of babies dying, compared with 2% 
of babies with moderate NE (Table 4.9). 
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Table 4.9: Use of cooling and outcomes of encephalopathy by Sarnat stage among NE babies 2010–2017 
  
    Sarnat stage 
NE babies Moderate Severe 
n=542 n=375 n=167 
n % n % n % 
Induced cooling       
Yes 415 76.6 298 79.5 117 70.1 
No 127 23.4 77 20.5 50 29.9 
Deceased       
Yes 108 19.9 7 1.9 101 60.5 
No 434 80.1 368 98.1 66 39.5 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2017. 
 
 
Of those babies with NE who survived, nearly half of those with moderate NE had a normal physical 
examination on discharge or transfer, compared with 15% of those with severe NE. Nearly all babies (97%) 
with severe NE had an MRI prior to discharge (Table 4.10). The PMMRC has previously recommended that 
all babies with moderate and severe NE should receive an MRI scan.40 
Table 4.10: Investigations and neonatal outcome by Sarnat stage of NE survivors 2010–2017 
Investigations 
Total NE survivors 
Sarnat stage 
Moderate Severe 
n=434 n=368 n=66 
n % n % N % 
Examination on discharge/transfer       
Normal 193 44.5 183 49.7 10 15.2 
Mild or moderate abnormality 150 34.6 126 34.2 24 36.4 
Severe abnormality 30 6.9 6 1.6 24 36.4 
Not examined 22 5.1 19 5.2 3 4.5 
Examined but finding unknown 17 3.9 13 3.5 4 6.1 
Missing data 22 5.1 21 5.7 <3 x 
MRI (investigation done) 334 77.0 270 73.4 64 97.0 
No MRI or Unknown 100 23.0 98 26.6 <3 x 
Results of MRI       
Moderately/Severely abnormal 123 28.3 81 22.0 42 63.6 
Normal or only mildly abnormal 205 47.2 184 50.0 21 31.8 
Unknown result 6 1.4 5 1.4 <3 x 
MRI = magnetic resonance imaging (of the brain). 
‘x’ indicates percentage suppressed due to small numbers. 
Source: PMMRC’s NE data extract ≥37 weeks 2010–2017. 
                                               
40 PMMRC. 2013. Seventh Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2011. 
URL: https://www.hqsc.govt.nz/assets/PMMRC/Publications/Seventh-PMMRC-Report-FINAL-June-2013.pdf (accessed 
2 September 2019). 
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Neonatal encephalopathy appended tables 







(/1,000 term births) 
N=450,097* n=542   
n % n % /1,000 95% CI 
Prioritised ethnic group (mother)       
Māori 112,614 25.0 144 26.6 1.28 1.07–1.49 
Pacific peoples 48,467 10.8 73 13.5 1.51 1.18–1.89 
Asian 65,599 14.6 67 12.4 1.02 0.79–1.30 
Indian 20,367 4.5 30 5.5 1.47 0.99–2.10 
Other Asian 45,232 10.0 37 6.8 0.82 0.58–1.13 
MELAA 10,006 2.2 9 1.7 0.90 0.41–1.71 
European 213,391 47.4 249 45.9 1.17 1.02–1.31 
NZ European 169,638 37.7 217 40.0 1.28 1.11–1.45 
Other European 43,753 9.7 32 5.9 0.73 0.50–1.03 
Other - - - - - - 
Maternal age (years)       
<20 24,099 5.4 34 6.3 1.41 0.98–1.97 
20–34 331,714 73.7 405 74.7 1.22 1.10–1.34 
35–39 75,935 16.9 84 15.5 1.11 0.88–1.37 
≥40 18,326 4.1 19 3.5 1.04 0.62–1.62 
Unknown 23 0.0 - - - - 
NZDep2013 quintile       
1 (least deprived) 64,296 14.3 49 9.0 0.76 0.56–1.01 
2 70,481 15.7 79 14.6 1.12 0.89–1.40 
3 82,352 18.3 101 18.6 1.23 0.99–1.47 
4 102,499 22.8 144 26.6 1.40 1.18–1.63 
5 (most deprived) 127,616 28.4 169 31.2 1.32 1.12–1.52 
Unknown 2,853 0.6 - - - - 
* Includes 20 unknown maternal ethnicity among MAT births. 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2017; Denominator: MAT births ≥37 weeks 2010–2017. 
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Table 4.12: NE rates (per 1,000 term births) by DHB of maternal residence 2010–2017 




NE cases# Rate 
(/1,000 term births) 
N=446,356 n=540 
n n /1,000 95% CI 
Northland 16,761 15 0.89 0.50–1.48 
Waitematā 58,451 50 0.86 0.63–1.13 
Auckland 46,677 44 0.94 0.68–1.27 
Counties Manukau 62,332 68 1.09 0.85–1.38 
Waikato 39,694 67 1.69 1.31–2.14 
Bay of Plenty 21,480 29 1.35 0.90–1.94 
Lakes 11,317 15 1.33 0.74–2.19 
Hauora Tairāwhiti 5,384 7 1.30 0.52–2.68 
Taranaki 11,272 22 1.95 1.22–2.95 
Hawke’s Bay 15,851 21 1.32 0.82–2.03 
Whanganui 6,203 12 1.93 1.00–3.38 
MidCentral 15,910 16 1.01 0.57–1.63 
Capital & Coast 27,198 48 1.76 1.30–2.34 
Hutt Valley 14,631 22 1.50 0.94–2.28 
Nelson Marlborough 11,427 15 1.31 0.73–2.17 
West Coast 2,741 6 2.19 0.80–4.76 
Canterbury 45,775 47 1.03 0.75–1.37 
South Canterbury 4,806 11 2.29 1.14–4.10 
Southern 25,824 25 0.97 0.63–1.43 
Other* 2,622 - - - 
* Other includes Overseas, Unknown and Other. 
# Wairarapa DHB excluded from this table (numerator and denominator) as there were <3 cases for the time period. 
Sources: Numerator: PMMRC’s NE data extract ≥37 weeks 2010–2017; Denominator: MAT births ≥37 weeks 2010–2017. 
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Neonatal encephalopathy appendix: Review of previous recommendations 
 
10. The PMMRC recommends that DHBs with 
rates of NE significantly higher than the 
national rate review, or continue to review, the 
higher rate of NE in their area and identify 
areas for improvement. 
Taranaki DHB acknowledges that their DHB rate 
of NE (2.71/1,000 term births) for the 2012–2016 
period is significantly higher than the national rate 
(1.19/1,000 term births). Taranaki DHB note that 
the year-by-year numbers are small, so it is difficult 
to generalise. There was an increased rate of NE 
cases in 2012, which is likely responsible for 
Taranaki DHB’s overall findings. All cases of NE 
are captured by the Taranaki DHB maternity 
obstetric outcomes protocol in which a key 
indicator for review is unexpected admission to the 
Neonatal Unit. Any actions or quality improvements 
identified are entered onto a work plan to ensure 
these are completed. Taranaki DHB has also 
adopted the Health Quality & Safety Commission’s 
guidance for SAC rating and reporting of maternity 
cases, which includes NE. 
Capital & Coast DHB continues to review each 
case of NE, looking for recurring themes that can 
be addressed. Communication workshops for 
senior medical officers and senior midwives to 
address culture/supervision issues have taken 
place. 
Education is supporting best practice. 
• Weekly multidisciplinary CTG (cardiotocograph) 
education sessions are in place. 
• All employed midwives and obstetricians are 
required to attend our mandatory Fetal 
Surveillance Education Programme. 
• There is no cost for LMCs to attend the Fetal 
Surveillance Education Programme at Capital & 
Coast DHB. 
Staffing is a challenge, and monitoring and 
systems around safe staffing are in place and 





5 Te mate o ngā whaea | Maternal mortality 
Definitions 
Maternal death is the death of a woman while pregnant or within 42 days of termination of pregnancy 
(miscarriage, termination or birth), irrespective of the duration and site of the pregnancy, from any cause 
related to or aggravated by the pregnancy or its management, but not from accidental or incidental 
causes.41 
The cause of maternal death is sub-classified into the following categories based on The WHO 
Application of ICD-10 to Deaths during Pregnancy, Childbirth and Puerperium: ICD MM.42 
• Direct maternal deaths: those resulting from obstetric complications of the pregnant state
(pregnancy, labour or puerperium) from interventions, omissions, incorrect treatment or from a chain
of events resulting from the above. In 2018, the PMMRC adopted the World Health Organization
(WHO) revision to include deaths by suicide with direct maternal deaths. This was then applied
retrospectively to data from previous years.
• Indirect maternal deaths: those resulting from previous existing disease or disease that developed
during pregnancy and was not due to direct obstetric causes but that was aggravated by the
physiologic effects of pregnancy.
• Unknown/Undetermined (or Unclassifiable) maternal death is a death during pregnancy,
childbirth and the puerperium where the underlying cause is unknown or was not determined.
• Coincidental maternal deaths: deaths from unrelated causes that happen to occur in pregnancy or
the puerperium.
Findings 
The number of maternal deaths has fluctuated substantially over the time period 2006–2017, with a range 
from 3.30 deaths per 100,000 to 24.40 deaths per 100,000 maternities. There is some evidence43 of a 
reduction in the total number of maternal deaths over the time period (Figure 5.1 and Table 5.1). 
41 World Health Organization. (nd). Maternal mortality ratio (per 100 000 live births). URL: 
https://www.who.int/healthinfo/statistics/indmaternalmortality/en/ (accessed 16 August 2019). 
42 World Health Organization. 2012. The WHO Application of ICD-10 to deaths during pregnancy, childbirth and the puerperium: 
ICD-MM. URL: 
https://apps.who.int/iris/bitstream/handle/10665/70929/9789241548458_eng.pdf;jsessionid=CC029155D5B4A0E7BB4AE0129A0A
6CEB?sequence=1 (accessed 16 August 2019). 
43 Chi-squared test for trend in proportions p=0.044. 
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Figure 5.1: Maternal mortality ratios (per 100,000 maternities) (rolling one-year and three-year)* 2006–2017 
 
* Rolling three-year maternal mortality ratio represented at final year of triennium. 
MMR = maternal mortality ratio. 
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Table 5.1: Single-year and three-year rolling maternal mortality ratios (per 100,000 maternities) 2006–2017 
  




             Cause-specific ratio 
n n n n n n n n n n n n n % /100,000 maternities 
Total maternal deaths 15 11 9 14 9 9 10 13 4 11 <3 9 116 100.0 15.46 
0.044 
Single-year MMR 24.40 16.87 13.71 21.47 13.75 14.23 15.80 21.62 6.66 18.40 s 14.89 - - - 
Three-year rolling MMR 
- - 06–08 07–09 08–10 09–11 10–12 11–13 12–14 13–15 14–16 15–17 - - - 
- - 18.20 17.34 16.30 16.50 14.59 17.14 14.71 15.56 9.42 12.17 - - - 
MMR = maternal mortality ratio. 
‘s’ indicates rate not calculated due to small numbers. 
Sources: Numerator: PMMRC’s maternal mortality data extract 2006–2017; Denominator: MAT data 2006–2017. 
 
Substantial gains have been made in the rate of maternal death since the 1970s. Figure 5.2 shows the maternal mortality ratio over time, and by the different 
data sources that were available at various time periods. As well as an overall reduction in deaths over time, this figure shows that in the past, routine data 
sets are unlikely to have detected all maternal deaths, and there is now much better case ascertainment with active review of cases. 
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MMR = maternal mortality ratio. 
MDAC = Maternal Deaths Assessment Committee. 
Sources:  
MMR: MDAC: Data from the MDAC, including maternal deaths to three months postpartum. 
MMR: routine sources: Data from routine New Zealand data sets (ie, the Births, Deaths and Marriages (BDM) Mortality Collection 
and the National Minimum Dataset), including maternal deaths to six weeks postpartum. 
MMR: PMMRC: PMMRC’s maternal mortality data extract 2006–2017, including maternal deaths to six weeks postpartum; 
Denominator: MAT data 2006–2017. 
 
The incidence of maternal death increased with age, with those aged 40 years and over having the highest 
rate (42.21 per 100,000 maternities). When examined by prioritised ethnic group, Māori and Pacific women 
had the highest rates, with 23.38 and 23.88 deaths per 100,000 maternities respectively. Women residing 
in the most deprived areas (NZDep2013 quintile 5) had the highest rate of mortality; there was some 
evidence of a statistically significant association between risk of death and increasing deprivation, as 
measured by NZDep2013 quintile (p=0.02).  
 
Parity was unknown in 63,000 women over this time period, therefore it is not possible to comment on 
parity and the association with maternal death. This is largely due to a technical issue in the MAT data set. 
The Ministry of Health needs to urgently address this issue. It is recognised that high maternal BMI is 
associated with adverse outcomes for both the mother44 and baby.45 However, again, there were 
substantial amounts of missing data, with nearly 166,000 records (22%) with either height or weight 
                                               
44 McCall SJ, Li Z, Kurinczuk JJ, et al. 2017. Binational cohort study comparing the management and outcomes of pregnant women 
with a BMI >50–59.9 kg/m2 and those with a BMI ≥60 kg/m2. British Medical Journal Open 8:e021055. doi:10.1136/bmjopen-2017-
021055.  
45 PMMRC. 2018. Twelfth Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2016. 
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incomplete. Given the significance of body size as a risk factor, it is of concern that information on height 
and weight is not consistently collected (Table 5.2). 












n % n % 
/100,000 
maternities 
Maternal age (years)         
<20 46,684 6.2 6 5.2 12.85 4.72–27.97 1.04 0.43–2.51 
20–24 132,895 17.7 16 13.8 12.04 6.88–19.55 0.97 0.52–1.80 
25–29 192,288 25.6 31 26.7 16.12 10.95–22.88 1.30 0.78–2.18 
30–34 217,643 29.0 27 23.3 12.41 8.18–18.05 1.00 - 
35–39 129,941 17.3 23 19.8 17.70 11.22–26.56 1.43 0.82–2.49 
≥40 30,798 4.1 13 11.2 42.21 22.48–72.18 3.40 1.76–6.59 
Unknown 274 0.0 - - - - - - 
Prioritised ethnic group (mother)         
Māori 192,462 25.6 45 38.8 23.38 17.05–31.29 1.90 1.22–2.94 
Pacific peoples 83,742 11.2 20 17.2 23.88 14.59–36.89 1.94 1.12–3.35 
Asian 94,855 12.6 12 10.3 12.65 6.54–22.10     
Indian 29,841 4.0 4 3.4 13.40 3.65–34.32 1.09 0.39–3.05 
Other Asian 65,014 8.7 8 6.9 12.31 5.31–24.25 1.00 0.46–2.15 
MELAA 15,170 2.0 - - - - - - 
European 363,827 48.5 39 33.6 10.72 7.62–14.65     
NZ European 291,963 38.9 36 31.0 12.33 8.64–17.07 1.00 0.63–1.59 
Other European 71,864 9.6 3 2.6 4.17 0.86–12.20 0.34 0.10–1.10 
Other - - - - - - -   - 
Unknown 467 0.1 - - - -  -  - 
NZDep2013 quintile         
1 (least deprived) 105,602 14.1 11 9.5 10.42 5.20–18.64 1.00 - 
2 114,379 15.2 11 9.5 9.62 4.80–17.21 0.92 0.40–2.13 
3 136,046 18.1 23 19.8 16.91 10.72–25.37 1.62 0.79–3.33 
4 172,442 23.0 31 26.7 17.98 12.21–25.52 1.73 0.87–3.43 
5 (most deprived) 215,196 28.7 40 34.5 18.59 13.28–25.31 1.78 0.92–3.48 
Unknown 6,858 0.9 - - - - - - 
Parity*         
0 272,435 36.3 31 26.7     
1–3 377,774 50.3 57 49.1     
4+ 36,893 4.9 25 21.6     
Unknown 63,421 8.5 3 2.6     
Maternal BMI (kg/m2)#         
<18.50 16,271 2.2 3 2.6     
18.50–24.99 284,596 37.9 39 33.6     
25.00–29.99 151,031 20.1 20 17.2     
30.00–34.99 77,165 10.3 23 19.8     
35.00–39.99 35,054 4.7 15 12.9     
≥40 20,414 2.7 12 10.3     
Missing data for height and or weight 165,992 22.1 4 3.4     
* Mortality rates by parity not calculated as denominator data unreliable. 
# Mortality rates by BMI not calculated as denominator data unreliable. 
BMI = body mass index. 
MELAA = Middle Eastern, Latin American, or African. 
Sources: Numerator: PMMRC’s maternal mortality data extract 2006–2017; Denominator: MAT data 2006–2017. 
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When examined by prioritised ethnicity, Māori women, until recently, had higher mortality rates than New 
Zealand European women. However, over the past four years their mortality rate has reduced and is 
currently similar to that for New Zealand European women. Over the time period 2006–2017 there is some 
evidence of a statistically significant reduction in deaths for wāhine Māori (p=0.04). There has been no 
change in the mortality rate for New Zealand European women over this time (Figure 5.3). 
Figure 5.3: Maternal three-year rolling mortality ratios (per 100,000 maternities) by prioritised ethnic group 
(Māori and New Zealand European) and year 2006–2017 
Sources: Numerator: PMMRC’s maternal mortality data extract 2006–2017; Denominator: MAT data 2006–2017. 
Table 5.3: Maternal mortality ratios (per 100,000 maternities) and cause of maternal death 2006–2017 
2006–2017 
n=116 Cause-specific ratio 
n % /100,000 maternities 
Maternities 750,523 
Direct maternal death 66 56.9 8.79 
Suicide 30 25.9 4.00 
Pregnancies with abortive outcome (ectopic and miscarriage)* 3 2.6 0.40 
Hypertensive disorders 4 3.4 0.53 
Obstetric haemorrhage 3 2.6 0.40 
Pregnancy-related infection 6 5.2 0.80 
Other obstetric complications 20 17.2 2.66 
Amniotic fluid embolism 13 11.2 1.73 
Venous thrombo-embolism 6 5.2 0.80 
Other obstetric complications <3 x s 
Indirect maternal death 44 37.9 5.86 
Cardiac 11 9.5 1.47 
Neurological 13 11.2 1.73 
Infections not a direct result of pregnancy 8 6.9 1.07 
Other non-obstetric complications 12 10.3 1.60 
Unknown/undetermined 6 5.2 0.80 
* This is the WHO category that includes first trimester pregnancy complications such as miscarriages and ectopic pregnancy.
Excludes 22 coincidental maternal deaths. 
‘x’ indicates percentage suppressed due to small numbers. 
‘s’ indicates rate suppressed due to small numbers. 
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There were 66 direct maternal and 44 indirect maternal deaths over the 12-year study period 2006–2017 
inclusive. The single largest cause of maternal death in Aotearoa/New Zealand is suicide, with 30 deaths 
during this time (45%). The next leading causes were amniotic fluid embolism and neurological conditions, 
which caused 13 deaths (11.2%) each (Table 5.3). While there were only three deaths due to ectopic 
pregnancy, these are highly preventable deaths. Suicide deaths particularly affect wāhine Māori, with both 
the largest number of deaths and the highest rate, compared with other ethnic groups. Wāhine Māori were 
3.41 times more likely to die by suicide than New Zealand European women (Table 5.4). 
Table 5.4: Maternal suicide by prioritised ethnic group* 2006–2017 
Ethnicity (prioritised) N n Rate Rate ratio 95% CI 
Māori 192,462 18 9.35 3.41 1.48–7.85 
NZ European 291,963 8 2.74 1.00 - 
* Excludes four cases that were in Pacific and ‘Other Asian’ ethnic groups. There were no deaths due to suicide in Indian; Middle 
Eastern, Latin American, or African (MELAA); Other European; or other ethnic groups. 
Sources: Numerator: PMMRC’s maternal mortality data extract 2006–2017; Denominator: MAT data 2006–2017. 
 
Figure 5.4 shows that rates of maternal death in Aotearoa/New Zealand compared with the United Kingdom 
(UK) are generally higher, with a statistically significantly higher rate of direct deaths. For most individual 
causes there were no statistically significant differences between rates in Aotearoa/New Zealand with the 
UK, except for suicide, where the New Zealand rate was substantially higher. 
 
Given that suicide is the leading cause of maternal death, it is imperative that comprehensive action is 
taken. There are currently screening guidelines during the antenatal and postnatal period; however, their 
use is variable. Difficulties arise when mild to moderate illness is diagnosed, as maternal mental health 
service provision is variable within Aotearoa/New Zealand, with particularly limited resources for women 
with mild to moderate illness. 
 
We have identified that wāhine Māori are a group at high risk, and warrant routine screening. The 
Edinburgh Postnatal Depression Scale has been used widely across many different cultures and found to 
have good validity across cultures.46 However, this tool has never specifically been validated for Māori, and 
it has been shown that different cultural groups within Aotearoa/New Zealand may require different cut-offs 
to adequately detect women who require intervention.47 While both suicide prevention and mental well-
being are topical currently, there has not been any governmental budget provided specifically to reduce 
maternal suicide deaths. There has been only limited investment in maternal well-being – for example, 
there is inadequate provision of mother–baby units. Our findings show there is an urgent need for 
investment in this area, in the areas of prevention, developing appropriate screening tools and treatment for 
women and their babies. A previous review of maternal suicide in wāhine Māori made a number of 
recommendations around early recognition of risk factors, comprehensive assessment and active follow-
up.48 (See also ‘Practice point: Psychosocial health and maternal suicide’.) 
 
                                               
46 Di Florio A, Putnam K, Altemus M, et al. 2017. The impact of education, country, race and ethnicity on the self-report of 
postpartum depression using the Edinburgh Postnatal Depression Scale. Psychological Medicine 47(5): 787–99. 
47 Ekeroma AJ, Ikenasio-Thorpe B, Weeks S, et al. 2012. Validation of the Edinburgh Postnatal Depression Scale (EPDS) as a 
screening tool for postnatal depression in Samoan and Tongan women living in New Zealand. New Zealand Medical Journal 
125(1355): 41–50. 
48 PMMRC. 2017. Eleventh Annual Report of the Perinatal and Maternal Mortality Review Committee: Reporting mortality 2015. 
URL: https://www.hqsc.govt.nz/assets/PMMRC/Publications/2017_PMMRC_Eleventh_Annual_Report.pdf (accessed 12 August 
2019). 
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‘s’ indicates rate not calculated due to small numbers.  
AFE = amniotic fluid embolism. 
MMR = maternal mortality ratio. 
VTE = venous thromboembolism. 
‘Other direct’ includes cardiomyopathy. 
‘Other indirect’ includes endocrine, respiratory, neoplasm, other pre-existing medical. 
‘Coincidental’ includes motor vehicle accident, external causes of accidental injury, assault, malignancy not related to pregnancy. 
The shaded bars represent total of direct, indirect, unclassifiable and coincidental deaths. 
Sources: 
• NZ MMR: Numerator: PMMRC’s maternal mortality data extract 2011–2017; Denominator: MAT data 2011–2017. 
• UK MMR: Numerator: Maternal Deaths and Morbidity, includes surveillance data on women who died during or up to one year after pregnancy 2011–2016 in the UK. 
• UK MMR: Denominator: The number of pregnancies that result in a live birth at any gestation or stillbirths occurring at or after 24 completed weeks of gestation, supplied by organisations 
such as the Office for National Statistics, the General Register Office for Scotland, Northern Ireland Statistics and Research Agency, and Hospital Episode Statistics 2011–2016. 
• UK MMR: Mothers and Babies: Reducing Risk through Audits and Confidential Enquiries across the UK (MBRRACE-UK). 2018. Saving Lives, Improving Mothers Care: Lessons learned to 
inform maternity care from the UK and Ireland Confidential Enquiries into Maternal Deaths and Morbidity 2014–16. URL: https://www.npeu.ox.ac.uk/downloads/files/mbrrace-
uk/reports/MBRRACE-UK%20Maternal%20Report%202018%20-%20Web%20Version.pdf (accessed 16 August 2019). 
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Practice point: Psychosocial health and maternal suicide 
Pregnancy and the postpartum period are not protective against mental illness, and can be a trigger for onset and for 
deterioration of mental illness. 
Suicide is a leading cause of maternal mortality, with Māori women and young women (<20 years old) over-represented among 
maternal suicides. 
Psychosocial health screening 
Early during a woman’s contact with health services, including request for termination of pregnancy, a comprehensive 
assessment of her psychosocial health and risk factors should be undertaken. This will involve identifying: 
• her current social situation, including relationship with partner/ex-partner, whānau supports, and social stressors such as 
financial issues, housing, whether their other children are in care of other people, and phone and transport availability 
• any previous and current experience of family violence, sexual abuse and assault 
• a history of termination of pregnancy or miscarriage in the previous 12 months 
• any past or present mental illness, including self-harm and previous suicide attempts, use of alcohol and other drugs 
• any past or present treatment by a specialist mental health service, including inpatient care 
• a family history of severe mental illness, including perinatal mental illness or suicide in a close relative. 
Pregnant and postpartum women who use substances often have complex social and mental health needs, and face additional 
barriers in accessing services. 
Communication 
All clinicians involved in a woman’s care need relevant mental health history and current knowledge of a woman’s pregnancy to 
support them to provide the best care. Routine sharing of relevant information across general practice, LMC, maternity and 
mental health service interfaces will enable better-informed care, and any concerns regarding risk need to be clearly 
communicated to all clinicians involved. 
Care provision 
Women who have a history of severe mental illness (eg, severe depression/bipolar disorder/psychosis) should be referred to a 
secondary mental health service even if currently well, as their risk of relapse in the postpartum period may be high. They need 
an appropriate mental health birth plan and monitoring for the peripartum period, with advice around avoiding sleep deprivation. 
Mental health medications should not be stopped without review by a doctor and risk–benefit analysis. Consultation 
with a perinatal psychiatrist should be considered. 
Women should have continuity of, and culturally appropriate, mental health care. During pregnancy and the postpartum period 
there may be more than one mental health team involved – in such cases there should be one identified individual who 
coordinates care. 
Doctors who refer women for termination of pregnancy should actively follow-up these women to ensure they have their free 
post-termination of pregnancy check, which should specifically include assessment of mental health status. 
Acute mental health episodes 
Any of the following identified at any time suggests a serious mental illness and requires urgent (same day) assessment by 
mental health services, including early consultant psychiatrist review and consultation with perinatal mental health services: 
• suicidal ideation (new or increasing thoughts) and/or thoughts to harm baby or others 
• suicide attempts 
• psychotic symptoms 
• recent significant change in mental state including fluctuating or emergence of new symptoms 
• pervasive guilt or hopelessness 
• ongoing beliefs of inadequacy as a mother 
• a sense of estrangement or disconnection from the infant. 
Following recovery 
It is the responsibility of the treating team to ensure that all women experiencing postpartum psychosis or other severe 
postpartum mental illness receive a clear explanation of: 
• future risk 
• the availability of risk minimisation strategies including pre-pregnancy consultations prior to subsequent pregnancies 
• the need for re-referral during subsequent pregnancies. 
The GP should also be notified of risk, risk minimisation strategies and of any subsequent pregnancies. 
Partners, family, whānau and other support people require explanation and education regarding maternal mental illness and its 
accompanying risks. 
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Maternal mortality appendix: Update on maternal mortality recommendations 
 
13. The PMMRC recommends that a Maternal and 
Infant Mental Health Network is funded by the 
Ministry of Health and that the network then 
determine an achievable work stream by the 
end of 2018 detailing work to be completed by 
the end of 2020, to include as potential areas of 
priority: 
a. a stocktake of current mental health 
services available across New Zealand for 
pregnant and recently pregnant women to 
identify both the strengths of services and 
gaps or inequity in current services and 
skills in the workforce 
b. a national pathway for accessing maternal 
mental health services, including: 
i. cultural appropriateness to ensure 
service access and provision 
ii. appropriate screening 
iii. care for women with a history of mental 
illness 
iv. communication and coordination. 
The Ministry of Health is currently planning the 
implementation of the Government’s response to 
He Ara Oranga and the Wellbeing Budget 2019, of 
which mental health and addiction is a priority area. 
While there is no specific recommendation for 
maternal and infant mental health services, the 
underlying message of the report is one of 
expanding access and choice, investing in 
workforce development and placing people at the 
centre. In order to achieve this vision, significant 
stakeholder engagement and sector co-design is 
required, and the Ministry of Health welcomes the 
PMMRC’s participation in this work. Some of the 
mental wellbeing initiatives the Ministry of Health 
will be implementing include: 
• funding to co-design approaches to meet the 
needs of local communities 
• funding to extend the pregnancy and parenting 
service 
• the development of an enhanced support pilot 
for parents and whānau with mental wellbeing 
needs during pregnancy for the first years of a 
child’s life or following a stillbirth 
• $30 million over four years for primary maternity 
services to increase the fees paid to LMCs 
• $4.3 million paid over four years to increase the 
Pacific nursing and midwifery workforce and to 
offer wrap-around support for Pacific nursing 
and midwifery students 
• $67 million over four years for primary health 
care to cover increasing costs and demands for 




Ngā whakarāpopoto | Abbreviations 
ACC Accident Compensation Corporation 
AFE Amniotic fluid embolism 
APH Antepartum haemorrhage 
BE Base excess 
βhCG Beta human chorionic gonadotropin 
BMI Body mass index (kg/m2) 
CI Confidence interval 
CTG Cardiotocograph 
DHB District health board 
ETT Endotracheal tube 
GAP Growth Assessment Protocol 
GP General practitioner 
IPPV Intermittent positive pressure ventilation 
LMC Lead maternity carer 
MAT National Maternity Collection 
MDAC Maternal Deaths Assessment Committee 
MELAA Middle Eastern, Latin American, or African 
MIHI  Māori Indigenous Health Institute 
MMR Maternal mortality ratio 
MQSP Maternity Quality and Safety Programme 
MRI Magnetic resonance imaging 
NE Neonatal encephalopathy 
NMDS  National Minimum Dataset 
NZCOM New Zealand College of Midwives 
NZDep2013 New Zealand Index of Deprivation 2013 
PMMRC Perinatal and Maternal Mortality Review Committee 
PSANZ  Perinatal Society of Australia and New Zealand 
PSANZ-NDC  PSANZ neonatal death classification 
PSANZ-PDC  PSANZ perinatal death classification 
PUL pregnancy of unknown location 
RANZCOG Royal Australian and New Zealand College of Obstetricians and Gynaecologists 
SAC Severity Assessment Code 
SIDS Sudden infant death syndrome 
SUDI Sudden unexpected death in infancy 
UK United Kingdom 
VTE Venous thromboembolism 
WHO World Health Organization 
 
